Home Carboxys 7-[(4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

7-[(4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

CAS No.:
151096-09-2
Catalog Number:
AG001N37
Molecular Formula:
C21H24FN3O4
Molecular Weight:
401.4314
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
98%
In Stock USA
United States
$25
- +
5g
98%
In Stock USA
United States
$63
- +
25g
98%
In Stock USA
United States
$188
- +
100g
98%
In Stock USA
United States
$394
- +
Product Description
Catalog Number:
AG001N37
Chemical Name:
7-[(4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
CAS Number:
151096-09-2
Molecular Formula:
C21H24FN3O4
Molecular Weight:
401.4314
MDL Number:
MFCD04117996
IUPAC Name:
7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid
InChI:
InChI=1S/C21H24FN3O4/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28)/t11-,16+/m0/s1
InChI Key:
FABPRXSRWADJSP-MEDUHNTESA-N
SMILES:
COc1c(N2C[C@@H]3[C@H](C2)CCCN3)c(F)cc2c1n(cc(c2=O)C(=O)O)C1CC1
EC Number:
604-773-0
UNII:
U188XYD42P
Properties
Complexity:
727  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Defined Bond Stereocenter Count:
0
Exact Mass:
401.175g/mol
Formal Charge:
0
Heavy Atom Count:
29  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
401.438g/mol
Monoisotopic Mass:
401.175g/mol
Rotatable Bond Count:
4  
Topological Polar Surface Area:
82.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.6  
Literature
Title Journal
QT/QTc study conducted in Japanese adult healthy subjects: a novel xanthine oxidase inhibitor topiroxostat was not associated with QT prolongation. Journal of clinical pharmacology 20140401
Bactericidal activity and mechanism of action of AZD5847, a novel oxazolidinone for treatment of tuberculosis. Antimicrobial agents and chemotherapy 20140101
Methyl-thiazoles: a novel mode of inhibition with the potential to develop novel inhibitors targeting InhA in Mycobacterium tuberculosis. Journal of medicinal chemistry 20131114
Assessment of clofazimine activity in a second-line regimen for tuberculosis in mice. American journal of respiratory and critical care medicine 20130901
Synthesis, in vitro antimycobacterial and antibacterial evaluation of IMB-070593 derivatives containing a substituted benzyloxime moiety. Molecules (Basel, Switzerland) 20130328
Synthesis of gatifloxacin derivatives and their biological activities against Mycobacterium leprae and Mycobacterium tuberculosis. Bioorganic & medicinal chemistry 20130215
A liquid chromatography-tandem mass spectrometry assay for the determination of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, in human plasma and urine and its application to a single-dose pharmacokinetic study in healthy Chinese volunteers. Biomedical chromatography : BMC 20121101
Development and validation of liquid chromatography-mass spectrometric method for simultaneous determination of moxifloxacin and ketorolac in rat plasma: application to pharmacokinetic study. Biomedical chromatography : BMC 20121101
Emerging fluoroquinolone resistance in Streptococcus agalactiae in South Korea. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20121101
Identification of a novel resistance mutation in parE that confers high-level resistance to moxifloxacin in Streptococcus pneumoniae. The Journal of antimicrobial chemotherapy 20121101
Switch from intravenous to enteral moxifloxacin in critically ill patients: a pilot study. Scandinavian journal of infectious diseases 20121101
6-hydrogen-8-methylquinolones active against replicating and non-replicating Mycobacterium tuberculosis. Chemical biology & drug design 20121101
Photodegradation of fluoroquinolones in surface water and antimicrobial activity of the photoproducts. Water research 20121101
In vitro susceptibility of Mycobacterium bovis against moxifloxacin. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20121101
[Current data and trends on the development of antibiotic resistance of Clostridium difficile]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 20121101
Primary resistance of Helicobacter pylori to levofloxacin and moxifloxacine in Iran. Internal and emergency medicine 20121001
Shortening of the QT interval after food can be used to demonstrate assay sensitivity in thorough QT studies. Journal of clinical pharmacology 20121001
Seasonality of Clostridium difficile infections in Southern Germany. Epidemiology and infection 20121001
Fungal keratitis responsive to moxifloxacin monotherapy. Cornea 20121001
Antibiotic susceptibility in prostate-derived Propionibacterium acnes isolates. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 20121001
Infectious keratitis after Boston type 1 keratoprosthesis implantation. Cornea 20121001
Evaluation of the effects of bitopertin (RG1678) on cardiac repolarization: a thorough corrected QT study in healthy male volunteers. Clinical therapeutics 20121001
Towards a new tuberculosis drug: pyridomycin - nature's isoniazid. EMBO molecular medicine 20121001
Moxifloxacin in multidrug-resistant tuberculosis: is there any indication for therapeutic drug monitoring? The European respiratory journal 20121001
The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment. American journal of respiratory and critical care medicine 20120915
14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial. Lancet (London, England) 20120915
Bupivacaine extended release liposome injection does not prolong QTc interval in a thorough QT/QTc study in healthy volunteers. Journal of clinical pharmacology 20120901
Microcolonies in fluoroquinolone agar proportion susceptibility testing of Mycobacterium tuberculosis: an indicator of drug resistance. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20120901
[The fate of 20 sea breams. Mycobacterium marinum infection]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20120901
Negative electro-mechanical windows are required for drug-induced Torsades de Pointes in the anesthetized guinea pig. Journal of pharmacological and toxicological methods 20120901
The role of the anaesthetised guinea-pig in the preclinical cardiac safety evaluation of drug candidate compounds. Toxicology and applied pharmacology 20120901
Identifying patients at risk of late recovery (≥ 8 days) from acute exacerbation of chronic bronchitis and COPD. Respiratory medicine 20120901
Activity of JNJ-Q2 against Staphylococcus aureus isolated from patients with acute bacterial skin and skin-structure infection obtained during a Phase 2 clinical trial. Diagnostic microbiology and infectious disease 20120901
Synthesis and in vitro antibacterial activity of gemifloxacin derivatives containing a substituted benzyloxime moiety. European journal of medicinal chemistry 20120901
Effects of a supratherapeutic dose of investigational orally inhaled dihydroergotamine (MAP0004) on QT interval: a randomized, double-blind, active- and placebo-controlled crossover study in healthy volunteers. Clinical therapeutics 20120901
[Spectrum and drug sensitivity of pathogenic bacteria in children with nephrotic syndrome complicated by urinary tract infection: an analysis of 97 cases]. Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 20120901
[Helicobacter pylori-related diseases]. Gastroenterologia y hepatologia 20120901
In vivo metabolic investigation of moxifloxacin using liquid chromatography/electrospray ionization tandem mass spectrometry in combination with online hydrogen/deuterium exchange experiments. Rapid communications in mass spectrometry : RCM 20120830
Quadruple therapy with moxifloxacin and bismuth for first-line treatment of Helicobacter pylori. World journal of gastroenterology 20120828
Characterization of the human QT interval: novel distribution-based assessment of the repolarization effects of moxifloxacin. Journal of clinical pharmacology 20120801
A randomized, crossover, placebo- and moxifloxacin-controlled study to evaluate the effects of bosutinib (SKI-606), a dual Src/Abl tyrosine kinase inhibitor, on cardiac repolarization in healthy adult subjects. International journal of cancer 20120801
In vitro antichlamydial activity of garenoxacin against Chlamydia trachomatis. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20120801
Moxifloxacin punctum plug for sustained drug delivery. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20120801
Repeated supratherapeutic dosing of strontium ranelate over 15 days does not prolong QT(c) interval in healthy volunteers. British journal of clinical pharmacology 20120801
Inhibitory activity of garenoxacin against DNA gyrase of Mycoplasma pneumoniae. The Journal of antimicrobial chemotherapy 20120801
Changing trends in antimicrobial susceptibility of Streptococcus pneumoniae isolates in Taiwan, 2006-2007. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 20120801
Anti-inflammatory effects of moxifloxacin on rat airway smooth muscle cells exposed to allergen: Inhibition of extracellular-signal-regulated kinase and nuclear factor-κB activation and of interleukin-8 and eotaxin synthesis. Respirology (Carlton, Vic.) 20120801
A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging. The Journal of antimicrobial chemotherapy 20120801
Antimicrobial susceptibility testing of Clostridium difficile using EUCAST epidemiological cut-off values and disk diffusion correlates. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20120801
In vitro and in vivo activity of clofazimine against Mycobacterium tuberculosis persisters. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20120801
Bilateral acute iris transillumination following systemic moxifloxacin for respiratory illness: report of two cases and review of the literature. Ocular immunology and inflammation 20120801
Synthesis, antitubercular and antimicrobial evaluation of 3-(4-chlorophenyl)-4-substituted pyrazole derivatives. Bioorganic & medicinal chemistry letters 20120801
Sugammadex is not associated with QT/QTc prolongation: methodology aspects of an intravenous moxifloxacin-controlled thorough QT study. International journal of clinical pharmacology and therapeutics 20120801
New drugs for the treatment of tuberculosis: hope and reality. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20120801
[Sepsis. Update 2012]. Deutsche medizinische Wochenschrift (1946) 20120801
Herpes zoster ophthalmicus complicated by ipsilateral isolated Bell's palsy: a case report and review of the literature. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20120801
[Abstracts of 8th Moxifloxacin Research Workshop. November 17-18, 2012. Leverkusen, Germany]. Infection 20120801
New drug combination for TB is tested in unique trial. BMJ (Clinical research ed.) 20120725
Construction and functionalization of fused pyridine ring leading to novel compounds as potential antitubercular agents. Bioorganic & medicinal chemistry letters 20120715
Ocular infections caused by non-tuberculous mycobacteria: update on epidemiology and management. Clinical & experimental ophthalmology 20120701
Stenotrophomonas maltophilia in the respiratory tract of medical intensive care unit patients. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20120701
Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results. The European respiratory journal 20120701
Comparison of moxifloxacin and levofloxacin in an epithelial disorder model using cultured rabbit corneal epithelial cell sheets. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20120701
Role of mixed ion channel effects in the cardiovascular safety assessment of the novel anti-MRSA fluoroquinolone JNJ-Q2. British journal of pharmacology 20120701
Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection. Ophthalmology 20120701
Triprotic site-specific acid-base equilibria and related properties of fluoroquinolone antibacterials. Journal of pharmaceutical and biomedical analysis 20120701
Induced osteoclastogenesis by fluoroquinolones in unstimulated and stimulated human osteoclast precursor cells. Bone 20120701
Activities of moxifloxacin in combination with macrolides against clinical isolates of Mycobacterium abscessus and Mycobacterium massiliense. Antimicrobial agents and chemotherapy 20120701
Association between PCR ribotypes and antimicrobial susceptibility among Clostridium difficile isolates from healthcare-associated infections in South Korea. International journal of antimicrobial agents 20120701
Laboratory diagnosis of Clostridium difficile associated diarrhoea and molecular characterization of clinical isolates. The new microbiologica 20120701
Antimicrobial chemotherapy of Mycoplasma genitalium-positive non-gonococcal urethritis. Expert review of anti-infective therapy 20120701
The evaluation of antimicrobial susceptibility of urine enterococci with the Vitek 2 automated system in eastern Turkey. The Southeast Asian journal of tropical medicine and public health 20120701
Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial. JAMA 20120613
Lack of significant effect of bilastine administered at therapeutic and supratherapeutic doses and concomitantly with ketoconazole on ventricular repolarization: results of a thorough QT study (TQTS) with QT-concentration analysis. Journal of clinical pharmacology 20120601
Formulation and evaluation of micro hydrogel of Moxifloxacin hydrochloride. European journal of drug metabolism and pharmacokinetics 20120601
Antimicrobial efficacies of several antibiotics against uterine cervicitis caused by Mycoplasma genitalium. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20120601
Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis. The European respiratory journal 20120601
Safety of prophylactic intracameral moxifloxacin use in cataract surgery. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20120601
Early surgical debridement in the management of infectious scleritis after pterygium excision. Journal of ophthalmic inflammation and infection 20120601
A single-dose placebo- and moxifloxacin-controlled study of the effects of temsirolimus on cardiac repolarization in healthy adults. Cancer chemotherapy and pharmacology 20120601
Inter-individual variability in the pre-clinical drug cardiotoxic safety assessment--analysis of the age-cardiomyocytes electric capacitance dependence. Journal of cardiovascular translational research 20120601
In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China. Diagnostic microbiology and infectious disease 20120601
Penetration of moxifloxacin into liver tissue. International journal of antimicrobial agents 20120601
ESBL-positive Enterobacteria isolates in drinking water. Emerging infectious diseases 20120601
LASIK interface-captured foreign bodies after mild traumatic corneal scratch without flap displacement. Korean journal of ophthalmology : KJO 20120601
Moxifloxacin safety: an analysis of 14 years of clinical data. Drugs in R&D 20120601
Besifloxacin ophthalmic suspension, 0.6%: a novel topical fluoroquinolone for bacterial conjunctivitis. Advances in therapy 20120601
In vitro assessment of the cytotoxicity of six topical antibiotics to four cultured ocular surface cell lines. Biocontrol science 20120601
Ciprofloxacin and the risk for cardiac arrhythmias: culprit delicti or watching bystander? Acta cardiologica 20120601
Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20120515
Pharmacokinetics and repolarization effects of intravenous and transdermal granisetron. Clinical cancer research : an official journal of the American Association for Cancer Research 20120515
The electro-mechanical window in anaesthetized guinea pigs: a new marker in screening for Torsade de Pointes risk. British journal of pharmacology 20120501
Midostaurin does not prolong cardiac repolarization defined in a thorough electrocardiogram trial in healthy volunteers. Cancer chemotherapy and pharmacology 20120501
Multidrug-resistant North American pulsotype 2 Clostridium difficile was the predominant toxigenic hospital-acquired strain in the province of Manitoba, Canada, in 2006-2007. Journal of medical microbiology 20120501
Activity of sitafloxacin against extracellular and intracellular Staphylococcus aureus in vitro and in vivo: comparison with levofloxacin and moxifloxacin. The Journal of antibiotics 20120501
gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis. The Journal of antimicrobial chemotherapy 20120501
Effects of bilastine on T-wave morphology and the QTc interval: a randomized, double-blind, placebo-controlled, thorough QTc study. Clinical drug investigation 20120501
Tuberculosis: the drug development pipeline at a glance. European journal of medicinal chemistry 20120501
Sensitivities of ciprofloxacin-resistant Mycobacterium tuberculosis clinical isolates to fluoroquinolones: role of mutant DNA gyrase subunits in drug resistance. International journal of antimicrobial agents 20120501
Safety and efficacy of moxifloxacin-dexamethasone eyedrops as treatment for bacterial ocular infection associated with bacterial blepharitis. Advances in therapy 20120501
More efficient ways of assessing treatments for neglected tropical diseases are required: innovative study designs, new endpoints, and markers of effects. PLoS neglected tropical diseases 20120501
Drug use evaluation of moxifloxacin (avelox) using a hand-held electronic device at a canadian teaching hospital. P & T : a peer-reviewed journal for formulary management 20120501
[Evaluation of bacterial colonization of the conjunctival sac in ranibizumab intravitreal injections treated patients]. Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti 20120501
Structure-based design of novel benzoxazinorifamycins with potent binding affinity to wild-type and rifampin-resistant mutant Mycobacterium tuberculosis RNA polymerases. Journal of medicinal chemistry 20120426
Thorough QT/QTc study of ritonavir-boosted saquinavir following multiple-dose administration of therapeutic and supratherapeutic doses in healthy participants. Journal of clinical pharmacology 20120401
Correlation between variable-number tandem-repeat-based genotypes and drug susceptibility in Mycobacterium avium isolates. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20120401
Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India. The European respiratory journal 20120401
Prophylactic effect of topical fluoroquinolones in a rabbit model of Staphylococcus aureus endophthalmitis. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20120401
Isolation and characterization of small qnrS1-carrying plasmids from imported seafood isolates of Salmonella enterica that are highly similar to plasmids of clinical isolates. FEMS immunology and medical microbiology 20120401
Amino acid substitutions of quinolone resistance determining regions in GyrA and ParC associated with quinolone resistance in Acinetobacter baumannii and Acinetobacter genomic species 13TU. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 20120401
Antimicrobial resistance of Moraxella catarrhalis isolates in Taiwan. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 20120401
In vivo antibacterial activity of chinfloxacin, a new fluoroquinolone antibiotic. The Journal of antimicrobial chemotherapy 20120401
Characterization of vaginal lactobacilli in women after kidney transplantation. Anaerobe 20120401
Activity of JNJ-Q2, a new fluoroquinolone, tested against contemporary pathogens isolated from patients with community-acquired bacterial pneumonia. International journal of antimicrobial agents 20120401
Moxifloxacin versus placebo modeling of the QT interval. Journal of pharmacokinetics and pharmacodynamics 20120401
Effect of a single supratherapeutic dose of dolutegravir on cardiac repolarization. Pharmacotherapy 20120401
QT effect of semagacestat at therapeutic and supratherapeutic doses. International journal of clinical pharmacology and therapeutics 20120401
Drug susceptibility of Mycobacterium tuberculosis Beijing genotype and association with MDR TB. Emerging infectious diseases 20120401
Essentials for selecting antimicrobial therapy for intra-abdominal infections. Drugs 20120401
Recent perspectives in the diagnosis and evidence-based treatment of Mycoplasma genitalium. Expert review of anti-infective therapy 20120401
Comparison of corneal and aqueous humor penetration of moxifloxacin, gatifloxacin and levofloxacin during keratoplasty. Advances in therapy 20120401
Update on the cardiac safety of moxifloxacin. Current drug safety 20120401
Moxifloxacin-induced hypoglycemia in a non-diabetic patient. Current drug safety 20120401
Trial tests new combination of drugs to treat tuberculosis. BMJ (Clinical research ed.) 20120320
Reevaluation of moxifloxacin pharmacokinetics and their direct effect on the QT interval. Journal of clinical pharmacology 20120301
Pyrazinamide-induced sideroblastic anemia. American journal of hematology 20120301
Treatment failure in pneumonia: impact of antibiotic treatment and cost analysis. The European respiratory journal 20120301
[Maculo-papular exanthem with acute renal failure. Drug-induced hypersensitivity syndrome]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20120301
Nocardia scleritis-clinical presentation and management: a report of three cases and review of literature. Journal of ophthalmic inflammation and infection 20120301
No evidence of QT prolongation with supratherapeutic doses of aleglitazar. Journal of cardiovascular pharmacology 20120301
Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium. International journal of antimicrobial agents 20120301
Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2. European journal of medicinal chemistry 20120301
Antimicrobial susceptibility of Stenotrophomonas maltophilia isolates from a Korean tertiary care hospital. Yonsei medical journal 20120301
Moxifloxacin for tuberculosis. The Lancet. Infectious diseases 20120301
Moxifloxacin for tuberculosis. The Lancet. Infectious diseases 20120301
Use of clarithromycin and adverse cardiovascular events among older patients receiving donepezil: a population-based, nested case-control study. Drugs & aging 20120301
[In vitro antibiotic susceptibility to fluoroquinolones]. Archivos de la Sociedad Espanola de Oftalmologia 20120301
Detection of QT prolongation using a novel electrocardiographic analysis algorithm applying intelligent automation: prospective blinded evaluation using the Cardiac Safety Research Consortium electrocardiographic database. American heart journal 20120301
Group B streptococcus mycotic aneurysm of the abdominal aorta: report of a case and review of the literature. The Yale journal of biology and medicine 20120301
PanACEA: a new approach to tuberculosis research. The Lancet. Infectious diseases 20120301
Design and evaluation of moxifloxacin hydrochloride ocular inserts. Acta pharmaceutica (Zagreb, Croatia) 20120301
Development and characterisation of thermo reversible mucoadhesive moxifloxacin hydrochloride in situ ophthalmic gel. Journal of pharmacy & bioallied sciences 20120301
Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions. The Journal of infectious diseases 20120215
Effect of trabectedin on the QT interval in patients with advanced solid tumor malignancies. Cancer chemotherapy and pharmacology 20120201
Assessment of the cardiac safety of prucalopride in healthy volunteers: a randomized, double-blind, placebo- and positive-controlled thorough QT study. British journal of clinical pharmacology 20120201
The steroids for corneal ulcers trial: study design and baseline characteristics. Archives of ophthalmology (Chicago, Ill. : 1960) 20120201
Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT). Archives of ophthalmology (Chicago, Ill. : 1960) 20120201
Challenges in assessing microbial susceptibility and predicting clinical response to newer-generation fluoroquinolones. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20120201
Pharmacokinetics of moxifloxacin in an infant with Mycoplasma hominis meningitis. The Pediatric infectious disease journal 20120201
In vitro pharmacodynamic evaluation of garenoxacin against quinolone-resistant Streptococcus pneumoniae. International journal of antimicrobial agents 20120201
Drug susceptibility testing and pharmacokinetics question current treatment regimens in Mycobacterium simiae complex disease. International journal of antimicrobial agents 20120201
Occurrence and fate of quinolone and fluoroquinolone antibiotics in a municipal sewage treatment plant. Water research 20120201
Spectrofluorimetric study of the interaction between europium(III) and moxifloxacin in micellar solution and its analytical application. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20120201
Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine. The Journal of antimicrobial chemotherapy 20120201
Efficacy and safety of moxifloxacin as antibacterial prophylaxis for patients receiving autologous haematopoietic stem cell transplantation: a randomised trial. International journal of antimicrobial agents 20120201
Determination of photostability and photodegradation products of moxifloxacin in the presence of metal ions in solutions and solid phase. Kinetics and identification of photoproducts. Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology 20120201
Bilateral methicillin-resistant Staphylococcus aureus keratitis following hyperopic photorefractive surgery. International ophthalmology 20120201
Role of moxifloxacin for the treatment of community-acquired [corrected] complicated intra-abdominal infections in Taiwan. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 20120201
Moxifloxacin monotherapy for treatment of complicated intra-abdominal infections: a meta-analysis of randomised controlled trials. International journal of clinical practice 20120201
Syndrome of inappropriate antidiuretic hormone associated with moxifloxacin. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20120201
Evaluation of gabapentin enacarbil on cardiac repolarization: a randomized, double-blind, placebo- and active-controlled, crossover thorough QT/QTc study in healthy adults. Clinical therapeutics 20120201
[Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 20120201
Comparative in vitro activity of sitafloxacin against bacteria isolated from Thai patients with urinary tract infections and lower respiratory tract infections. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20120201
[Sensitivity surveillance of Streptococcus pneumoniae isolates for several antibacterial agents in Gifu and Aichi prefecture (2008-2009)]. The Japanese journal of antibiotics 20120201
Structure of Ddn, the deazaflavin-dependent nitroreductase from Mycobacterium tuberculosis involved in bioreductive activation of PA-824. Structure (London, England : 1993) 20120111
Current role of community-acquired methicillin-resistant Staphylococcus aureus among children with skin and soft tissue infections. Pediatric reports 20120102
Comparison of the IKr blockers moxifloxacin, dofetilide and E-4031 in five screening models of pro-arrhythmia reveals lack of specificity of isolated cardiomyocytes. British journal of pharmacology 20120101
Optimal dose finding of garenoxacin based on population pharmacokinetics/pharmacodynamics and Monte Carlo simulation. European journal of clinical pharmacology 20120101
Giant fornix syndrome: a case series. Ophthalmic plastic and reconstructive surgery 20120101
Neither moxifloxacin nor cefuroxime produces significant attenuation of inflammatory mediator release in patients exposed to cardiopulmonary bypass: a randomized controlled trial. The Journal of antimicrobial chemotherapy 20120101
Oral bioavailability of moxifloxacin after Roux-en-Y gastric bypass surgery. The Journal of antimicrobial chemotherapy 20120101
Topical ophthalmic moxifloxacin elicits minimal or no selection of fluoroquinolone resistance among bacteria isolated from the skin, nose, and throat. Journal of pediatric ophthalmology and strabismus 20120101
Synthesis and antibacterial activity of naphthyridone derivatives containing mono/difluoro-methyloxime pyrrolidine scaffolds. European journal of medicinal chemistry 20120101
Synthesis of osteotropic hydroxybisphosphonate derivatives of fluoroquinolone antibacterials. European journal of medicinal chemistry 20120101
Wild-type MIC distribution and epidemiological cut-off values in clinical Legionella pneumophila serogroup 1 isolates. Diagnostic microbiology and infectious disease 20120101
Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment. Investigative ophthalmology & visual science 20120101
Comparison of different techniques of cataract surgery in bacterial contamination of the anterior chamber in diabetic and non-diabetic population. Indian journal of ophthalmology 20120101
Evaluation of bleb characteristics after implantation of the EX-PRESS™ glaucoma filtration device. Molecular vision 20120101
Baseline predictors of sputum culture conversion in pulmonary tuberculosis: importance of cavities, smoking, time to detection and W-Beijing genotype. PloS one 20120101
Successful treatment of Chlamydophila pneumoniae acute respiratory distress syndrome with extracorporeal membrane oxygenator: a case report and diagnostic review. Journal of medical case reports 20120101
Two-drug antimicrobial chemotherapy: a mathematical model and experiments with Mycobacterium marinum. PLoS pathogens 20120101
Autoluminescent Mycobacterium tuberculosis for rapid, real-time, non-invasive assessment of drug and vaccine efficacy. PloS one 20120101
Candida albicans isolates from the gut of critically ill patients respond to phosphate limitation by expressing filaments and a lethal phenotype. PloS one 20120101
High prevalence of multidrug-resistant tuberculosis, Swaziland, 2009-2010. Emerging infectious diseases 20120101
Mycobacterium riyadhense pulmonary infection, France and Bahrain. Emerging infectious diseases 20120101
Ocular medicines in children: the regulatory situation related to clinical research. BMC pediatrics 20120101
Strategies for treating latent multiple-drug resistant tuberculosis: a decision analysis. PloS one 20120101
Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort study. PLoS neglected tropical diseases 20120101
Results at seven years after the use of intracamerular cefazolin as an endophthalmitis prophylaxis in cataract surgery. BMC ophthalmology 20120101
Evaluation of the levofloxacin release characters from a rabbit foldable capsular vitreous body. International journal of nanomedicine 20120101
How 'humane' is your endpoint? Refining the science-driven approach for termination of animal studies of chronic infection. PLoS pathogens 20120101
Descemet's stripping automated endothelial keratoplasty for congenital hereditary endothelial dystrophy. Clinical ophthalmology (Auckland, N.Z.) 20120101
Staphylococcus aureus eye infections in two Indian hospitals: emergence of ST772 as a major clone. Clinical ophthalmology (Auckland, N.Z.) 20120101
Clostridia in premature neonates' gut: incidence, antibiotic susceptibility, and perinatal determinants influencing colonization. PloS one 20120101
Toward a New Gold Standard for Early Safety: Automated Temperature-Controlled hERG Test on the PatchLiner. Frontiers in pharmacology 20120101
Adverse drug reactions in a complementary medicine hospital: a prospective, intensified surveillance study. Evidence-based complementary and alternative medicine : eCAM 20120101
Case series of mycobacterium abscessus infections associated with a trigger point injection and epidural block at a rural clinic. Epidemiology and health 20120101
Chronic necrotizing pulmonary aspergillosis presenting as bilateral pleural effusion: a case report. Journal of medical case reports 20120101
Post-traumatic endophthalmitis with retained intraocular foreign body - a case report with review of literature. Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH 20120101
Trends in tropical medicine research in India. Indian journal of pharmacology 20120101
Short-term visual outcomes of Boston keratoprosthesis type I in saudi arabia. Middle East African journal of ophthalmology 20120101
Plasmid-Mediated Quinolone Resistance; Interactions between Human, Animal, and Environmental Ecologies. Frontiers in microbiology 20120101
Mechanism of Honey Bacteriostatic Action Against MRSA and VRE Involves Hydroxyl Radicals Generated from Honey's Hydrogen Peroxide. Frontiers in microbiology 20120101
Semiautomated QT interval measurement in electrocardiograms from a thorough QT study: comparison of the grouped and ungrouped superimposed median beat methods. Journal of electrocardiology 20120101
Hansen's disease (Leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactions. Pharmacotherapy 20120101
Simple and sensitive stability-indicating ion chromatography method for the determination of cyclopropylamine in nevirapine and moxifloxacin hydrochloride drug substances. Scientia pharmaceutica 20120101
Streptococcus pneumoniae: susceptibility to penicillin and moxifloxacin. Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 20120101
Rhodococcus bacteremia in cancer patients is mostly catheter related and associated with biofilm formation. PloS one 20120101
Capsaicin protects mice from community-associated methicillin-resistant Staphylococcus aureus pneumonia. PloS one 20120101
Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan. Substance abuse treatment, prevention, and policy 20120101
Unilateral conjunctival ulcer due to Stenotrophomonas maltophilia infection. Indian journal of ophthalmology 20120101
Short-term outcome of Boston Type 1 keratoprosthesis for bilateral limbal stem cell deficiency. Indian journal of ophthalmology 20120101
Efficacy of directly observed treatment short-course intermittent regimen in spinal tuberculosis. Indian journal of orthopaedics 20120101
Clostridium difficile genotypes other than ribotype 078 that are prevalent among human, animal and environmental isolates. BMC microbiology 20120101
SCCmec Type IX Element in Methicillin Resistant Staphylococcusaureusspa Type t337 (CC9) Isolated from Pigs and Pork in Thailand. Frontiers in microbiology 20120101
Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review. PloS one 20120101
Multiple Pyogenic Liver Abscesses Caused by Eggerthella lenta Treated with Ertapenem: A Case Report. Case reports in medicine 20120101
European ST80 community-associated methicillin-resistant Staphylococcus aureus orbital cellulitis in a neonate. BMC ophthalmology 20120101
Interaction of avelox with bovine serum albumin and effect of the coexistent drugs on the reaction. International journal of analytical chemistry 20120101
Bleb morphology and histology in a rabbit model of glaucoma filtration surgery using Ozurdex® or mitomycin-C. Molecular vision 20120101
Inhibition of VEGF expression and corneal neovascularization by shRNA targeting HIF-1α in a mouse model of closed eye contact lens wear. Molecular vision 20120101
Salmonella paratyphi neck abscess. Journal of global infectious diseases 20120101
Transmission and selection of macrolide resistant Mycoplasma genitalium infections detected by rapid high resolution melt analysis. PloS one 20120101
The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace. Frontiers in microbiology 20120101
Rescue Therapy for Helicobacter pylori Infection 2012. Gastroenterology research and practice 20120101
Initial experience with Descemet stripping automated endothelial keratoplasty in Saudi Arabia. Oman journal of ophthalmology 20120101
High genetic diversity among community-associated Staphylococcus aureus in Europe: results from a multicenter study. PloS one 20120101
Moxifloxacin (avelox) induced thrombotic thrombocytopenic purpura. Case reports in medicine 20120101
High-performance liquid chromatography assay for moxifloxacin in brain tissue and plasma: validation in a pharmacokinetic study in a murine model of cerebral listeriosis. Journal of analytical methods in chemistry 20120101
A case of endophthalmitis associated with limbal relaxing incision. Indian journal of ophthalmology 20120101
Clinical and microbiologic characteristics of tcdA-negative variant Clostridium difficile infections. BMC infectious diseases 20120101
Differential epigenetic compatibility of qnr antibiotic resistance determinants with the chromosome of Escherichia coli. PloS one 20120101
Do β-defensins and other antimicrobial peptides play a role in neuroimmune function and neurodegeneration? TheScientificWorldJournal 20120101
Necrotizing keratitis after laser refractive surgery in patients with inactive inflammatory bowel disease. Case reports in ophthalmology 20120101
Acute retinal necrosis after Boston type I keratoprosthesis. Middle East African journal of ophthalmology 20120101
Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome. PloS one 20120101
Relationship between Gram negative enteric rods, Aggregatibacter actinomycetemcomitans, and clinical parameters in periodontal disease. Journal of Indian Society of Periodontology 20120101
Cardiorenal syndrome: Resistant to diuretics, sensitive to ultraflitration. Journal of cardiovascular disease research 20120101
Concomitant pulmonary tuberculosis in hospitalized healthcare-associated pneumonia in a tuberculosis endemic area: a multi-center retrospective study. PloS one 20120101
Outcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalence. PloS one 20120101
Successful salvage therapy of Fusarium endophthalmitis secondary to keratitis: an interventional case series. Clinical ophthalmology (Auckland, N.Z.) 20120101
Efficacy of a 'Rescue' Ciprofloxacin-Based Regimen for Eradication of Helicobacter pylori Infection after Treatment Failures. Gastroenterology research and practice 20120101
Plectranthus amboinicus and Centella asiatica Cream for the Treatment of Diabetic Foot Ulcers. Evidence-based complementary and alternative medicine : eCAM 20120101
Discovery of a novel hsp65 genotype within Mycobacterium massiliense associated with the rough colony morphology. PloS one 20120101
In vitro antibacterial activity of chinfloxacin, a new fluoroquinolone antibiotic. Chemotherapy 20120101
Uncontrolled penile erection and increased sexual desire with intravenous moxifloxacin. Indian journal of pharmacology 20120101
Safety of besifloxacin ophthalmic suspension 0.6% as a prophylactic antibiotic following routine cataract surgery: results of a prospective, parallel-group, investigator-masked study. Clinical ophthalmology (Auckland, N.Z.) 20120101
Effects of P-MAPA Immunomodulator on Toll-Like Receptors and p53: Potential Therapeutic Strategies for Infectious Diseases and Cancer. Infectious agents and cancer 20120101
Leukocytoclastic vasculitis induced by Mycoplasma pneumoniae infection. Acta dermatovenerologica Croatica : ADC 20120101
New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutations. PloS one 20120101
Mass spectrometic study of speciation in aluminium-fluoroquinolone solutions. European journal of mass spectrometry (Chichester, England) 20120101
Good penetration of moxifloxacin into human abscesses. Pharmacology 20120101
The first case of cutaneous infection with Mycobacterium parascrofulaceum. Therapeutics and clinical risk management 20120101
Stability indicating HPLC method for the simultaneous determination of moxifloxacin and prednisolone in pharmaceutical formulations. Chemistry Central journal 20120101
Assessment of the sensitivity of detecting drug-induced QTc changes using subject-specific rate correction. Journal of electrocardiology 20120101
New treatments for bacterial keratitis. Journal of ophthalmology 20120101
[Microbiological monitoring in therapy of patients with iatrogenic esophageotracheal fistula]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20120101
The Cardiac Safety Research Consortium ECG database. Journal of electrocardiology 20120101
Radiological followup of the evolution of inflammatory process in sacroiliac joint with magnetic resonance imaging: a case with pyogenic sacroiliitis. Case reports in rheumatology 20120101
Kinetic and thermodynamic studies of moxifloxacin hydrolysis in the presence and absence of metal ions in acidic solutions. Acta poloniae pharmaceutica 20120101
[Assessment of susceptibility of strictly anaerobic bacteria originated from different sources to fluoroquinolones and other antimicrobial drugs]. Medycyna doswiadczalna i mikrobiologia 20120101
High quality draft genome sequence of Segniliparus rugosus CDC 945(T)= (ATCC BAA-974(T)). Standards in genomic sciences 20111231
Modulation of the expression of ABC transporters in murine (J774) macrophages exposed to large concentrations of the fluoroquinolone antibiotic moxifloxacin. Toxicology 20111218
Synthesis, characterization and antimicrobial investigation of some moxifloxacin metal complexes. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20111215
Mycoplasma genitalium: should we treat and how? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20111215
[Development of subcutaneous nodules after mesotherapy]. Enfermedades infecciosas y microbiologia clinica 20111201
Stenotrophomonas maltophilia in cystic fibrosis: improved detection by the use of selective agar and evaluation of antimicrobial resistance. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 20111201
In vitro activity of ceftobiprole and seven other antimicrobial agents against invasive Streptococcus pneumoniae isolates in Spain. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20111201
Treatment of experimental Bacillus cereus endophthalmitis using intravitreal moxifloxacin with or without dexamethasone. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20111201
Antimicrobial resistance profiles of ocular and nasal flora in patients undergoing intravitreal injections. American journal of ophthalmology 20111201
[Helicobacter pylori eradication therapy in Korea]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20111201
[Primary antibiotic resistance of Helicobacter pylori strains and eradication rate according to gastroduodenal disease in Korea]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20111201
Comparative in vitro activity of finafloxacin against staphylococci displaying normal and small colony variant phenotypes. The Journal of antimicrobial chemotherapy 20111201
Surveillance of JNJ-Q2 activity tested against Staphylococcus aureus and beta-hemolytic streptococci as a component of the 2010 SENTRY Antimicrobial Surveillance Program. Diagnostic microbiology and infectious disease 20111201
Synthesis and in-vitro antimycobacterial activity of fluoroquinolone derivatives containing a coumarin moiety. Archiv der Pharmazie 20111201
Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20111201
A novel hemotropic Mycoplasma (hemoplasma) in a patient with hemolytic anemia and pyrexia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20111201
Randomized trial on 14 versus 7 days of esomeprazole, moxifloxacin, and amoxicillin for second-line or rescue treatment of Helicobacter pylori infection. Helicobacter 20111201
European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997-2009). The Journal of antimicrobial chemotherapy 20111201
Moxifloxacin relieves the persistent symptoms of lower urinary tract after cessation of ketamine abuse. Hong Kong medical journal = Xianggang yi xue za zhi 20111201
[Diagnosis and treatment of atypical mycobacterial infections of the respiratory tract]. Revue des maladies respiratoires 20111201
In vitro comparison of the cytotoxic effects of clinically available ophthalmic solutions of fluoroquinolones on human keratocytes. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20111201
Otomastoiditis with acute left facial nerve paralysis caused by Mycobacterium chelonae. Ear, nose, & throat journal 20111201
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS computational biology 20111201
Simple and rapid liquid chromatography method for determination of moxifloxacin in saliva. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20111115
Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in Asia: report from the Community-Acquired Respiratory Tract Infection Pathogen Surveillance (CARTIPS) study, 2009-2010. International journal of antimicrobial agents 20111101
A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections. The Journal of antimicrobial chemotherapy 20111101
Exploiting bacterial DNA gyrase as a drug target: current state and perspectives. Applied microbiology and biotechnology 20111101
Effect of nalmefene 20 and 80 mg on the corrected QT interval and T-wave morphology: a randomized, double-blind, parallel-group, placebo- and moxifloxacin-controlled, single-centre study. Clinical drug investigation 20111101
Moxifloxacin as an alternative or additive therapy for treatment of pulmonary tuberculosis. The Annals of pharmacotherapy 20111101
Alcaligenes xylosoxidans contact lens-related keratitis--a case report and literature review. Eye & contact lens 20111101
Thorough QT/QTc study of tocilizumab after single-dose administration at therapeutic and supratherapeutic doses in healthy subjects. International journal of clinical pharmacology and therapeutics 20111101
Vancomycin, ceftazidime, and moxifloxacin can be safely stored in single-use, polypropylene syringes. Retina (Philadelphia, Pa.) 20111101
International spread of MDR TB from Tugela Ferry, South Africa. Emerging infectious diseases 20111101
Mycobacterium indicus pranii as stand-alone or adjunct immunotherapeutic in treatment of experimental animal tuberculosis. The Indian journal of medical research 20111101
6-Benzyl-6,7-dihydro-5H-pyrrolo-[3,4-b]pyridine-5,7-dione. Acta crystallographica. Section E, Structure reports online 20111101
Determination of quinolone residues in infant and young children powdered milk combining solid-phase extraction and ultra-performance liquid chromatography-tandem mass spectrometry. Journal of chromatography. A 20111021
Synthesis and structure-activity relationships of novel substituted 8-amino, 8-thio, and 1,8-pyrazole congeners of antitubercular rifamycin S and rifampin. Bioorganic & medicinal chemistry letters 20111015
Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience. The European respiratory journal 20111001
Tuberculous hepatic abscess appearing after liver transplantation in a patient with human immunodeficiency virus and hepatitis B and C virus co-infection. Transplant infectious disease : an official journal of the Transplantation Society 20111001
Clinical features, antimicrobial susceptibilities, and outcomes of Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteremia at a medical center in Taiwan, 1999-2006. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20111001
Life-threatening disseminated tuberculosis as a complication of TNF-α blockade in an adolescent. European journal of pediatrics 20111001
Isoniazid-resistant intracranial tuberculoma treated with a combination of moxifloxacin and first-line anti-tuberculosis medication. Journal of medical microbiology 20111001
Pharmacokinetics of moxifloxacin in plasma and tissue of morbidly obese patients. The Journal of antimicrobial chemotherapy 20111001
Comparison of the bactericidal activity of various fluoroquinolones against Mycobacterium tuberculosis in an in vitro experimental model. The Journal of antimicrobial chemotherapy 20111001
Multidrug resistance in European Clostridium difficile clinical isolates. The Journal of antimicrobial chemotherapy 20111001
Pre-clinical studies of a new quinolone (UB-8902) against Acinetobacter baumannii resistant to ciprofloxacin. International journal of antimicrobial agents 20111001
Mooren's-type ulceration associated with severe hidradenitis suppurativa: a case report and literature review. Ocular immunology and inflammation 20111001
Microbiology at first visit of moderate-to-severe diabetic foot infection with antimicrobial activity and a survey of quinolone monotherapy. Diabetes research and clinical practice 20111001
Bilateral microbial keratitis in highly active antiretroviral therapy-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a case series. Ocular immunology and inflammation 20111001
Efficacy and safety of moxifloxacin for community-acquired bacterial pneumonia based on pharmacokinetic analysis. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20111001
Ophthalmic antibiotic use and multidrug-resistant staphylococcus epidermidis: a controlled, longitudinal study. Ophthalmology 20111001
Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review. Drug safety 20111001
Primary antibiotic resistance of Helicobacter pylori isolated from Beijing children. Helicobacter 20111001
A thorough QT study to evaluate the effects of singledose exenatide 10 μg on cardiac repolarization in healthy subjects. International journal of clinical pharmacology and therapeutics 20111001
Chronic rhinosinusitis: therapeutic efficacy of anti-inflammatory and antibiotic approaches. Allergy, asthma & immunology research 20111001
A case of Stenotrophomonas maltophilia keratitis effectively treated with moxifloxacin. Korean journal of ophthalmology : KJO 20111001
Bilateral acute iris transillumination. Archives of ophthalmology (Chicago, Ill. : 1960) 20111001
Prevalence, enumeration, and antimicrobial agent resistance of Clostridium difficile in cattle at harvest in the United States. Journal of food protection 20111001
Prevalence of plasmid-mediated quinolone resistance and its association with extended-spectrum beta-lactamase and AmpC beta-lactamase in Enterobacteriaceae. The Korean journal of laboratory medicine 20111001
Epidemiology and clinical characteristics of Clostridium difficile infection in a Korean tertiary hospital. Journal of Korean medical science 20111001
The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile. PLoS pathogens 20111001
Moxifloxacinium chloride monohydrate. Acta crystallographica. Section E, Structure reports online 20111001
Moxifloxacin-Gelrite in situ ophthalmic gelling system against photodynamic therapy for treatment of bacterial corneal inflammation. Archives of pharmacal research 20111001
[Helicobacter pylori-related diseases: dyspepsia, ulcers and gastric cancer]. Gastroenterologia y hepatologia 20111001
Aqueous humour penetration of moxifloxocin and gatifloxacin eye drops in different dosing regimens before phacoemulsification surgery. The British journal of ophthalmology 20110901
Antibiotic therapy for acute Q fever in The Netherlands in 2007 and 2008 and its relation to hospitalization. Epidemiology and infection 20110901
[Microbiological analysis in contact lens-associated keratits]. Klinische Monatsblatter fur Augenheilkunde 20110901
A supratherapeutic dose of the Janus kinase inhibitor tasocitinib (CP-690,550) does not prolong QTc interval in healthy participants. Journal of clinical pharmacology 20110901
Antibiotic susceptibility of cocultures in polymicrobial infections such as peri-implantitis or periodontitis: an in vitro model. Journal of periodontology 20110901
Bacteriological findings and antimicrobial resistance in odontogenic and non-odontogenic chronic maxillary sinusitis. Journal of medical microbiology 20110901
PCR ribotype prevalence and molecular basis of macrolide-lincosamide-streptogramin B (MLSB) and fluoroquinolone resistance in Irish clinical Clostridium difficile isolates. The Journal of antimicrobial chemotherapy 20110901
In vitro and in vivo antibacterial activities of garenoxacin against group G Streptococcus dysgalactiae subsp. equisimilis. International journal of antimicrobial agents 20110901
Azithromycin plus chloroquine: combination therapy for protection against malaria and sexually transmitted infections in pregnancy. Expert opinion on drug metabolism & toxicology 20110901
Cellular accumulation of fluoroquinolones is not predictive of their intracellular activity: studies with gemifloxacin, moxifloxacin and ciprofloxacin in a pharmacokinetic/pharmacodynamic model of uninfected and infected macrophages. International journal of antimicrobial agents 20110901
The use of beat-to-beat electrocardiogram analysis to distinguish QT/QTc interval changes caused by moxifloxacin from those caused by vardenafil. Clinical pharmacology and therapeutics 20110901
Moxifloxacin-dependent Torsades de Pointes. Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 20110901
Single-agent, broad-spectrum fluoroquinolones for the outpatient treatment of low-risk febrile neutropenia. The Annals of pharmacotherapy 20110901
Tattoo-associated Mycobacterium haemophilum skin infection in immunocompetent adult, 2009. Emerging infectious diseases 20110901
Hepatotoxicity in the treatment of tuberculosis using moxifloxacin-containing regimens. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20110901
The activity of several newer antimicrobials against logarithmically multiplying M. leprae in mice. Leprosy review 20110901
Evaluation of the effect of dapagliflozin on cardiac repolarization: a thorough QT/QTc study. Diabetes therapy : research, treatment and education of diabetes and related disorders 20110901
[The effect of moxifloxacin on apoptosis of airway smooth muscle cells and mitochondria membrane potential]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 20110901
Oxidized multi-walled carbon nanotubes for the dispersive solid-phase extraction of quinolone antibiotics from water samples using capillary electrophoresis and large volume sample stacking with polarity switching. Journal of chromatography. A 20110805
Bacteraemia caused by Weissella confusa at a university hospital in Taiwan, 1997-2007. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20110801
In vitro activity of multiple antibiotic combinations against Nocardia: relationship with a short-term treatment strategy in heart transplant recipients with pulmonary nocardiosis. Transplant infectious disease : an official journal of the Transplantation Society 20110801
Population pharmacokinetic and concentration--QTc models for moxifloxacin: pooled analysis of 20 thorough QT studies. Journal of clinical pharmacology 20110801
Assessing the ecotoxicologic hazards of a pandemic influenza medical response. Environmental health perspectives 20110801
Multi-drug resistant Bacteroides fragilis recovered from blood and severe leg wounds caused by an improvised explosive device (IED) in Afghanistan. Anaerobe 20110801
Characterization and antimicrobial susceptibility of Clostridium difficile strains isolated from adult patients with diarrhoea hospitalized in two university hospitals in Poland, 2004-2006. Journal of medical microbiology 20110801
Susceptibility of hamsters to infection by historic and epidemic BI Clostridium difficile strains during daily administration of three fluoroquinolones. Anaerobe 20110801
Effect of gatifloxacin against Mycoplasma genitalium-related urethritis: an open clinical trial. Sexually transmitted infections 20110801
Low rate of fluoroquinolone resistance in Mycobacterium tuberculosis isolates from northern Tanzania. The Journal of antimicrobial chemotherapy 20110801
Synthesis and in-vitro antibacterial activity of 7-(3-aminopyrrolo[3,4-c]pyrazol-5(2H,4H,6H)-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivatives. Archiv der Pharmazie 20110801
Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006-2009. Anaerobe 20110801
Synthesis and evaluation of 1-cyclopropyl-2-thioalkyl-8-methoxy fluoroquinolones. Bioorganic & medicinal chemistry letters 20110801
Moxifloxacin prophylaxis for chemoembolization or embolization in patients with previous biliary interventions: a pilot study. AJR. American journal of roentgenology 20110801
[Current value of quinolones in Helicobacter pylori therapy]. Zeitschrift fur Gastroenterologie 20110801
The TB Alliance: overcoming challenges to chart the future course of TB drug development. Future medicinal chemistry 20110801
Risk factors of postoperative pneumonia after lung cancer surgery. Journal of Korean medical science 20110801
Contact-lens-related corneal ulcer caused by Klebsiella pneumoniae. Clinics (Sao Paulo, Brazil) 20110801
Prevalence of and Risk Factors for Levofloxacin-Resistant E. coli Isolated from Outpatients with Urinary Tract Infection. Korean journal of urology 20110801
Clarithromycin and amikacin vs. clarithromycin and moxifloxacin for the treatment of post-acupuncture cutaneous infections due to Mycobacterium abscessus: a prospective observational study. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20110701
Creation of a knowledge management system for QT analyses. Journal of clinical pharmacology 20110701
Interface blood after descemet stripping automated endothelial keratoplasty. Cornea 20110701
The DPP-4 inhibitor linagliptin does not prolong the QT interval at therapeutic and supratherapeutic doses. British journal of clinical pharmacology 20110701
T-wave morphology abnormalities in benign, potent, and arrhythmogenic I(kr) inhibition. Heart rhythm 20110701
Ophthalmic antibiotics and antimicrobial resistance a randomized, controlled study of patients undergoing intravitreal injections. Ophthalmology 20110701
Mycobacterium tuberculosis and cholinesterase inhibitors from Voacanga globosa. European journal of medicinal chemistry 20110701
Supra-therapeutic doses of roflumilast have no effect on cardiac repolarization in healthy subjects. Expert opinion on drug safety 20110701
Hepatic safety of antibiotics used in primary care. The Journal of antimicrobial chemotherapy 20110701
Thorough QT study of the effects of vildagliptin, a dipeptidyl peptidase IV inhibitor, on cardiac repolarization and conduction in healthy volunteers. Current medical research and opinion 20110701
Microbiological efficacy of a new ophthalmic formulation of moxifloxacin dosed twice-daily for bacterial conjunctivitis. Advances in therapy 20110701
Interaction study of moxifloxacin and lomefloxacin with co-administered drugs. Pakistan journal of pharmaceutical sciences 20110701
A placebo- and active-controlled assessment of 6- and 50-mg oral doxepin on cardiac repolarization in healthy volunteers: a thorough QT evaluation. Clinical therapeutics 20110701
Effect of topical immunomodulatory interleukin 1 receptor antagonist therapy on corneal healing in New Zealand white rabbits (Oryctolagus cunniculus) after photorefractive keratectomy. Archives of ophthalmology (Chicago, Ill. : 1960) 20110701
Emergence of Clostridium difficile ribotype 027 in Korea. The Korean journal of laboratory medicine 20110701
[The effectiveness of intraocular delivery of 5-fluoroquinolones for prophylaxis of intraocular infection]. Voenno-meditsinskii zhurnal 20110701
Extensively drug-resistant tuberculosis: New Zealand's first case and the challenges of management in a low-prevalence country. The Medical journal of Australia 20110606
Effect of number of replicate electrocardiograms recorded at each time point in a thorough QT study on sample size and study cost. Journal of clinical pharmacology 20110601
Aclidinium bromide, a long-acting antimuscarinic, does not affect QT interval in healthy subjects. Journal of clinical pharmacology 20110601
Incidence, occurrence rate, and characteristics of suture-related corneal infections after penetrating keratoplasty. Cornea 20110601
Clinical and histopathologic features of fluoroquinolone-induced liver injury. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20110601
Facile transformation of Biginelli pyrimidin-2(1H)-ones to pyrimidines. In vitro evaluation as inhibitors of Mycobacterium tuberculosis and modulators of cytostatic activity. European journal of medicinal chemistry 20110601
Preventing endophthalmitis after cataract surgeries. The British journal of ophthalmology 20110601
Fatal Pseudomonas aeruginosa pneumonia in a previously healthy woman was most likely associated with a contaminated hot tub. Infection 20110601
Comparative in vitro susceptibility of Burkholderia pseudomallei to doripenem, ertapenem, tigecycline and moxifloxacin. International journal of antimicrobial agents 20110601
Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-4-amino-4-methylpiperidin-1-yl) fluoroquinolone derivatives. European journal of medicinal chemistry 20110601
Helicobacter pylori isolates from proximal and distal stomach of patients never treated and already treated show genetic variability and discordant antibiotic resistance. European journal of gastroenterology & hepatology 20110601
Limited-sampling strategies for therapeutic drug monitoring of moxifloxacin in patients with tuberculosis. Therapeutic drug monitoring 20110601
A review of the epidemiology, diagnosis and evidence-based management of Mycoplasma genitalium. Sexual health 20110601
Human aqueous humor concentrations of besifloxacin, moxifloxacin, and gatifloxacin after topical ocular application. Journal of cataract and refractive surgery 20110601
Conventional Epi-LASIK and lamellar epithelial debridement in myopic patients with dermatologic keloids. Korean journal of ophthalmology : KJO 20110601
Diagnosis and management of community-acquired pneumonia in adults. American family physician 20110601
Intravenous moxifloxacin. Even more harmful than the oral form. Prescrire international 20110601
Retrospective comparison of levofloxacin and moxifloxacin on multidrug-resistant tuberculosis treatment outcomes. The Korean journal of internal medicine 20110601
Evidence-based guidelines for empirical therapy of neutropenic fever in Korea. The Korean journal of internal medicine 20110601
Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies. PLoS medicine 20110601
Thrombocytopenia, INR prolongation and fall in fibrinogen under daptomycin. Journal of chemotherapy (Florence, Italy) 20110601
Binary toxin and death after Clostridium difficile infection. Emerging infectious diseases 20110601
High vancomycin MIC and complicated methicillin-susceptible Staphylococcus aureus bacteremia. Emerging infectious diseases 20110601
[Activity of macrolides and fluoroquinolones against intracellular Legionella pneumophila]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 20110601
Molecular epidemiology of clostridium difficile in a tertiary medical center in Israel: emergence of the polymerase chain reaction ribotype 027. The Israel Medical Association journal : IMAJ 20110601
[Tuberculous meningitis: tips for diagnosis and proposals for treatment]. Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia 20110601
Immunoasssay chromatographic antigen test for rapid diagnosis of Group A beta hemolytic Streptococcus pharyngitis in children: A cross/ sectional study. Iranian journal of microbiology 20110601
Exploration of the activity of 7-pyrrolidino-8-methoxyisothiazoloquinolones against methicillin-resistant Staphylococcus aureus (MRSA). Journal of medicinal chemistry 20110512
Selenophene-containing inhibitors of type IIA bacterial topoisomerases. Journal of medicinal chemistry 20110512
Mycobacterium avium ssp. hominissuis biofilm is composed of distinct phenotypes and influenced by the presence of antimicrobials. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20110501
Effects of levofloxacin, moxifloxacin and prulifloxacin on murine gut colonization by Candida albicans. Medical mycology 20110501
Healthcare-associated bacteraemia caused by Leuconostoc species at a university hospital in Taiwan between 1995 and 2008. The Journal of hospital infection 20110501
Modelling biphasic killing of fluoroquinolones: guiding optimal dosing regimen design. The Journal of antimicrobial chemotherapy 20110501
Determination of moxifloxacin in dried blood spots using LC-MS/MS and the impact of the hematocrit and blood volume. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110501
Moxifloxacin-acetaminophen-warfarin interaction during bacille Calmette-Guerin treatment for bladder cancer. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110501
Effect of efflux pump inhibitors on drug susceptibility of ofloxacin resistant Mycobacterium tuberculosis isolates. The Indian journal of medical research 20110501
Mycoplasma genitalium: an emerging cause of sexually transmitted disease in women. PLoS pathogens 20110501
Cost effectiveness of outpatient treatment for febrile neutropaenia in adult cancer patients. British journal of cancer 20110426
Synthesis and biological evaluation of tetracyclic thienopyridones as antibacterial and antitumor agents. Bioorganic & medicinal chemistry 20110415
Molecular epidemiology and susceptibility profiles of Clostridium difficile in New Zealand, 2009. The New Zealand medical journal 20110415
A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer. Cancer chemotherapy and pharmacology 20110401
Effects of antibiotics on Chlamydia trachomatis viability as determined by real-time quantitative PCR. Journal of medical microbiology 20110401
IL-5 release of CD4+ non-effector lymphocytes is increased in COPD--modulating effects of moxifloxacin and dexamethasone. International immunopharmacology 20110401
Radiosynthesis and biological evaluation of the (99m)Tc-tricarbonyl moxifloxacin dithiocarbamate complex as a potential Staphylococcus aureus infection radiotracer. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20110401
Impact of pH on bacterial growth and activity of recent fluoroquinolones in pooled urine. Research in microbiology 20110401
The epidemiology of Clostridium difficile in Scotland. The Journal of infection 20110401
A rare case of peripartum endogenous bacterial endophthalmitis. International ophthalmology 20110401
Comparative in vitro and in vivo antimicrobial activities of sitafloxacin, gatifloxacin and moxifloxacin against Mycobacterium avium. International journal of antimicrobial agents 20110401
Novel thiolactone-isatin hybrids as potential antimalarial and antitubercular agents. Bioorganic & medicinal chemistry letters 20110401
Modelling the impact of antibiotic use on antibiotic-resistant Escherichia coli using population-based data from a large hospital and its surrounding community. The Journal of antimicrobial chemotherapy 20110401
In vitro time-kill experiments with besifloxacin, moxifloxacin and gatifloxacin in the absence and presence of benzalkonium chloride. The Journal of antimicrobial chemotherapy 20110401
Moxifloxacin-containing triple therapy versus bismuth-containing quadruple therapy for second-line treatment of Helicobacter pylori infection: a meta-analysis. Helicobacter 20110401
Fluoroquinolone use is not associated with the change in imipenem susceptibility of Pseudomonas aeruginosa in 25 hospitals. Advances in therapy 20110401
Rational use of moxifloxacin for tuberculosis treatment. The Lancet. Infectious diseases 20110401
Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures. Archives of ophthalmology (Chicago, Ill. : 1960) 20110401
Mycobacterium bolletii/Mycobacterium massiliense furunculosis associated with pedicure footbaths: a report of 3 cases. Archives of dermatology 20110401
[Regional difference of antibiotic resistance of helicobacter pylori strains in Korea]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20110401
Pharmacokinetic/pharmacodynamic-based treatment of disseminated Mycobacterium avium. Future microbiology 20110401
Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin. Journal of chemotherapy (Florence, Italy) 20110401
Evaluation of the effect of bacterial efflux pumps on the antibacterial activity of the novel fluoroquinolone besifloxacin. Journal of chemotherapy (Florence, Italy) 20110401
Comparison of the chromatographic behavior of levofloxacin, ciprofloxacin and moxifloxacin on various HPLC phases. Die Pharmazie 20110401
[Comparative evaluation of e-test and disk diffusion methods for susceptibility testing of Nocardia species]. Mikrobiyoloji bulteni 20110401
Prophylactic effect of intravenous moxifloxacin in a rabbit model of Staphylococcus epidermidis endophthalmitis. Investigative ophthalmology & visual science 20110325
Synthesis and in vitro antibacterial activity of 7-(3-amino-6,7-dihydro-2-methyl-2H-pyrazolo[4,3-c] pyridin-5(4H)-yl)fluoroquinolone derivatives. Molecules (Basel, Switzerland) 20110322
[Practical ECG problems in the elderly patient. Case number 16. Moxifloxacin-associated QT interval prolongation]. Revue medicale suisse 20110316
Synthesis, characterization and anti-tumor activity of moxifloxacin-copper complexes against breast cancer cell lines. Bioorganic & medicinal chemistry letters 20110315
High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions. Analytical chemistry 20110315
Geographical clustering of cases of infection with moxifloxacin-resistant Clostridium difficile PCR-ribotypes 012, 017 and 046 in Sweden, 2008 and 2009. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 20110310
Enterococcus gallinarum meningitis: a case report and literature review. Journal of infection in developing countries 20110304
Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20110301
Perioperative moxifloxacin treatment in rats subjected to deep hypothermic circulatory arrest: reduction in cerebral inflammation but without improvement in cognitive performance. The Journal of thoracic and cardiovascular surgery 20110301
Antimicrobial resistance profile of Staphylococcus aureus isolated from clinical samples and foods of animal origin. Foodborne pathogens and disease 20110301
Significant ecological impact on the progression of fluoroquinolone resistance in Escherichia coli with increased community use of moxifloxacin, levofloxacin and amoxicillin/clavulanic acid. The Journal of antimicrobial chemotherapy 20110301
Activity of moxifloxacin against intracellular community-acquired methicillin-resistant Staphylococcus aureus: comparison with clindamycin, linezolid and co-trimoxazole and attempt at defining an intracellular susceptibility breakpoint. The Journal of antimicrobial chemotherapy 20110301
Moxifloxacin monotherapy versus ß-lactam mono- or combination therapy in hospitalized patients with community-acquired pneumonia. The Journal of infection 20110301
Moxifloxacin and pyrazinamide susceptibility testing in a complex case of multidrug-resistant tuberculosis. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20110301
Tear, cornea, and aqueous humor concentrations of ciprofloxacin and moxifloxacin after topical ocular application in ophthalmologically normal horses. American journal of veterinary research 20110301
Epidemiology of Mycobacterium bovis disease in humans, The Netherlands, 1993-2007. Emerging infectious diseases 20110301
Molecular epidemiology of Mycobacterium tuberculosis, Buenos Aires, Argentina. Emerging infectious diseases 20110301
New drugs for tuberculosis treatment. Enfermedades infecciosas y microbiologia clinica 20110301
Torticollis in mice intravenously infected with Mycobacterium tuberculosis. Journal of the American Association for Laboratory Animal Science : JAALAS 20110301
Recent developments in treatment of latent tuberculosis infection. The Indian journal of medical research 20110301
Should quinolones come first in Helicobacter pylori therapy? Therapeutic advances in gastroenterology 20110301
Enzymatic quorum quenching increases antibiotic susceptibility of multidrug resistant Pseudomonas aeruginosa. Iranian journal of microbiology 20110301
Detection of cross-infection associated to a Brazilian PCR-ribotype of Clostridium difficile in a university hospital in Rio de Janeiro, Brazil. Antonie van Leeuwenhoek 20110201
In vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones. Allergy 20110201
Pharmacokinetics and penetration of moxifloxacin into infected diabetic foot tissue in a large diabetic patient cohort. European journal of clinical pharmacology 20110201
Response of Gardnerella vaginalis biofilm to 5 days of moxifloxacin treatment. FEMS immunology and medical microbiology 20110201
Characterization of toxin genes and antimicrobial susceptibility of Staphylococcus aureus isolates from Louisiana retail meats. Foodborne pathogens and disease 20110201
Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa. Dermatology (Basel, Switzerland) 20110201
Molecular epidemiology of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolated from the eye. Current eye research 20110201
Year in review in Intensive Care Medicine 2010: II. Pneumonia and infections, cardiovascular and haemodynamics, organization, education, haematology, nutrition, ethics and miscellanea. Intensive care medicine 20110201
Moxifloxacin-tetracycline-lansoprazole triple therapy for first-line treatment of Helicobacter pylori infection: a prospective study. Helicobacter 20110201
Segniliparus rugosus-associated bronchiolitis in California sea lion. Emerging infectious diseases 20110201
Surface layer protein A variant of Clostridium difficile PCR-ribotype 027. Emerging infectious diseases 20110201
Clinical effectiveness and safety of gemifloxacin versus cefpodoxime in acute exacerbation of chronic bronchitis: A randomized, controlled trial. Indian journal of pharmacology 20110201
Severe isoniazid related sideroblastic anemia. Hematology reports 20110113
Susceptibility of rapidly growing mycobacteria isolated from cats and dogs, to ciprofloxacin, enrofloxacin and moxifloxacin. Veterinary microbiology 20110110
Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis. Investigative ophthalmology & visual science 20110105
Inter-α inhibitor proteins: a novel therapeutic strategy for experimental anthrax infection. Shock (Augusta, Ga.) 20110101
Shifting trends in in vitro antibiotic susceptibilities for common bacterial conjunctival isolates in the last decade at the New York Eye and Ear Infirmary. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20110101
Low prevalence of fluoroquinolone resistant strains and resistance precursor strains in Streptococcus pneumoniae from patients with community-acquired pneumonia despite high fluoroquinolone usage. International journal of medical microbiology : IJMM 20110101
Epidemiology of Streptococcus pneumoniae and Staphylococcus aureus colonization in healthy Venezuelan children. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20110101
Status epilepticus attributed to moxifloxacin in an adolescent patient with spina bifida occulta. European journal of clinical pharmacology 20110101
Efficacy and safety of adjunctive local moxifloxacin delivery in the treatment of periodontitis. Journal of periodontology 20110101
Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitis. Cornea 20110101
What's in a Name? Can Mullein Weed Beat TB Where Modern Drugs Are Failing? Evidence-based complementary and alternative medicine : eCAM 20110101
Effect of fluoroquinolones on the expression of matrix metalloproteinase in debrided cornea of rats. Toxicology mechanisms and methods 20110101
Modulation of Salmonella gene expression by subinhibitory concentrations of quinolones. The Journal of antibiotics 20110101
Reduced levofloxacin susceptibility in clinical respiratory isolates of Haemophilus influenzae is not yet associated with mutations in the DNA gyrase and topoisomerase II genes in Korea. Yonsei medical journal 20110101
Moxifloxacin 0.5% ophthalmic solution: in bacterial conjunctivitis. Drugs 20110101
Effects of multistrain probiotic-containing yogurt on second-line triple therapy for Helicobacter pylori infection. Journal of gastroenterology and hepatology 20110101
Relevance of aqueous humor concentrations of fluoroquinolones. Journal of cataract and refractive surgery 20110101
Treatment outcome and mortality among patients with multidrug-resistant tuberculosis in tuberculosis hospitals of the public sector. Journal of Korean medical science 20110101
WSES consensus conference: Guidelines for first-line management of intra-abdominal infections. World journal of emergency surgery : WJES 20110101
Treatment of disseminated mycobacterial infection with high-dose IFN-γ in a patient with IL-12Rβ1 deficiency. Clinical & developmental immunology 20110101
Comparison of 5 methods of QT interval measurements on electrocardiograms from a thorough QT/QTc study: effect on assay sensitivity and categorical outliers. Journal of electrocardiology 20110101
Eosinophilic pneumonia associated with daptomycin: a case report and a review of the literature. Journal of medical case reports 20110101
Activities of rifampin, Rifapentine and clarithromycin alone and in combination against mycobacterium ulcerans disease in mice. PLoS neglected tropical diseases 20110101
Highly automated QT measurement techniques in 7 thorough QT studies implemented under ICH E14 guidelines. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20110101
A novel approach to pharmacodynamic assessment of antimicrobial agents: new insights to dosing regimen design. PLoS computational biology 20110101
Development and implementation of a performance improvement project in adult intensive care units: overview of the Improving Medicine Through Pathway Assessment of Critical Therapy in Hospital-Acquired Pneumonia (IMPACT-HAP) study. Critical care (London, England) 20110101
Animal models of bacterial keratitis. Journal of biomedicine & biotechnology 20110101
'The difference in determinants of Chlamydia trachomatis and Mycoplasma genitalium in a sample of young Australian women'. BMC infectious diseases 20110101
Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial. Trials 20110101
Canadian clinical practice guidelines for acute and chronic rhinosinusitis. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 20110101
Vitreous and aqueous penetration of orally and topically administered moxifloxacin. Ophthalmic research 20110101
[Highlights of the Congress of the National Infectious Disease Medicine Days 2010]. Medecine et maladies infectieuses 20110101
Hematoma and abscess formation caused by Mycoplasma hominis following cesarean section. International journal of women's health 20110101
Tuberculous meningitis in Denmark: a review of 50 cases. BMC infectious diseases 20110101
A Comprehensive review of abdominal infections. World journal of emergency surgery : WJES 20110101
Acute endophthalmitis following 23-gauge sutureless transconjunctival vitrectomy. Indian journal of ophthalmology 20110101
A spatial approach for the epidemiology of antibiotic use and resistance in community-based studies: the emergence of urban clusters of Escherichia coli quinolone resistance in Sao Paulo, Brasil. International journal of health geographics 20110101
Long-term potency, sterility, and stability of vancomycin, ceftazidime, and moxifloxacin for treatment of bacterial endophthalmitis. Retina (Philadelphia, Pa.) 20110101
Efficacy and tolerability of a combined gatifloxacin plus prednisolone formulation for topical prophylaxis after LASIK. Clinical ophthalmology (Auckland, N.Z.) 20110101
Development of novel in silico model to predict corneal permeability for congeneric drugs: a QSPR approach. Journal of biomedicine & biotechnology 20110101
Laboratory animal models for brucellosis research. Journal of biomedicine & biotechnology 20110101
Severe pneumococcal pneumonia: impact of new quinolones on prognosis. BMC infectious diseases 20110101
Sterilizing activity of second-line regimens containing TMC207 in a murine model of tuberculosis. PloS one 20110101
Pharmacokinetic-pharmacodynamic modelling of the effect of Moxifloxacin on QTc prolongation in telemetered cynomolgus monkeys. Journal of pharmacological and toxicological methods 20110101
Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi. PloS one 20110101
Decline in Clostridium difficile-associated disease rates in Singapore public hospitals, 2006 to 2008. BMC research notes 20110101
Transfer kinetics from colloidal drug carriers and liposomes to biomembrane models: DSC studies. Journal of pharmacy & bioallied sciences 20110101
Generic antibiotic industries: Challenges and implied strategies with regulatory perspectives. Journal of pharmacy & bioallied sciences 20110101
Association of mutation patterns in gyrA/B genes and ofloxacin resistance levels in Mycobacterium tuberculosis isolates from East China in 2009. BMC infectious diseases 20110101
Location of intra- and extracellular M. tuberculosis populations in lungs of mice and guinea pigs during disease progression and after drug treatment. PloS one 20110101
Antimicrobial susceptibilities of Brucella isolates from various clinical specimens. International journal of medical sciences 20110101
Legionnaires' disease with facial nerve palsy. Case reports in medicine 20110101
Antimicrobial and efflux pump inhibitory activity of caffeoylquinic acids from Artemisia absinthium against gram-positive pathogenic bacteria. PloS one 20110101
Antimicrobial treatment of 'complicated' intra-abdominal infections and the new IDSA guidelines ? a commentary and an alternative European approach according to clinical definitions. European journal of medical research 20110101
2009 H1N1 influenza and experience in three critical care units. International journal of medical sciences 20110101
First report of molecular detection of fluoroquinolone resistance-associated gyrA mutations in multidrug-resistant clinical Mycobacterium tuberculosis isolates in Kuwait. BMC research notes 20110101
Geographic differences in time to culture conversion in liquid media: Tuberculosis Trials Consortium study 28. Culture conversion is delayed in Africa. PloS one 20110101
Urinary elimination of coproporphyrins is dependent on ABCC2 polymorphisms and represents a potential biomarker of MRP2 activity in humans. Journal of biomedicine & biotechnology 20110101
Antibiotic resistance and molecular epidemiology of Staphylococcus aureus in Nigeria. BMC microbiology 20110101
Characteristics and treatment outcomes of patients with MDR and XDR tuberculosis in a TB referral hospital in Beijing: a 13-year experience. PloS one 20110101
Fusidic acid resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in a Taiwanese hospital. BMC microbiology 20110101
A Case Of Staphylococcus lugdunensis Related Pyomyoma Occurring after Cesarean Section. Journal of global infectious diseases 20110101
Pulmonary strongyloidiasis associated CD3+ large granular lymphocytosis. Annals of thoracic medicine 20110101
SCEDOSPORIUM INFECTION IN A PATIENT WITH ANTI-TNFα THERAPY. Indian journal of dermatology 20110101
Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis. Clinical ophthalmology (Auckland, N.Z.) 20110101
Size and usage patterns of private TB drug markets in the high burden countries. PloS one 20110101
Clinical characteristics and therapeutic outcomes of nosocomial super-infection in adult bacterial meningitis. BMC infectious diseases 20110101
Persistent neutrophilic meningitis in an immunocompetent patient after basilar skull fracture: case report. BMC infectious diseases 20110101
[Beta-lactamases of clinical isolates of Enterobacteriaceae family]. Mikrobiolohichnyi zhurnal (Kiev, Ukraine : 1993) 20110101
The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis. Clinical drug investigation 20110101
Cardiac safety of indacaterol in healthy subjects: a randomized, multidose, placebo- and positive-controlled, parallel-group thorough QT study. BMC pulmonary medicine 20110101
Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: retrospective analysis of three medical/pharmacy claims databases. BMC ophthalmology 20110101
Intravenous moxifloxacin in routine hospital treatment of respiratory tract infections in China: results of a multicenter, noninterventional study. International journal of general medicine 20110101
Potential role of tigecycline in the treatment of community-acquired bacterial pneumonia. Infection and drug resistance 20110101
Survival of civilian and prisoner drug-sensitive, multi- and extensive drug- resistant tuberculosis cohorts prospectively followed in Russia. PloS one 20110101
Evaluation of direct inoculation of the BD PHOENIX system from positive BACTEC blood cultures for both Gram-positive cocci and Gram-negative rods. BMC microbiology 20110101
Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence. BMC microbiology 20110101
Unnecessary use of fluoroquinolone antibiotics in hospitalized patients. BMC infectious diseases 20110101
Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex for first and second line drugs by broth dilution in a microtiter plate format. Journal of visualized experiments : JoVE 20110101
A clinical pathway for community-acquired pneumonia: an observational cohort study. BMC infectious diseases 20110101
Effect of administration of moxifloxacin plus rifampin against Mycobacterium tuberculosis for 7 of 7 days versus 5 of 7 days in an in vitro pharmacodynamic system. mBio 20110101
Update and critical appraisal of the use of topical azithromycin ophthalmic 1% (AzaSite) solution in the treatment of ocular infections. Clinical ophthalmology (Auckland, N.Z.) 20110101
A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology. International journal of chronic obstructive pulmonary disease 20110101
The thorough QT study: let's be precise. Cardiology journal 20110101
Improving the precision of QT measurements. Cardiology journal 20110101
Efficacy and tolerability of a combined moxifloxacin/dexamethasone formulation for topical prophylaxis in phacoemulsification: an open-label single-arm clinical trial. Journal of ophthalmology 20110101
Potential economic viability of two proposed rifapentine-based regimens for treatment of latent tuberculosis infection. PloS one 20110101
Influence of a probiotic soy product on fecal microbiota and its association with cardiovascular risk factors in an animal model. Lipids in health and disease 20110101
Clostridium difficile-associated diarrhea in radiooncology: an underestimated problem for the feasibility of the radiooncological treatment? Radiation oncology (London, England) 20110101
Prevalence of aac(6')-Ib-cr plasmid-mediated and chromosome-encoded fluoroquinolone resistance in Enterobacteriaceae in Italy. Gut pathogens 20110101
Is C. Pneumoniae research in peril? Frontiers in microbiology 20110101
Fluoroquinolones, the cornerstone of treatment of drug-resistant tuberculosis: a pharmacokinetic and pharmacodynamic approach. Current pharmaceutical design 20110101
In vitro and in vivo modeling of tuberculosis drugs and its impact on optimization of doses and regimens. Current pharmaceutical design 20110101
Outcome of in-the-bag implanted square-edge polymethyl methacrylate intraocular lenses with and without primary posterior capsulotomy in pediatric traumatic cataract. Indian journal of ophthalmology 20110101
Visual perception changes and optical stability after intracorneal ring segment implantation: comparison between 3 months and 1 year after surgery. Clinical ophthalmology (Auckland, N.Z.) 20110101
Single intravitreal ranibizumab for myopic choroidal neovascularization. Clinical ophthalmology (Auckland, N.Z.) 20110101
Cataract surgery in a patient with amyotrophic lateral sclerosis: a case report. Case reports in ophthalmology 20110101
Treatment of tuberculosis in a region with high drug resistance: outcomes, drug resistance amplification and re-infection. PloS one 20110101
Tuberculosis chemotherapy in the 21 century: Back to the basics. Lung India : official organ of Indian Chest Society 20110101
New therapeutic approach for latent tuberculosis infection. Lung India : official organ of Indian Chest Society 20110101
Cross sensitivity between ciprofloxacin and levofloxacin for an immediate hypersensitivity reaction. Journal of pharmacology & pharmacotherapeutics 20110101
A toxin-antitoxin module in Bacillus subtilis can both mitigate and amplify effects of lethal stress. PloS one 20110101
Treatment of drug-resistant tuberculosis. Infection and drug resistance 20110101
Moxifloxacin-induced delirium with hallucinations. Psychosomatics 20110101
Clostridium difficile Infection and Inflammatory Bowel Disease: A Review. Gastroenterology research and practice 20110101
Rare occurrence of methicillin-resistant Staphylococcus aureus CC130 with a novel mecA homologue in humans in Germany. PloS one 20110101
Clonal population of Mycobacterium tuberculosis strains reside within multiple lung cavities. PloS one 20110101
Internalization of Staphylococcus aureus in lymphocytes induces oxidative stress and DNA fragmentation: possible ameliorative role of nanoconjugated vancomycin. Oxidative medicine and cellular longevity 20110101
Molecular detection of fluoroquinolone-resistance in multi-drug resistant tuberculosis in Cambodia suggests low association with XDR phenotypes. BMC infectious diseases 20110101
The chicken cornea as a model of wound healing and neuronal re-innervation. Molecular vision 20110101
Topoisomerase mutations that are associated with high-level resistance to earlier fluoroquinolones in Staphylococcus aureus have less effect on the antibacterial activity of besifloxacin. Chemotherapy 20110101
Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations. International journal of chronic obstructive pulmonary disease 20110101
Rhodococcus equi infection after reduction mammaplasty in an immunocompetent patient. Revista do Instituto de Medicina Tropical de Sao Paulo 20110101
The National Formulary of India 2010: Thorough and extensive revision of the preprint version needed. Journal of pharmacology & pharmacotherapeutics 20110101
Pharmacodynamic evaluation of commonly prescribed oral antibiotics against respiratory bacterial pathogens. BMC infectious diseases 20110101
Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: microbiological eradication outcomes. Clinical ophthalmology (Auckland, N.Z.) 20110101
Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: etiology of bacterial conjunctivitis and antibacterial susceptibility profile. Clinical ophthalmology (Auckland, N.Z.) 20110101
Evaluation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK. Clinical ophthalmology (Auckland, N.Z.) 20110101
Hypervirulent Clostridium difficile PCR-ribotypes exhibit resistance to widely used disinfectants. PloS one 20110101
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy. Drug, healthcare and patient safety 20110101
Ertapenem for treatment of osteomyelitis: a case series. BMC research notes 20110101
Mycobacterium genavense as a cause of subacute pneumonia in patients with severe cellular immunodeficiency. BMC infectious diseases 20110101
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis. PloS one 20110101
Paraneoplastic syndrome mimicking adult-onset Still's disease caused by advanced lung cancer: a case report. BMC cancer 20110101
Antimicrobial therapy for the treatment of opportunistic infections in HIV/AIDS patients: a critical appraisal. HIV/AIDS (Auckland, N.Z.) 20110101
Molecular and immunological characterization of Staphylococcus aureus in pediatric atopic dermatitis: implications for prophylaxis and clinical management. Clinical & developmental immunology 20110101
Computer aided screening and evaluation of herbal therapeutics against MRSA infections. Bioinformation 20110101
Ambulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, India. PloS one 20110101
Completeness and timeliness of tuberculosis notification in Taiwan. BMC public health 20110101
Transient peripheral edema following displaced corneal graft after descemet stripping automated endothelial keratoplasty (DSAEK): case presentation. BMC ophthalmology 20110101
Docking studies on novel analogues of 8 methoxy fluoroquinolones against GyrA mutants of Mycobacterium tuberculosis. BMC structural biology 20110101
QT prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications. Cardiology 20110101
Characterization of Abcc4 gene amplification in stepwise-selected mouse J774 macrophages resistant to the topoisomerase II inhibitor ciprofloxacin. PloS one 20110101
'Ten Commandments' for the Appropriate use of Antibiotics by the Practicing Physician in an Outpatient Setting. Frontiers in microbiology 20110101
Discovery of novel MDR-Mycobacterium tuberculosis inhibitor by new FRIGATE computational screen. PloS one 20110101
Impact of sub-inhibitory antibiotics on fibronectin-mediated host cell adhesion and invasion by Staphylococcus aureus. BMC microbiology 20110101
Different cellular effects of four anti-inflammatory eye drops on human corneal epithelial cells: independent in active components. Molecular vision 20110101
Surveillance of broad-spectrum antibiotic prescription in Singaporean hospitals: a 5-year longitudinal study. PloS one 20110101
Influenza A/H1N1 septic shock in a patient with systemic lupus erythematosus. A case report. BMC infectious diseases 20110101
In the quest of drugs for bad bugs: are newer fluoroquinolones any better? Journal of laboratory physicians 20110101
Development and validation of spectrophotometric, atomic absorption and kinetic methods for determination of moxifloxacin hydrochloride. Analytical chemistry insights 20110101
Oxidative stress induced by fluoroquinolones on treatment for complicated urinary tract infections in Indian patients. Journal of young pharmacists : JYP 20110101
Treatment of acute pelvic inflammatory disease. Infectious diseases in obstetrics and gynecology 20110101
Modulation of biofilm of strains isolated from patients with chronic obstructive pulmonary disease by levofloxacin, moxifloxacin, ciprofloxacin, amoxicillin/clavulanic acid and ceftriaxone. International journal of immunopathology and pharmacology 20110101
Mycoplasma genitalium: an emerging cause of pelvic inflammatory disease. Infectious diseases in obstetrics and gynecology 20110101
Investigation of parameters highlighting drug induced small changes of the T-wave's morphology for drug safety studies. Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 20110101
Drug-resistant tuberculosis: emerging treatment options. Clinical pharmacology : advances and applications 20110101
Factors affecting the cost effectiveness of antibiotics. Chemotherapy research and practice 20110101
Antibiotic Combinations with Daptomycin for Treatment of Staphylococcus aureus Infections. Chemotherapy research and practice 20110101
[Present and future in the use of anti-tubercular drugs]. Pneumologia (Bucharest, Romania) 20110101
[Crystalline keratopathy: an infrequent corneal infection produced by the Streptococcus mitis group]. Revista Argentina de microbiologia 20110101
Tuberculous meningitis: diagnosis and treatment overview. Tuberculosis research and treatment 20110101
Traumatic Endophthalmitis due to Cellulosimicrobium cellulans. Case reports in ophthalmological medicine 20110101
Inhibition of DNA gyrase by levofloxacin and related fluorine-containing heterocyclic compounds. Acta naturae 20110101
Mycobacterial brain tuberculomas due to Bacille Calmette-Guérin intravesical chemotherapy for bladder cancer: A case report and literature review. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale 20110101
High performance liquid chromatography assay with ultraviolet detection for moxifloxacin: validation and application to a pharmacokinetic study in Chinese volunteers. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20101215
Drugs in development for tuberculosis. Drugs 20101203
Aspergillus keratitis in vernal shield ulcer--a case report and review. International ophthalmology 20101201
Comparison of resistance against erythromycin and moxifloxacin, presence of binary toxin gene and PCR ribotypes in Clostridium difficile isolates from 1990 and 2008. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20101201
Antibiotic resistance of conjunctiva and nasopharynx evaluation study: a prospective study of patients undergoing intravitreal injections. Ophthalmology 20101201
MLVA typing and antibiotic susceptibility of Brucella human isolates from Liaoning, China. Transactions of the Royal Society of Tropical Medicine and Hygiene 20101201
Antimicrobial susceptibility and heteroresistance in Chinese Clostridium difficile strains. Anaerobe 20101201
Conjunctival concentrations of a new ophthalmic solution formulation of moxifloxacin 0.5% in cataract surgery patients. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20101201
Antibacterial activity of finafloxacin under different pH conditions against isogenic strains of Escherichia coli expressing combinations of defined mechanisms of fluoroquinolone resistance. The Journal of antimicrobial chemotherapy 20101201
In vitro susceptibility of Actinobaculum schaalii to 12 antimicrobial agents and molecular analysis of fluoroquinolone resistance. The Journal of antimicrobial chemotherapy 20101201
Can intraocular lenses deliver antibiotics intracamerally? Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20101201
Penetration and effectiveness of prophylactic fluoroquinolones in experimental methicillin-sensitive or methicillin-resistant Staphylococcus aureus anterior chamber infections. Journal of cataract and refractive surgery 20101201
Moxifloxacin and cholesterol combined treatment of pneumococcal keratitis. Current eye research 20101201
Half-century-old TB drugs get a facelift in new cocktails. Nature medicine 20101201
Novel technologies: A weapon against tuberculosis. Indian journal of pharmacology 20101201
[Chinfloxacin hydrochloride inhibits HERG potassium channel at open state]. Yao xue xue bao = Acta pharmaceutica Sinica 20101201
[In vitro activity of sitafloxacin against clinical isolates in 2009]. The Japanese journal of antibiotics 20101201
Fatal cases associated with pandemic influenza A (H1N1) reported in Greece. PLoS currents 20101109
Single therapeutic and supratherapeutic doses of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, do not prolong the QTcF interval in healthy volunteers. Journal of clinical pharmacology 20101101
Pharmacokinetics and pharmacodynamics of three moxifloxacin dosage forms: implications for blinding in active-controlled cardiac repolarization studies. Journal of clinical pharmacology 20101101
High resistance against clindamycin, metronidazole and amoxicillin in Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans isolates of periodontal disease. Medicina oral, patologia oral y cirugia bucal 20101101
Comparative antimicrobial susceptibility of biofilm versus planktonic forms of Salmonella enterica strains isolated from children with gastroenteritis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20101101
In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20101101
Comparison of the effects of fourth-generation fluoroquinolones on epithelial healing after photorefractive keratectomy. Cornea 20101101
Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study. BJOG : an international journal of obstetrics and gynaecology 20101101
Pharmacokinetics of azithromycin and moxifloxacin in human conjunctiva and aqueous humor during and after the approved dosing regimens. American journal of ophthalmology 20101101
Impact of different empirical antibiotic treatment regimens for community-acquired pneumonia on the emergence of Clostridium difficile. The Journal of antimicrobial chemotherapy 20101101
German multicentre survey of the antibiotic susceptibility of Bacteroides fragilis group and Prevotella species isolated from intra-abdominal infections: results from the PRISMA study. The Journal of antimicrobial chemotherapy 20101101
Complicated skin and soft tissue infection. The Journal of antimicrobial chemotherapy 20101101
Presumed corneal stromal graft rejection after deep anterior lamellar keratoplasty in a patient with systemic lupus erythematosis. Eye & contact lens 20101101
Two pediatric cases of multidrug-resistant tuberculosis treated with linezolid and moxifloxacin. Pediatrics 20101101
Mycobacterium heckeshornense infection in HIV-infected patient. Emerging infectious diseases 20101101
Fluoroquinolones in the management of community-acquired pneumonia in primary care. Expert review of anti-infective therapy 20101101
Current medical management of diabetic foot infections. Expert review of anti-infective therapy 20101101
All-oral antibiotic treatment for buruli ulcer: a report of four patients. PLoS neglected tropical diseases 20101101
Synthesis of non-purine analogs of 6-aryl-9-benzylpurines, and their antimycobacterial activities. Compounds modified in the imidazole ring. Bioorganic & medicinal chemistry 20101015
[Use of moxifloxacin in tuberculosis regimen in a French teaching hospital]. Medecine et maladies infectieuses 20101001
Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20101001
Short-course fluoroquinolone therapy in exacerbations of chronic bronchitis and COPD. Respiratory medicine 20101001
Clinical update on the use of moxifloxacin in the treatment of community-acquired complicated intraabdominal infections. Surgical infections 20101001
Practice patterns for antibiotic de-escalation in culture-negative healthcare-associated pneumonia. Infection 20101001
Post-antibiotic effect (PAE) of moxifloxacin in multidrug-resistant Stenotrophomonas maltophilia. International journal of antimicrobial agents 20101001
Thorough cardiac QTc interval conductance assessment of a novel oral tranexamic acid treatment for heavy menstrual bleeding. Expert opinion on pharmacotherapy 20101001
Fluoroquinolones induce the expression of patA and patB, which encode ABC efflux pumps in Streptococcus pneumoniae. The Journal of antimicrobial chemotherapy 20101001
Comparative antibiotic failure rates in the treatment of community-acquired pneumonia: Results from a claims analysis. Advances in therapy 20101001
Evaluation of the effects of AZD3480 on cardiac repolarization: a thorough QT/QTc study using moxifloxacin as a positive control. Clinical pharmacology and therapeutics 20101001
Efficacy of moxifloxacin compared to teicoplanin in the treatment of implant-related chronic osteomyelitis in rats. Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20101001
Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20101001
Single-dose ticagrelor does not prolong the QT interval in healthy subjects. International journal of clinical pharmacology and therapeutics 20101001
A thorough QT/QTc study of multiple doses of tapentadol immediate release in healthy subjects. International journal of clinical pharmacology and therapeutics 20101001
Investigation of toxin gene diversity, molecular epidemiology, and antimicrobial resistance of Clostridium difficile isolated from 12 hospitals in South Korea. The Korean journal of laboratory medicine 20101001
Accurate detection of drug-induced delayed ventricular repolarization with a suitable correction formula in Langendorff guinea pig heart. The Journal of toxicological sciences 20101001
Clostridium difficile-associated diarrhea in a tertiary care medical center. Proceedings (Baylor University. Medical Center) 20101001
A case of Pantoea endophthalmitis. Korean journal of ophthalmology : KJO 20101001
[A case of cerebral abscess due to methicillin-resistant Staphylococcus aureus which is treated with linezolid + rifampin combination]. Mikrobiyoloji bulteni 20101001
[A case of spinal osteomyelitis due to Mycobacterium intracellulare with pulmonary Mycobacterium avium complex]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20101001
Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 20101001
The evolution of Helicobacter pylori antibiotics resistance over 10 years in Beijing, China. Helicobacter 20101001
Advantages of azithromycin over erythromycin in improving the gastric emptying half-time in adult patients with gastroparesis. Journal of neurogastroenterology and motility 20101001
[The role of moxifloxacin in the prophylaxis of post-surgical endophthalmitis]. Archivos de la Sociedad Espanola de Oftalmologia 20101001
[Antimicrobial susceptibility, capsular serotypes and clonal relationship of invasive streptococcus pneumoniae isolates in adult population of the Bio-Bio region, Chile. 2005-2006]. Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia 20101001
Ninety-seven Years Old Hispanic Male With Mantle Cell Lymphoma. Journal of clinical medicine research 20101001
Endophthalmitis caused by Stenotrophomonas maltophilia. Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 20100922
An adaptable HPLC method for the analysis of frequently used antibiotics in ocular samples. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100915
Moxifloxacin in the treatment of acute bacterial rhinosinusitis: results of a multicenter, non-interventional study. Acta oto-laryngologica 20100901
Synergistic activities between carbapenems and other antimicrobial agents against Acinetobacter baumannii including multidrug-resistant and extensively drug-resistant isolates. International journal of antimicrobial agents 20100901
Artifactual measurement of low serum HDL-cholesterol due to paraproteinemia. Clinical research in cardiology : official journal of the German Cardiac Society 20100901
Antimicrobial activity of DW286 against Streptococcus pneumoniae. International journal of antimicrobial agents 20100901
Dichotomous selection of high-level oxacillin resistance in Staphylococcus aureus by fluoroquinolones. International journal of antimicrobial agents 20100901
Aqueous penetration of moxifloxacin 0.5% ophthalmic solution and besifloxacin 0.6% ophthalmic suspension in cataract surgery patients. Journal of cataract and refractive surgery 20100901
Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones. Journal of cataract and refractive surgery 20100901
Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy. Drug safety 20100901
Cerebrospinal fluid concentrations of antituberculosis agents in adults and children. Tuberculosis (Edinburgh, Scotland) 20100901
Acute cervical lymphadenitis caused by Mycobacterium florentinum. Emerging infectious diseases 20100901
Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance. Nature structural & molecular biology 20100901
Evaluation of MGIT 960 and the colorimetric-based method for tuberculosis drug susceptibility testing. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20100901
Anterior chamber and vitreous concordance in endophthalmitis: implications for prophylaxis. Archives of ophthalmology (Chicago, Ill. : 1960) 20100901
Cytotoxicity of topical medications used for infection and inflammation control after cataract surgery in cultured corneal endothelial cells. Biocontrol science 20100901
Comparison of the influence of intracameral gentamicin, gatifloxacin, and moxifloxacin on the corneal endothelium in a rabbit model. Japanese journal of ophthalmology 20100901
Thermoreversible mucoadhesive ophthalmic in situ hydrogel: Design and optimization using a combination of polymers. Acta pharmaceutica (Zagreb, Croatia) 20100901
Sensitivity pattern of methicillin resistant Staphylococcus aureus isolated from patients admitted in a tertiary care hospital of Pakistan. Iranian journal of microbiology 20100901
Synthesis and biological evaluation of tetracyclic fluoroquinolones as antibacterial and anticancer agents. Bioorganic & medicinal chemistry 20100815
In vitro susceptibility to 17 antimicrobials of clinical Clostridium difficile isolates collected in 1993-2007 in Sweden. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20100801
[Intracameral moxifloxacin: a safe option for endophthalmitis prophylaxis? In vitro safety profile for intraocular application]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 20100801
Microbiological analysis of epidermal growth factor receptor inhibitor therapy-associated paronychia. Journal of the European Academy of Dermatology and Venereology : JEADV 20100801
Pharmacokinetics and bioavailability of moxifloxacin in buffalo calves. Research in veterinary science 20100801
Experimental pulmonary infection and colonization of Haemophilus influenzae in emphysematous hamsters. Pulmonary pharmacology & therapeutics 20100801
An in vitro investigation of synergy or antagonism between antimicrobial combinations against isolates from bacterial keratitis. Investigative ophthalmology & visual science 20100801
Colonisation of fluoroquinolone-resistant Haemophilus influenzae among nursing home residents in southern Taiwan. The Journal of hospital infection 20100801
Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin. Eye (London, England) 20100801
Maternal and fetal blood levels of moxifloxacin, levofloxacin, cefepime and cefoperazone. International journal of antimicrobial agents 20100801
Oritavancin, a new lipoglycopeptide antibiotic: results from a thorough QT study. Journal of clinical pharmacology 20100801
Synthesis and in vitro antimycobacterial activity of balofloxacin ethylene isatin derivatives. European journal of medicinal chemistry 20100801
In vitro antituberculosis activities of ACH-702, a novel isothiazoloquinolone, against quinolone-susceptible and quinolone-resistant isolates. Antimicrobial agents and chemotherapy 20100801
Lack of effect of dalcetrapib on QT interval in healthy subjects following multiple dosing. European journal of clinical pharmacology 20100801
Rapid assays for fluoroquinolone resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. The Journal of antimicrobial chemotherapy 20100801
Antibiotic resistance of subgingival species in chronic periodontitis patients. Journal of periodontal research 20100801
New antituberculous drugs in development. Current HIV/AIDS reports 20100801
Moxifloxacin enhances etoposide-induced cytotoxic, apoptotic and anti-topoisomerase II effects in a human colon carcinoma cell line. International journal of oncology 20100801
Electrochemical determination of gatifloxacin, moxifloxacin and sparfloxacin fluoroquinolonic antibiotics on glassy carbon electrode in pharmaceutical formulations. Drug testing and analysis 20100801
A single-dose, crossover, placebo- and moxifloxacin-controlled study to assess the effects of neratinib (HKI-272) on cardiac repolarization in healthy adult subjects. Clinical cancer research : an official journal of the American Association for Cancer Research 20100801
Doxycycline failure in lymphogranuloma venereum. Sexually transmitted infections 20100801
Severe corneal changes following intravitreal injection of bevacizumab. Ocular immunology and inflammation 20100801
[Questionnaire surveying nephrologists on drug dose adjustment in patients with impaired kidney function]. Wiener klinische Wochenschrift 20100801
Pharmacodynamics of moxifloxacin versus vancomycin against biofilms of methicillin-resistant Staphylococcus aureus and epidermidis in an in vitro model. Journal of chemotherapy (Florence, Italy) 20100801
Clinical efficacy of moxifloxacin versus comparator therapies for community-acquired pneumonia caused by Legionella spp. Journal of chemotherapy (Florence, Italy) 20100801
Safety of moxifloxacin and voriconazole in corneal storage media on porcine corneal endothelial cells. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20100801
Two cases of corneal ulcer due to methicillin-resistant Staphylococcus aureus in high risk groups. Korean journal of ophthalmology : KJO 20100801
Variations in TcdB activity and the hypervirulence of emerging strains of Clostridium difficile. PLoS pathogens 20100801
[Mutant prevention concentrations of garenoxacin against Streptococcus pneumoniae isolates from otorhinolaryngological infections]. The Japanese journal of antibiotics 20100801
Mayamycin, a cytotoxic polyketide from a Streptomyces strain isolated from the marine sponge Halichondria panicea. Journal of natural products 20100723
Identification of Qnr and AAC(6')-1b-cr plasmid-mediated fluoroquinolone resistance determinants in multidrug-resistant Enterobacter spp. isolated from extraintestinal infections in companion animals. Veterinary microbiology 20100714
[R207910 (TMC207): a new antibiotic for the treatment of tuberculosis]. Medecine et maladies infectieuses 20100701
Aspergillus niger: an unusual cause of invasive pulmonary aspergillosis. Journal of medical microbiology 20100701
Moxifloxacin monotherapy versus beta-lactam-based standard therapy for community-acquired pneumonia: a meta-analysis of randomised controlled trials. International journal of antimicrobial agents 20100701
Comparison of pharmacokinetic profiles of moxifloxacin in Caesarean versus non-pregnant sectioned women by fully validated HPLC with fluorescence detection. Combinatorial chemistry & high throughput screening 20100701
Bactericidal activity of besifloxacin against staphylococci, Streptococcus pneumoniae and Haemophilus influenzae. The Journal of antimicrobial chemotherapy 20100701
Covariate analysis of QTc and T-wave morphology: new possibilities in the evaluation of drugs that affect cardiac repolarization. Clinical pharmacology and therapeutics 20100701
Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers. Cornea 20100701
Spontaneous subconjunctival abscess because of Haemophilus influenzae. Cornea 20100701
Methicillin-resistant Staphylococcus aureus in wound cultures recovered from a combat support hospital in Iraq. The Journal of trauma 20100701
Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis. Wiener klinische Wochenschrift 20100701
Eltrombopag does not affect cardiac repolarization: results from a definitive QTc study in healthy subjects. British journal of clinical pharmacology 20100701
Treatment of Drug-resistant Pneumococcal Meningitis. Current infectious disease reports 20100701
From 6-aminoquinolone antibacterials to 6-amino-7-thiopyranopyridinylquinolone ethyl esters as inhibitors of Staphylococcus aureus multidrug efflux pumps. Journal of medicinal chemistry 20100610
Fungal keratitis associated with ocular rosacea. International ophthalmology 20100601
A severely symptomatic case of anaerobic chronic bacterial prostatitis successfully resolved with moxifloxacin therapy. Anaerobe 20100601
Pharmacokinetics, plasma protein binding and bioavailability of moxifloxacin in Muscovy ducks after different routes of administration. Research in veterinary science 20100601
Pharmacokinetics of moxifloxacin in patients with severe sepsis or septic shock. Intensive care medicine 20100601
In vitro activities of DC-159a, a novel fluoroquinolone, against Mycobacterium species. Antimicrobial agents and chemotherapy 20100601
Update on antithrombotic therapy for stroke prevention in atrial fibrillation. Current treatment options in cardiovascular medicine 20100601
Causes of infection after earthquake, China, 2008. Emerging infectious diseases 20100601
Comparative efficacy of besifloxacin and other fluoroquinolones in a prophylaxis model of penicillin-resistant Streptococcus pneumoniae rabbit endophthalmitis. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20100601
Maternal blood and amniotic fluid levels of moxifloxacin, levofloxacin and cefixime. The journal of obstetrics and gynaecology research 20100601
Tsukamurella: an emerging opportunistic ocular pathogen. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20100601
Antimicrobial susceptibility and multiplex PCR screening of AmpC genes from isolates of Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 20100601
Intensive care of a weils disease with multiorgan failure. Journal of clinical medicine research 20100601
Direct detection and serogroup characterization of Neisseria meningitidis from outbreak of meningococcal meningitis in Delhi. Iranian journal of microbiology 20100601
Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study. Lancet (London, England) 20100522
Polypyrrole solid phase microextraction: A new approach to rapid sample preparation for the monitoring of antibiotic drugs. Analytica chimica acta 20100514
Distribution of gyrA mutations in fluoroquinolone-resistant Helicobacter pylori strains. World journal of gastroenterology 20100514
Comparison of fluoroquinolones: cytotoxicity on human corneal epithelial cells. Eye (London, England) 20100501
A comparison of culture-positive and culture-negative health-care-associated pneumonia. Chest 20100501
Minimum inhibitory concentrations of standard and novel antimicrobials for isolates from bacterial keratitis. Investigative ophthalmology & visual science 20100501
Ultra high-pressure liquid chromatographic assay of moxifloxacin in rabbit aqueous humor after topical instillation of moxifloxacin nanoparticles. Journal of pharmaceutical and biomedical analysis 20100501
Absence of pharmacokinetic interference of moxifloxacin on cyclosporine and tacrolimus in kidney transplant recipients. Journal of clinical pharmacology 20100501
Effects of the selective alpha 1a-adrenoceptor antagonist silodosin on ECGs of healthy men in a randomized, double-blind, placebo- and moxifloxacin-controlled study. Clinical pharmacology and therapeutics 20100501
Sewage sludge and liquid pig manure as possible sources of antibiotic resistant bacteria. Environmental research 20100501
Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data. The Journal of antimicrobial chemotherapy 20100501
The relationship between inpatient fluoroquinolone use and Clostridium difficile-associated diarrhea. The Annals of pharmacotherapy 20100501
Statistical characteristics of moxifloxacin-induced QTc effect. Journal of biopharmaceutical statistics 20100501
Statistical consideration in testing for assay sensitivity in a 'thorough' QT study. Journal of biopharmaceutical statistics 20100501
Revisit the combination validation test of Tsong et al. for thorough QT/QTc clinical trials. Journal of biopharmaceutical statistics 20100501
Response to letter to the editor: Statistical issues of QT prolongation assessment based on linear concentration modeling by Yi Tsong et al. Journal of biopharmaceutical statistics 20100501
Levofloxacin-induced Achilles tendinitis in a young adult in the absence of predisposing conditions. Yonsei medical journal 20100501
Multihospital outbreak of Clostridium difficile infection, Cleveland, Ohio, USA. Emerging infectious diseases 20100501
Thorough QT study of the effect of fesoterodine on cardiac repolarization. International journal of clinical pharmacology and therapeutics 20100501
Moxifloxacin five-day therapy versus placebo in acute bacterial rhinosinusitis. The Laryngoscope 20100501
Aqueous humor and plasma concentrations of ciprofloxacin and moxifloxacin following topical ocular administration in ophthalmologically normal horses. American journal of veterinary research 20100501
Oral moxifloxacin and topical amikacin for Mycobacterium abscessus keratitis after laser in situ keratomileusis. Journal of cataract and refractive surgery 20100501
Comparing the effectiveness of moxifloxacin and povidone-iodine with povidone-iodine alone. Journal of cataract and refractive surgery 20100501
Inguinal panniculitis in a young Tasmanian devil (Sarcophilus harrisii) caused by Mycobacterium mageritense. Australian veterinary journal 20100501
Municipal wastewater effluents as a source of listerial pathogens in the aquatic milieu of the Eastern Cape Province of South Africa: a concern of public health importance. International journal of environmental research and public health 20100501
[Susceptibility test of the Mycobacterium avium complex to sixteen anti-infective agents]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 20100501
Synthesis and antitubercular evaluation of new fluoroquinolone derivatives coupled with carbohydrates. Carbohydrate research 20100419
Moxifloxacin increases anti-tumor and anti-angiogenic activity of irinotecan in human xenograft tumors. Biochemical pharmacology 20100415
10th survey of antimicrobial resistance in noninvasive clinical isolates of Streptococcus pneumoniae collected in Belgium during winter 2007-2008. Pathologie-biologie 20100401
Bacterial contamination of the vitreous cavity associated with transconjunctival 25-gauge microincision vitrectomy surgery. Ophthalmology 20100401
Effects of milnacipran on cardiac repolarization in healthy participants. Journal of clinical pharmacology 20100401
A novel Listeria monocytogenes-based DNA delivery system for cancer gene therapy. Human gene therapy 20100401
Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig. The Journal of antimicrobial chemotherapy 20100401
Efficacy and safety of besifloxacin ophthalmic suspension 0.6% in children and adolescents with bacterial conjunctivitis: a post hoc, subgroup analysis of three randomized, double-masked, parallel-group, multicenter clinical trials. Paediatric drugs 20100401
[Efficacy of moxifloxacin in treating bacterial conjunctivitis: a meta-analysis]. Journal francais d'ophtalmologie 20100401
Molecular characterization of moxifloxacin resistance from Canadian Clostridium difficile clinical isolates. Diagnostic microbiology and infectious disease 20100401
Immediate hypersensitivity to moxifloxacin with tolerance to ciprofloxacin: report of three cases and review of the literature. The Annals of pharmacotherapy 20100401
Antimicrobials and the risk of torsades de pointes: the contribution from data mining of the US FDA Adverse Event Reporting System. Drug safety 20100401
Efficacy of besifloxacin in an early treatment model of methicillin-resistant Staphylococcus aureus keratitis. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20100401
Antimicrobial susceptibility of Moraxella catarrhalis isolated from children in Kalgoorlie-Boulder, Western Australia. Pathology 20100401
Fluoroquinolone resistance and Clostridium difficile, Germany. Emerging infectious diseases 20100401
Hypervirulent Clostridium difficile strains in hospitalized patients, Canada. Emerging infectious diseases 20100401
Novel Corynebacterium diphtheriae in domestic cats. Emerging infectious diseases 20100401
Clostridium difficile in ground meat, France. Emerging infectious diseases 20100401
Update on the management of antibiotic allergy. Allergy, asthma & immunology research 20100401
Red eye, blurry vision, and cough. The Journal of family practice 20100401
Levofloxacin can be used effectively as a positive control in thorough QT/QTc studies in healthy volunteers. British journal of clinical pharmacology 20100401
No cardiac effects of therapeutic and supratherapeutic doses of rupatadine: results from a 'thorough QT/QTc study' performed according to ICH guidelines. British journal of clinical pharmacology 20100401
Determination of moxifloxacin in human plasma, plasma ultrafiltrate, and cerebrospinal fluid by a rapid and simple liquid chromatography- tandem mass spectrometry method. Journal of analytical toxicology 20100401
High prevalence of Fluoroquinolone- and Methicillin-resistant Staphylococcus pseudintermedius isolates from canine pyoderma and otitis externa in veterinary teaching hospital. Journal of microbiology and biotechnology 20100401
[Antimicrobial activity of oral quinolones against clinical isolates of Bifidobacterium group and Clostridium difficile]. The Japanese journal of antibiotics 20100401
Clostridium difficile in raw products of animal origin. International journal of food microbiology 20100331
[Fatal acute hepatitis and cholestasis associated with liver disease]. Medicina clinica 20100320
Update in tuberculosis 2009. American journal of respiratory and critical care medicine 20100315
Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis? The European respiratory journal 20100301
Changes in antibiotic susceptibility and ribotypes in Clostridium difficile isolates from southern Scotland, 1979-2004. Journal of medical microbiology 20100301
Effects of moxifloxacin and clinafloxacin on murine limb buds cultured in regular and in magnesium-deficient medium. Archives of toxicology 20100301
Contribution of reactive oxygen species to pathways of quinolone-mediated bacterial cell death. The Journal of antimicrobial chemotherapy 20100301
Safety considerations of fluoroquinolones in the elderly: an update. Drugs & aging 20100301
A comparison of treatment outcomes for moxifloxacin versus ofloxacin/metronidazole for first-line treatment of uncomplicated non-gonococcal pelvic inflammatory disease. International journal of STD & AIDS 20100301
[Treatment of critically ill influenza A H1N1 patients in plateau region]. Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue 20100301
Besifloxacin: a topical fluoroquinolone for the treatment of bacterial conjunctivitis. Clinical therapeutics 20100301
Disseminated systemic Nocardia farcinica infection complicating alefacept and infliximab therapy in a patient with severe psoriasis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20100201
Efficacy of four different moxifloxacin-based triple therapies for first-line H. pylori treatment. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20100201
Acute granulomatous acanthamoeba encephalitis in an immunocompetent patient. Neurocritical care 20100201
Synthesis and evaluation of (99m)Tc-moxifloxacin, a potential infection specific imaging agent. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20100201
Hospital visits and costs following outpatient treatment of CAP with levofloxacin or moxifloxacin. Current medical research and opinion 20100201
Beauveria keratitis and biopesticides: case histories and a random amplification of polymorphic DNA comparison. Cornea 20100201
Synthesis, antimalarial and antitubercular activity of acetylenic chalcones. Bioorganic & medicinal chemistry letters 20100201
Activity of various drugs alone or in combination against Mycobacterium fortuitum. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20100201
Investigating an airborne tularemia outbreak, Germany. Emerging infectious diseases 20100201
Disseminated Mycobacterium kansasii infection associated with skin lesions: a case report and comprehensive review of the literature. Journal of Korean medical science 20100201
Simultaneous scrofuloderma and intracranial tuberculomas: a rare presentation of systemic tuberculosis. The Australasian journal of dermatology 20100201
Antimicrobial susceptibility of moxifloxacin against gram-negative enteric rods from colombian patients with chronic periodontitis. Journal of periodontology 20100201
[Antibiotic susceptibility of blood-borne Streptococcus pneumoniae and efficacy assessment of respiratory quinolones using Monte Carlo simulation]. The Japanese journal of antibiotics 20100201
Exposure-response modeling and clinical trial simulation of the effect of tolterodine on QT intervals in healthy volunteers. Drug discoveries & therapeutics 20100201
[Efficacy of second-line treatment based on moxifloxacin triple therapy for Helicobacter pylori infection]. Zhonghua yi xue za zhi 20100112
[Efficacy of moxifloxacin-based triple therapy to eradicate Helicobacter pylori infection]. Zhonghua yi xue za zhi 20100112
In vitro elution of moxifloxacin from cancellous bone allografts. Journal of biomedical materials research. Part A 20100101
Comparison of in vitro susceptibilities of Gram-positive cocci isolated from ocular infections against the second and fourth generation quinolones at a tertiary eye care centre in South India. Eye (London, England) 20100101
Use of a mydriatic cocktail with a wick for preoperative mydriasis in cataract surgery: a prospective randomised controlled trial. Eye (London, England) 20100101
Oral moxifloxacin for outpatient treatment of low-risk, febrile neutropenic patients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20100101
Moxifloxacin associated vanishing bile duct syndrome. Journal of clinical gastroenterology 20100101
Dexrazoxane protects the heart from acute doxorubicin-induced QT prolongation: a key role for I(Ks). British journal of pharmacology 20100101
Subinhibitory concentrations of moxifloxacin decrease adhesion and biofilm formation of Stenotrophomonas maltophilia from cystic fibrosis. Journal of medical microbiology 20100101
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms. Antimicrobial agents and chemotherapy 20100101
Determination of the mutant selection window for clindamycin, doxycycline, linezolid, moxifloxacin and trimethoprim/sulfamethoxazole against community-associated meticillin-resistant Staphylococcus aureus (MRSA). International journal of antimicrobial agents 20100101
The use of baseline covariates in crossover studies. Biostatistics (Oxford, England) 20100101
In vitro susceptibility of bacterial keratitis isolates to fourth-generation fluoroquinolones. European journal of ophthalmology 20100101
Neglected diseases caused by bacterial infections. Current medicinal chemistry 20100101
Effects of prulifloxacin on cardiac repolarization in healthy subjects: a randomized, crossover, double-blind versus placebo, moxifloxacin-controlled study. Clinical drug investigation 20100101
Thorough QT Studies: Questions and Quandaries. Drug safety 20100101
Adding moxifloxacin is associated with a shorter time to culture conversion in pulmonary tuberculosis. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20100101
[On the way to shortening tuberculosis treatments: clinical trials of the Unitat d' Investagació en Tuberculosi de Barcelona supported by the Centers for Disease Control and Prevention]. Gaceta sanitaria 20100101
A single supratherapeutic dose of rolofylline does not prolong the QTcF interval in healthy volunteers. American journal of therapeutics 20100101
Besifloxacin ophthalmic suspension 0.6%. Drugs 20100101
Skin lesion caused by ST398 and ST1 MRSA, Spain. Emerging infectious diseases 20100101
Sequential bilateral lung resection in a patient with Mycobacterium abscessus lung disease refractory to medical treatment. Yonsei medical journal 20100101
Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20100101
Characterization of the quinolone resistant determining regions in clinical isolates of pneumococci collected in Canada. Annals of clinical microbiology and antimicrobials 20100101
Systemic anaphylaxis caused by moxifloxacin. Allergologia et immunopathologia 20100101
Sensitivity of common marmosets to detect drug-induced QT interval prolongation: moxifloxacin case study. Journal of pharmacological and toxicological methods 20100101
Saudi guidelines for testing and treatment of latent tuberculosis infection. Annals of Saudi medicine 20100101
Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Respiratory research 20100101
Comparison of antifungal efficacies of moxifloxacin, liposomal amphotericin B, and combination treatment in experimental Candida albicans endophthalmitis in rabbits. Canadian journal of microbiology 20100101
Characteristics of ambulatory anticoagulant adverse drug events: a descriptive study. Thrombosis journal 20100101
Kinetics of kill of bacterial conjunctivitis isolates with moxifloxacin, a fluoroquinolone, compared with the aminoglycosides tobramycin and gentamicin. Clinical ophthalmology (Auckland, N.Z.) 20100101
Comparison of fluoroquinolone kinetics of kill in susceptible and resistant gram-positive conjunctival pathogens. Advances in therapy 20100101
Association between gefitinib and hemorrhagic cystitis and severely contracted bladder: a case report. BMC urology 20100101
Pharmacokinetics and bioavailability of moxifloxacin in calves following different routes of administrations. Chemotherapy 20100101
Intracellular persisting Staphylococcus aureus is the major pathogen in recurrent tonsillitis. PloS one 20100101
Kikuchi Fujimoto disease associated with cryptogenic organizing pneumonia: case report and literature review. BMC infectious diseases 20100101
Methicillin-resistant Staphylococcus epidermidis isolation from the vitrectomy specimen four hours after initial treatment with vancomycin and ceftazidime. Clinical ophthalmology (Auckland, N.Z.) 20100101
A focus on intra-abdominal infections. World journal of emergency surgery : WJES 20100101
Continuation treatment of major depressive disorder: is there a case for duloxetine? Drug design, development and therapy 20100101
Antibiotic treatment of exacerbations of COPD in general practice: long-term impact on health-related quality of life. International journal of chronic obstructive pulmonary disease 20100101
Moxifloxacin does not alter ciclosporin pharmacokinetics in transplant patients: a multiple-dose, uncontrolled, single-centre study. Clinical drug investigation 20100101
Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives. Clinical ophthalmology (Auckland, N.Z.) 20100101
Suture-related keratitis following cataract surgery caused by methicillin-resistant Staphylococcus aureus. Clinical ophthalmology (Auckland, N.Z.) 20100101
Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days Moxifloxacin based therapy for the eradication: a randomized controlled trial. Annals of clinical microbiology and antimicrobials 20100101
In vitro selection of resistance in Escherichia coli and Klebsiella spp. at in vivo fluoroquinolone concentrations. BMC microbiology 20100101
Dysglycemias in pregnancy: from diagnosis to treatment. Brazilian consensus statement. Diabetology & metabolic syndrome 20100101
Prulifloxacin ECG study. Clinical drug investigation 20100101
[In vitro synergistic effect of moxifloxacin and amphotericin B combination against Candida strains]. Mikrobiyoloji bulteni 20100101
Legionnaires' disease mimicking swine influenza (H1N1) pneumonia during the 'herald wave' of the pandemic. Heart & lung : the journal of critical care 20100101
The comparison of clinical outcomes of endophthalmitis from fluoroquinolone-resistant and susceptible bacteria. Clinical ophthalmology (Auckland, N.Z.) 20100101
Besifloxacin: a novel anti-infective for the treatment of bacterial conjunctivitis. Clinical ophthalmology (Auckland, N.Z.) 20100101
Intracameral vancomycin following cataract surgery: An eleven-year study. Clinical ophthalmology (Auckland, N.Z.) 20100101
Concentrations of besifloxacin, gatifloxacin, and moxifloxacin in human conjunctiva after topical ocular administration. Clinical ophthalmology (Auckland, N.Z.) 20100101
Colour of sputum is a marker for bacterial colonisation in chronic obstructive pulmonary disease. Respiratory research 20100101
Pharmacokinetics of Linezolid and Ertapenem in experimental parapneumonic pleural effusion. Journal of inflammation (London, England) 20100101
Pulmonary impairment after tuberculosis and its contribution to TB burden. BMC public health 20100101
Real-time visualization of photochemically induced fluorescence of 8-halogenated quinolones: lomefloxacin, clinafloxacin and Bay3118 in live human HaCaT keratinocytes. Photochemistry and photobiology 20100101
Metaplastic ossification in the cartilage of the bronchus of a patient with chronic multi-drug resistant tuberculosis: a case report. Journal of medical case reports 20100101
Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis. PloS one 20100101
Disparities of care for African-Americans and Caucasians with community-acquired pneumonia: a retrospective cohort study. BMC health services research 20100101
Effectiveness, tolerability and safety of azithromycin 1% in DuraSite for acute bacterial conjunctivitis. Patient preference and adherence 20100101
Left thoracotomy surgical approach for chronic instrumentation in dogs and monkeys providing high-quality electrocardiogram signals. Journal of pharmacological and toxicological methods 20100101
Bile and gallbladder tissue concentrations of moxifloxacin in patients with acute cholecystitis. The Annals of pharmacotherapy 20100101
Comparative in-vitro efficacy of fluoroquinolones against Streptococcus pneumoniae recovered from bacterial keratitis as determined by E-test. Indian journal of pathology & microbiology 20100101
[Prevalence of Clostridium difficile in the gastrointestinal tract of hospitalized children under two years of age]. Medycyna doswiadczalna i mikrobiologia 20100101
Evaluation of in vitro activities of tigecycline and various antibiotics against Brucella spp. Polish journal of microbiology 20100101
Effects of sugammadex doses up to 32 mg/kg alone or in combination with rocuronium or vecuronium on QTc prolongation: a thorough QTc study. Clinical drug investigation 20100101
Cardiovascular safety assessments in the conscious telemetered dog: utilisation of super-intervals to enhance statistical power. Journal of pharmacological and toxicological methods 20100101
Acute onset lactobacillus endophthalmitis after trabeculectomy: a case report. Journal of medical case reports 20100101
Structural basis of gate-DNA breakage and resealing by type II topoisomerases. PloS one 20100101
Clostridium difficile and the disease it causes. Methods in molecular biology (Clifton, N.J.) 20100101
Systemic Capillary Leak Syndrome associated with hypovolemic shock and compartment syndrome. Use of transpulmonary thermodilution technique for volume management. Scandinavian journal of trauma, resuscitation and emergency medicine 20100101
Mycoplasma pneumonia: Clinical features and management. Lung India : official organ of Indian Chest Society 20100101
Antibiotic susceptibility pattern of rapidly growing mycobacteria. Journal of postgraduate medicine 20100101
Empiric antibiotic therapy for Staphylococcus aureus bacteremia may not reduce in-hospital mortality: a retrospective cohort study. PloS one 20100101
Safety and tolerability of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis: data from six clinical and phase I safety studies. Clinical drug investigation 20100101
Sphingosine kinase-1 is required for toll mediated beta-defensin 2 induction in human oral keratinocytes. PloS one 20100101
Identification and antimicrobial resistance of Enterococcus spp. isolated from surface water. Water science and technology : a journal of the International Association on Water Pollution Research 20100101
Chordoma in the lateral medullary cistern in a patient with tuberous sclerosis: A case report and review of the literature. Surgical neurology international 20100101
A new approach for the discovery of antibiotics by targeting non-multiplying bacteria: a novel topical antibiotic for staphylococcal infections. PloS one 20100101
Voriconazole-refractory fungal infection of phacoemulsification tunnel. Indian journal of ophthalmology 20100101
Azithromycin in DuraSite for the treatment of blepharitis. Clinical ophthalmology (Auckland, N.Z.) 20100101
CASE REPORT Febrile Ulceronecrotic Mucha-Habermann Disease. Eplasty 20100101
Intravitreal Ampicillin Sodium for Antibiotic-Resistant Endophthalmitis: Streptococcus uberis First Human Intraocular Infection Report. Journal of ophthalmology 20100101
Biopsy proven acute interstitial nephritis after treatment with moxifloxacin. BMC nephrology 20100101
The combination of rifampin plus moxifloxacin is synergistic for suppression of resistance but antagonistic for cell kill of Mycobacterium tuberculosis as determined in a hollow-fiber infection model. mBio 20100101
Structural insights into the quinolone resistance mechanism of Mycobacterium tuberculosis DNA gyrase. PloS one 20100101
Sequential introduction of single room isolation and hand hygiene campaign in the control of methicillin-resistant Staphylococcus aureus in intensive care unit. BMC infectious diseases 20100101
Paroxysmal autonomic instability with dystonia in a patient with tuberculous meningitis: a case report. Journal of medical case reports 20100101
The antipsychotic thioridazine shows promising therapeutic activity in a mouse model of multidrug-resistant tuberculosis. PloS one 20100101
Greatest International ANtiinfective Trial (GIANT) with moxifloxacin in the treatment of acute exacerbation of chronic bronchitis: subanalysis of Chinese data of a global, multicenter, noninterventional study. Clinical epidemiology 20100101
[Adverse drug reactions in multidrug-resistant tuberculosis]. Medicina 20100101
Cytotoxicity of five fluoroquinolone and two nonsteroidal anti-inflammatory benzalkonium chloride-free ophthalmic solutions in four corneoconjunctival cell lines. Clinical ophthalmology (Auckland, N.Z.) 20100101
Low endotoxin release from Escherichia coli and Bacteroides fragilis during exposure to moxifloxacin. Chemotherapy 20100101
Quinolone and cephalosporin resistance in enteric Fever. Journal of global infectious diseases 20100101
Fatal spontaneous rectus sheath hematoma in a patient with cirrhosis. Journal of emergencies, trauma, and shock 20100101
Immune thrombocytopenia in a challenging case of disseminated tuberculosis: a case report and review of the literature. Case reports in medicine 20100101
Activity and interactions of antibiotic and phytochemical combinations against Pseudomonas aeruginosa in vitro. International journal of biological sciences 20100101
Serial interferon-gamma release assays during treatment of active tuberculosis in young adults. BMC infectious diseases 20100101
Etiology and antibacterial susceptibility pattern of community-acquired bacterial ocular infections in a tertiary eye care hospital in south India. Indian journal of ophthalmology 20100101
Visual Performance of Tecnis ZM900 Diffractive Multifocal IOL after 2500 Implants: A 3-Year Followup. Journal of ophthalmology 20100101
Enucleation following treatment with intravenous pentamidine for Acanthamoeba sclerokeratitis. Clinical ophthalmology (Auckland, N.Z.) 20100101
Profile of temsirolimus in the treatment of advanced renal cell carcinoma. OncoTargets and therapy 20100101
Disposition kinetics of levofloxacin in sheep after intravenous and intramuscular administration. Veterinary medicine international 20100101
Fluoroquinolone antibacterial eye drops: effects on normal human corneal epithelium, stroma, and endothelium. Clinical ophthalmology (Auckland, N.Z.) 20100101
Acanthamoeba and Stenotrophomonas maltophilia keratitis with fungal keratitis in the contralateral eye. Clinical ophthalmology (Auckland, N.Z.) 20100101
MRSA and cataract surgery - reflections for practice. Clinical ophthalmology (Auckland, N.Z.) 20100101
Three-year multicenter surveillance of community-acquired Listeria monocytogenes meningitis in adults. BMC infectious diseases 20100101
Mycoplasma hominis necrotizing pleuropneumonia in a previously healthy adolescent. BMC infectious diseases 20100101
Two Legionnaires' disease cases associated with industrial waste water treatment plants: a case report. BMC infectious diseases 20100101
New approaches in the diagnosis and treatment of latent tuberculosis infection. Respiratory research 20100101
Protection Afforded by Fluoroquinolones in Animal Models of Respiratory Infections with Bacillus anthracis, Yersinia pestis, and Francisella tularensis. The open microbiology journal 20100101
A protocol for the retina surgeon's safe initial intravitreal injections. Clinical ophthalmology (Auckland, N.Z.) 20100101
A role for spleen monocytes in post-ischemic brain inflammation and injury. Journal of neuroinflammation 20100101
Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin. European journal of medical research 20100101
Advances in the prevention, management, and treatment of community-acquired pneumonia. F1000 medicine reports 20100101
[Staphylococcus aureus: new and old antimicrobial agents]. Revista Argentina de microbiologia 20100101
Bacterial conjunctivitis. Clinical ophthalmology (Auckland, N.Z.) 20100101
Methicillin resistance of Staphylococcus species among health care and nonhealth care workers undergoing cataract surgery. Clinical ophthalmology (Auckland, N.Z.) 20100101
[Research regarding extended-spectrum beta-lactamases produced by enterobacteria strains]. Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 20100101
Antibiotic Treatment of Dogs and Cats during Pregnancy. Veterinary medicine international 20100101
Allergy to quinolones: low cross-reactivity to levofloxacin. Journal of investigational allergology & clinical immunology 20100101
MRSA: treating people with infection. BMJ clinical evidence 20100101
Leprosy therapy, past and present: can we hope to eliminate it? Indian journal of dermatology 20100101
Role of telavancin in treatment of skin and skin structure infections. Clinical, cosmetic and investigational dermatology 20100101
A rare case of toxic epidermal necrolysis with unexpected Fever resulting from dengue virus. Case reports in dermatology 20100101
Drug resistance in community-acquired respiratory tract infections: role for an emerging antibacterial. Infection and drug resistance 20100101
The use of anti-tuberculosis therapy for latent TB infection. Infection and drug resistance 20100101
Evaluation of surrogate animal models of melioidosis. Frontiers in microbiology 20100101
Characterization and evaluation of the directly observed treatment for tuberculosis in Santiago de Compostela (1996-2006). Risk management and healthcare policy 20100101
Enhancement of the antimalarial activity of ciprofloxacin using a double prodrug/bioorganometallic approach. Journal of medicinal chemistry 20091224
[Moxifloxacin and hepatic toxicity]. Gastroenterologia y hepatologia 20091201
Assessment of changes in the epidemiology of Clostridium difficile isolated from diarrheal patients in Hungary. Anaerobe 20091201
Clinical, microbiological profile and treatment outcome of ocular infections caused by Achromobacter xylosoxidans. Cornea 20091201
In vitro activities of moxifloxacin and tigecycline against bacterial isolates associated with intraabdominal infections at a medical center in Taiwan, 2001-2006. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20091201
Emerging prevalence of microsporidial keratitis in Singapore: epidemiology, clinical features, and management. Ophthalmology 20091201
Phenotypic changes in ciprofloxacin-resistant Staphylococcus aureus. Research in microbiology 20091201
Diversity of moxifloxacin resistance during a nosocomial outbreak of a predominantly ribotype ARU 027 Clostridium difficile diarrhea. Anaerobe 20091201
Lack of electrocardiographic effect of dexlansoprazole MR, a novel modified-release formulation of the proton pump inhibitor dexlansoprazole, in healthy participants. Journal of clinical pharmacology 20091201
In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan. The Journal of antimicrobial chemotherapy 20091201
Absence of effect of telbivudine on cardiac repolarization: results of a thorough QT/QTc study in healthy participants. Journal of clinical pharmacology 20091201
Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin. Eye (London, England) 20091201
Validation of a MLC method with fluorescence detection for the determination of quinolones in urine samples by direct injection. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20091201
Characterisation of exacerbations of chronic bronchitis and COPD in Europe: the GIANT study. Therapeutic advances in respiratory disease 20091201
Future treatment options for Gram-positive infections--looking ahead. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20091201
Assessment of the cardiac safety of fampridine-SR sustained-release tablets in a thorough QT/QTc evaluation at therapeutic and supratherapeutic doses in healthy individuals. Expert opinion on investigational drugs 20091201
Preoperative topical moxifloxacin 0.5% and povidone-iodine 5.0% versus povidone-iodine 5.0% alone to reduce bacterial colonization in the conjunctival sac. Journal of cataract and refractive surgery 20091201
Re: Association between moxifloxacin ophthalmic solution and fungal infection in patients with corneal ulcers and microbial keratitis. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20091201
Effect of cefuroxime and moxifloxacin on Staphylococcus epidermidis adherence to intraocular lenses. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20091201
Disseminated multiorgan MDR-TB resistant to virtually all first-line drugs. European respiratory review : an official journal of the European Respiratory Society 20091201
Electrocardiographic characterization of the QTc interval in patients with advanced solid tumors: pharmacokinetic- pharmacodynamic evaluation of sunitinib. Clinical cancer research : an official journal of the American Association for Cancer Research 20091115
Comparison of manual and automated measurements of the QT interval in healthy volunteers: an analysis of five thorough QT studies. Clinical pharmacology and therapeutics 20091101
Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPD. The European respiratory journal 20091101
Naltrexone and insulin are independently effective but not additive in accelerating corneal epithelial healing in type I diabetic rats. Experimental eye research 20091101
In vitro activities of the newly synthesised ER-2 against clinical isolates of Mycobacterium tuberculosis susceptible or resistant to antituberculosis drugs. International journal of antimicrobial agents 20091101
Efficacy of moxifloxacin or gatifloxacin as prophylaxis against experimental murine Brucella melitensis infection. International journal of antimicrobial agents 20091101
Moxifloxacin is non-inferior to combination therapy with ceftriaxone plus metronidazole in patients with community-origin complicated intra-abdominal infections. International journal of antimicrobial agents 20091101
Tissue penetration of moxifloxacin into human gallbladder wall in patients with biliary tract infections. The Journal of antimicrobial chemotherapy 20091101
Absence of QTc prolongation in a thorough QT study with subcutaneous liraglutide, a once-daily human GLP-1 analog for treatment of type 2 diabetes. Journal of clinical pharmacology 20091101
Flucloxacillin, still the empirical choice for putative Staphylococcus aureus infections in intensive care units in the Netherlands. The Journal of antimicrobial chemotherapy 20091101
Abuse of antibiotic prophylaxis in third molar surgeries. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20091101
Predicting the complicated neutropenic fever in the emergency department. Emergency medicine journal : EMJ 20091101
Buruli ulcer in United Kingdom tourist returning from Latin America. Emerging infectious diseases 20091101
Moxifloxacin-induced drug hypersensitivity syndrome with features of toxic epidermal necrolysis. Journal of drugs in dermatology : JDD 20091101
Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes. Journal of medicinal chemistry 20091022
Cost-effectiveness analysis of intracameral cefuroxime use for prophylaxis of endophthalmitis after cataract surgery. Ophthalmology 20091001
Evidence for moxifloxacin in community-acquired pneumonia: the impact of pharmaco-economic considerations on guidelines. Current medical research and opinion 20091001
Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficile. The Journal of hospital infection 20091001
Pharmacokinetics of moxifloxacin in cerebrospinal fluid and plasma in patients with tuberculous meningitis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20091001
Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis. Cornea 20091001
Design, synthesis and biological evaluations of novel 7-[3-(1-aminocycloalkyl)pyrrolidin-1-yl]-6-desfluoro-8-methoxyquinolones with potent antibacterial activity against multi-drug resistant Gram-positive bacteria. Bioorganic & medicinal chemistry 20091001
Besifloxacin, a new ophthalmic fluoroquinolone for the treatment of bacterial conjunctivitis. Expert opinion on pharmacotherapy 20091001
Moxifloxacin-containing triple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate. Helicobacter 20091001
Should moxifloxacin be substituted for isoniazid as a first-line antituberculosis drug? American journal of respiratory and critical care medicine 20091001
[Active drugs against Mycobacterium tuberculosis]. Enfermedades infecciosas y microbiologia clinica 20091001
Efficacy and safety of sequential intravenous/oral moxifloxacin vs intravenous/oral amoxicillin/clavulanate for complicated skin and skin structure infections. Infection 20091001
One-day application of topical moxifloxacin 0.5% to select for fluoroquinolone-resistant coagulase-negative Staphylococcus. Journal of cataract and refractive surgery 20091001
A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease. International journal of STD & AIDS 20091001
Community-associated methicillin-resistant Staphylococcus aureus, Iowa, USA. Emerging infectious diseases 20091001
Moxifloxacin: new indication. Inadequate restriction of indications in ENT and respiratory infections. Prescrire international 20091001
Moxifloxacin: new indication. Do not use in gynaecological infections or other conditions. Prescrire international 20091001
[Factors effecting the duration of hospitalization and mortality in patients with community-acquired pneumonia]. Mikrobiyoloji bulteni 20091001
Antibiotic therapy in elderly patients with acute exacerbation of chronic bronchitis. Expert review of respiratory medicine 20091001
Sterilizing activity of R207910 (TMC207)-containing regimens in the murine model of tuberculosis. American journal of respiratory and critical care medicine 20090915
Optimization of separation and determination of moxifloxacin and its related substances by RP-HPLC. Journal of pharmaceutical and biomedical analysis 20090908
Fluoroquinolone-resistant Brucella melitensis mutants obtained in vitro. International journal of antimicrobial agents 20090901
Antibacterial activity of lipophilic fluoroquinolone derivatives. Medicinal chemistry (Shariqah (United Arab Emirates)) 20090901
Efficacy of fluoroquinolones against pathogenic oral bacteria. Mini reviews in medicinal chemistry 20090901
Pharmacodynamics of moxifloxacin against a high inoculum of Escherichia coli in an in vitro infection model. The Journal of antimicrobial chemotherapy 20090901
Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US. Current medical research and opinion 20090901
Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis. Ophthalmology 20090901
Susceptibility and bactericidal activity of 8 oral quinolones against conventional-fluoroquinolone-resistant Streptococcus pneumoniae clinical isolates. Diagnostic microbiology and infectious disease 20090901
Kill rates of preserved and preservative-free topical 8-methoxy fluoroquinolones against various strains of Staphylococcus. Journal of cataract and refractive surgery 20090901
Extrapulmonary infections associated with nontuberculous mycobacteria in immunocompetent persons. Emerging infectious diseases 20090901
[Methicillin resistant Staphyloccus aureus infection: a case report and literature review]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 20090901
Addition of PNU-100480 to first-line drugs shortens the time needed to cure murine tuberculosis. American journal of respiratory and critical care medicine 20090815
Susceptibility of clinical isolates of frequently encountered bacterial species to tigecycline one year after the introduction of this new class of antibiotics: results of the second multicentre surveillance trial in Germany (G-TEST II, 2007). European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20090801
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis. American journal of respiratory and critical care medicine 20090801
Selective role of sulfotransferase 2A1 (SULT2A1) in the N-sulfoconjugation of quinolone drugs in humans. Drug metabolism and disposition: the biological fate of chemicals 20090801
Evaluation of the mutant selection window for fluoroquinolones against Neisseria gonorrhoeae. The Journal of antimicrobial chemotherapy 20090801
Mutational paths towards increased fluoroquinolone resistance in Legionella pneumophila. The Journal of antimicrobial chemotherapy 20090801
Prospective randomized comparison of 1-day and 3-day application of topical 0.5% moxifloxacin in eliminating preoperative conjunctival bacteria. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090801
Comparison of semiautomated and fully automated methods for QT measurement during a thorough QT/QTc study: variability and sample size considerations. Journal of clinical pharmacology 20090801
7-((4-Substituted)piperazin-1-yl) derivatives of ciprofloxacin: synthesis and in vitro biological evaluation as potential antitumor agents. Bioorganic & medicinal chemistry 20090801
A thorough QTc study to assess the effect of sitagliptin, a DPP4 inhibitor, on ventricular repolarization in healthy subjects. Journal of clinical pharmacology 20090801
Lack of effect of aprepitant or its prodrug fosaprepitant on QTc intervals in healthy subjects. Anesthesia and analgesia 20090801
Benzalkonium chloride enhances antibacterial activity of gatifloxacin and reduces its propensity to select for fluoroquinolone-resistant strains. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090801
Moxifloxacin-induced QT prolongation and torsades: an uncommon effect of a common drug. The American journal of the medical sciences 20090801
10 years' experience with the pneumococcal quinolone moxifloxacin. Expert review of anti-infective therapy 20090801
Prognostic factors and clinical features of non-typhoid Salmonella bacteremia in adults. Journal of the Chinese Medical Association : JCMA 20090801
Aqueous humor penetration of fourth-generation fluoroquinolone ophthalmic solutions given by multiple administration in a rabbit model. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20090801
Quinolones: action and resistance updated. Current topics in medicinal chemistry 20090801
Iatrogenic QT Abnormalities and Fatal Arrhythmias: Mechanisms and Clinical Significance. Current cardiology reviews 20090801
Acyclovir-induced renal failure in an obese patient. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20090715
Separation of fluoroquinolones in acidic buffer by capillary electrophoresis with contactless conductivity detection. Journal of chromatography. A 20090703
In vitro selection of fluoroquinolone resistance in Brucella melitensis. International journal of antimicrobial agents 20090701
Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types. Diagnostic microbiology and infectious disease 20090701
Comparative in vitro activities of nemonoxacin, doripenem, tigecycline and 16 other antimicrobials against Nocardia brasiliensis, Nocardia asteroides and unusual Nocardia species. The Journal of antimicrobial chemotherapy 20090701
Haemolytic anaemia following rituximab treatment in a patient with pemphigus vulgaris. The British journal of dermatology 20090701
Drug discovery using chemical systems biology: repositioning the safe medicine Comtan to treat multi-drug and extensively drug resistant tuberculosis. PLoS computational biology 20090701
Correction for QT/RR hysteresis in the assessment of drug-induced QTc changes--cardiac safety of gadobutrol. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20090701
[Successful treatment of Legionella pneumonia with moxifloxacin in a hemodialysis patient]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20090701
Treatment of multidrug-resistant and extensively drug-resistant tuberculosis: current status and future prospects. Expert review of clinical pharmacology 20090701
Spontaneous anterior lens capsular dehiscence causing lens particle glaucoma. Yonsei medical journal 20090630
Moxifloxacin versus ethambutol in initial tuberculosis treatment. Lancet (London, England) 20090627
Moxifloxacin versus ethambutol in initial tuberculosis treatment. Lancet (London, England) 20090627
Levofloxacin 0.5% ophthalmic solution: a review of its use in the treatment of external ocular infections and in intraocular surgery. Drugs 20090618
Pharmacokinetics after intravenous, intramuscular and subcutaneous administration of moxifloxacin in sheep. Veterinary journal (London, England : 1997) 20090601
Fluoroquinolone resistance in Mycobacterium tuberculosis: an assessment of MGIT 960, MODS and nitrate reductase assay and fluoroquinolone cross-resistance. The Journal of antimicrobial chemotherapy 20090601
Association between moxifloxacin ophthalmic solution and fungal infection in patients with corneal ulcers and microbial keratitis. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090601
Pharmacokinetic, pharmacodynamic, and electrocardiographic effects of dapoxetine and moxifloxacin compared with placebo in healthy adult male subjects. Journal of clinical pharmacology 20090601
Antibiotic susceptibility of conjunctival bacterial isolates from refractive surgery patients. Ophthalmology 20090601
Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090601
Late-onset laser in situ keratomileusis-related corneal ulcer--a case series. Cornea 20090601
Intracameral moxifloxacin: in vitro safety on human ocular cells. Cornea 20090601
Simultaneous determination of bisoprolol and hydrochlorothiazide in human plasma by HPLC coupled with tandem mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090601
Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases. Nature structural & molecular biology 20090601
Electrocardiographic QTc changes due to moxifloxacin infusion. Journal of clinical pharmacology 20090601
Changes in fluoroquinolone-resistant Streptococcus pneumoniae after 7-valent conjugate vaccination, Spain. Emerging infectious diseases 20090601
The first case of antibiotic-associated colitis by Clostridium difficile PCR ribotype 027 in Korea. Journal of Korean medical science 20090601
[A case of primary pulmonary nocardiosis with multiple pulmonary nodules successfully treated with moxifloxacin]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20090601
Rapid killing of M. leprae by moxifloxacin in two patients with lepromatous leprosy. Leprosy review 20090601
[Antibacterial activity of quinolones against various clinically isolated strains and evaluation of efficacy based on the pharmacokinetics/pharmacodynamics theory]. The Japanese journal of antibiotics 20090601
Propofol infusion syndrome: case report and literature review. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20090515
[First Danish case of Clostridium difficile ribotype 027]. Ugeskrift for laeger 20090504
Trimethoprim/sulfamethoxazole resistance in urinary tract infections. The Journal of emergency medicine 20090501
Comparative in vitro activity of REP3123 against Clostridium difficile and other anaerobic intestinal bacteria. The Journal of antimicrobial chemotherapy 20090501
Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin. The Journal of antimicrobial chemotherapy 20090501
Period correction of the QTc of moxifloxacin with multiple predose baseline ECGs is the least variable of 4 methods tested. Journal of clinical pharmacology 20090501
Antimicrobial ambiguine isonitriles from the cyanobacterium Fischerella ambigua. Journal of natural products 20090501
Cross-border dissemination of methicillin-resistant Staphylococcus aureus, Euregio Meuse-Rhin region. Emerging infectious diseases 20090501
Methicillin-Resistant Staphylococcus aureus ST398 from human patients, upper Austria. Emerging infectious diseases 20090501
Possible seasonality of Clostridium difficile in retail meat, Canada. Emerging infectious diseases 20090501
Clostridium difficile in ready-to-eat salads, Scotland. Emerging infectious diseases 20090501
Clostridium difficile in retail meat products, USA, 2007. Emerging infectious diseases 20090501
Effect of subconjunctival bevacizumab on primary pterygium. Cornea 20090501
Deferasirox does not induce QT/QTc-prolongation in healthy subjects. International journal of clinical pharmacology and therapeutics 20090501
Severe and symptomatic hyponatraemia after moxifloxacin intake. The Netherlands journal of medicine 20090501
Outbreak of Clostridium difficile 027 infection in Vienna, Austria 2008-2009. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 20090430
Outbreak of Clostridium difficile 027 in North Zealand, Denmark, 2008-2009. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 20090423
Simple and rapid liquid chromatography method for determination of moxifloxacin in plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090415
Antibiotic susceptibility of thermo-tolerant Escherichia coli 2 isolated from drinking water of Khairpur City, Sindh, Pakistan. Pakistan journal of biological sciences : PJBS 20090415
Measurement and regulation of cardiac ventricular repolarization: from the QT interval to repolarization morphology. Philosophical transactions. Series A, Mathematical, physical, and engineering sciences 20090413
'My foot hurts': a flare of rheumatoid arthritis? The Medical journal of Australia 20090406
Fourth-generation fluoroquinolones in tuberculosis. Lancet (London, England) 20090404
Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial. Lancet (London, England) 20090404
[Nosocomial urinary tract infections in the geriatric hospital - pathogen spectrum and resistancies]. Zeitschrift fur Gerontologie und Geriatrie 20090401
Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes. International journal of antimicrobial agents 20090401
Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a synthetic carrier of calcium sulphate (Stimulan) releasing moxifloxacin. International journal of antimicrobial agents 20090401
Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype and revertant strains. Antimicrobial agents and chemotherapy 20090401
In vitro selection of resistance in Streptococcus pneumoniae at in vivo fluoroquinolone concentrations. The Journal of antimicrobial chemotherapy 20090401
The mitochondria targeted antioxidant MitoQ protects against fluoroquinolone-induced oxidative stress and mitochondrial membrane damage in human Achilles tendon cells. Free radical research 20090401
Pharmacokinetics of fluoroquinolones in critical care patients: A bio-analytical HPLC method for the simultaneous quantification of ofloxacin, ciprofloxacin and moxifloxacin in human plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090401
Stability of extemporaneously prepared moxifloxacin oral suspensions. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20090401
Segniliparus rugosus infection, Australia. Emerging infectious diseases 20090401
Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones. Advances in therapy 20090401
Bactericidal activity of moxifloxacin on exponential and stationary phase cultures of Mycobacterium tuberculosis. Journal of chemotherapy (Florence, Italy) 20090401
Moxifloxacin for the treatment of patients with complicated intra-abdominal infections (the AIDA Study). Journal of chemotherapy (Florence, Italy) 20090401
[Severe bacterial keratitis and activity of fluoroquinolones]. Journal francais d'ophtalmologie 20090401
[Antimicrobial susceptibility surveillance of recent isolates from otorhinolaryngological infections to garenoxacin and other antimicrobial drugs]. The Japanese journal of antibiotics 20090401
The insulinotropic effect of fluoroquinolones. Biochemical pharmacology 20090315
Mycobacterium chelonae infection in a tattoo site. The Medical journal of Australia 20090302
In vitro antibiotic susceptibility of preoperative normal conjunctival bacteria. Eye (London, England) 20090301
Antimicrobial susceptibility of anaerobic bacteria in Belgium as determined by E-test methodology. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20090301
Enhanced distribution of fourth-generation fluoroquinolones in prostatic tissue. International journal of antimicrobial agents 20090301
Target specificity of the new fluoroquinolone besifloxacin in Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli. The Journal of antimicrobial chemotherapy 20090301
High doses of levofloxacin vs moxifloxacin against staphylococcal experimental foreign-body infection: the effect of higher MIC-related pharmacokinetic parameters on efficacy. The Journal of infection 20090301
Effects of standard and supratherapeutic doses of nelfinavir on cardiac repolarization: a thorough QT study. Journal of clinical pharmacology 20090301
Susceptibility comparisons of normal preoperative conjunctival bacteria to fluoroquinolones. Journal of cataract and refractive surgery 20090301
Exploration of the African green monkey as a preclinical pharmacokinetic model: oral pharmacokinetic parameters and drug-drug interactions. Xenobiotica; the fate of foreign compounds in biological systems 20090301
Topical and oral voriconazole in the treatment of fungal keratitis. Korean journal of ophthalmology : KJO 20090301
Pharmacokinetics and tissue residues of moxifloxacin in broiler chickens. British poultry science 20090301
Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience 20090206
Corticosteroids for bacterial corneal ulcers. The British journal of ophthalmology 20090201
Pharmacokinetics of intravenously administered moxifloxacin in eye compartments: an experimental study. International journal of antimicrobial agents 20090201
Spectrofluorimetric determination of fluoroquinolones in pharmaceutical preparations. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20090201
In vitro activity of ciprofloxacin, moxifloxacin, vancomycin and erythromycin against planktonic and biofilm forms of Corynebacterium urealyticum. The Journal of antimicrobial chemotherapy 20090201
Simultaneous quantification of linezolid, rifampicin, levofloxacin, and moxifloxacin in human plasma using high-performance liquid chromatography with UV. Therapeutic drug monitoring 20090201
Comparative pharmacodynamic interaction analysis between ciprofloxacin, moxifloxacin and levofloxacin and antifungal agents against Candida albicans and Aspergillus fumigatus. The Journal of antimicrobial chemotherapy 20090201
Patients' perception of recovery after third molar surgery following postoperative treatment with moxifloxacin versus amoxicillin and clavulanic acid: a randomized, double-blind, controlled study. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20090201
Fluorescence quenching as a tool to investigate quinolone antibiotic interactions with bacterial protein OmpF. The Journal of membrane biology 20090201
Fluoroquinolones and postoperative endophthalmitis. Journal of cataract and refractive surgery 20090201
Fluoroquinolones and postoperative endophthalmitis. Journal of cataract and refractive surgery 20090201
Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan. Helicobacter 20090201
Influence of type and neutralisation capacity of antacids on dissolution rate of ciprofloxacin and moxifloxacin from tablets. Bosnian journal of basic medical sciences 20090201
Emergence of pristinamycin resistance in India. Indian journal of pharmacology 20090201
Treatment of extensively drug-resistant tuberculosis. Lancet (London, England) 20090103
Clinical and microbiological efficacy of moxifloxacin versus amoxicillin/clavulanic acid in severe odontogenic abscesses: a pilot study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20090101
Successful treatment with moxifloxacin of experimental aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA). International journal of antimicrobial agents 20090101
Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study). International journal of antimicrobial agents 20090101
Community acquired Clostridium difficile infection due to a moxifloxacin susceptible ribotype 027 strain. Scandinavian journal of infectious diseases 20090101
A once-weekly R207910-containing regimen exceeds activity of the standard daily regimen in murine tuberculosis. American journal of respiratory and critical care medicine 20090101
Activity of antibiotics against Fusarium and Aspergillus. The British journal of ophthalmology 20090101
Cerebrospinal fluid of patients administered moxifloxacin modulates the secretion of cytokines from human monocytes. Diagnostic microbiology and infectious disease 20090101
Severe pseudomembranous colitis after moxifloxacin use: a case series. The Annals of pharmacotherapy 20090101
The resistance patterns of normal ocular bacterial flora to 4 fluoroquinolone antibiotics. Cornea 20090101
Nocardial infection in Crete, Greece: review of fifteen cases from 2003 to 2007. Scandinavian journal of infectious diseases 20090101
Clonal multidrug-resistant Corynebacterium striatum strains, Italy. Emerging infectious diseases 20090101
Buruli ulcer in long-term traveler to Senegal. Emerging infectious diseases 20090101
Automated QT measurement and application to detection of moxifloxacin-induced changes. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20090101
ECG evaluation of ventricular properties: the importance of cardiac cycle length. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20090101
Automated QT analysis that learns from cardiologist annotations. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20090101
Methicillin-resistant Staphylococcus aureus (MRSA) strain ST398 is present in midwestern U.S. swine and swine workers. PloS one 20090101
Screening for sterilizing activity of antibiotic combinations in an acid model of rapidly growing mycobacteria during the stationary phase of growth. Chemotherapy 20090101
Transmission of MDR and XDR tuberculosis in Shanghai, China. PloS one 20090101
Corneal collagen cross-linking with riboflavin and ultraviolet - a light for keratoconus: results in Indian eyes. Indian journal of ophthalmology 20090101
Emergence of respiratory Streptococcus agalactiae isolates in cystic fibrosis patients. PloS one 20090101
T-SPOT.TB responses during treatment of pulmonary tuberculosis. BMC infectious diseases 20090101
Second-line treatment for Helicobacter pylori infection based on moxifloxacin triple therapy: a randomized controlled trial. Wiener klinische Wochenschrift 20090101
Acute generalized exanthematous pustulosis following oral treatment with moxifloxacine. European journal of dermatology : EJD 20090101
Aspergillus iris granuloma: a case report with review of literature. Survey of ophthalmology 20090101
Penetration of moxifloxacin into rat mandibular bone and soft tissue. Acta odontologica Scandinavica 20090101
Personal and societal health quality lost to tuberculosis. PloS one 20090101
Defining the role of macrophages in local moxifloxacin tissue concentrations using biopsy data and whole-body physiologically based pharmacokinetic modelling. Clinical pharmacokinetics 20090101
Comparison of in vitro activities of tigecycline with other antimicrobial agents against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in two university hospitals in Istanbul, Turkey. Chemotherapy 20090101
Extensively drug resistance (XDR) tb is not always fatal. The Indian journal of tuberculosis 20090101
Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes. Drug safety 20090101
Validation of the normal, freely moving Göttingen minipig for pharmacological safety testing. Journal of pharmacological and toxicological methods 20090101
How beta-lactam antibiotics enter bacteria: a dialogue with the porins. PloS one 20090101
Efficacy of amoxycillin versus amoxycillin/clavulanate in acute exacerbations of chronic pulmonary obstructive disease in primary care. International journal of chronic obstructive pulmonary disease 20090101
Ten years of antibiotic consumption in ambulatory care: trends in prescribing practice and antibiotic resistance in Austria. BMC infectious diseases 20090101
Occurrence of HSV-1-induced pneumonitis in patients under standard immunosuppressive therapy for rheumatic, vasculitic, and connective tissue disease. BMC pulmonary medicine 20090101
[Conjunctivitis due to Achromobacter xylosoxidans: case report]. Arquivos brasileiros de oftalmologia 20090101
Gatifloxacin, moxifloxacin, and balofloxacin resistance due to mutations in the gyrA and parC genes of Staphylococcus epidermidis strains isolated from patients with endophthalmitis, corneal ulcers and conjunctivitis. Ophthalmic research 20090101
[New indications for novel fluoroquinolones: moxifloxacin in the treatment of nosocomial infections]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20090101
[Pharmacodynamics of antibiotics in CSF: principles and consequences (predictive factors of efficacy)]. Medecine et maladies infectieuses 20090101
Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter? Critical care (London, England) 20090101
Delineating bacteriostatic and bactericidal targets in mycobacteria using IPTG inducible antisense expression. PloS one 20090101
Genetic relatedness and molecular characterization of multidrug resistant Acinetobacter baumannii isolated in central Ohio, USA. Annals of clinical microbiology and antimicrobials 20090101
Conjugative IncFI plasmids carrying CTX-M-15 among Escherichia coli ESBL producing isolates at a University hospital in Germany. BMC infectious diseases 20090101
Scleral ulceration after vitreoretinal surgery. Indian journal of ophthalmology 20090101
Bacterial thymidine kinase as a non-invasive imaging reporter for Mycobacterium tuberculosis in live animals. PloS one 20090101
The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. American journal of therapeutics 20090101
[Study of efficacy of modern fluoroquinolones against agent of glanders in experiments in vivo]. Zhurnal mikrobiologii, epidemiologii, i immunobiologii 20090101
Risk factors for nasopharyngeal carriage of drug-resistant Streptococcus pneumoniae: data from a nation-wide surveillance study in Greece. BMC infectious diseases 20090101
Actinomyces species: A danish survey on human infections and microbiological characteristics. The open microbiology journal 20090101
Intracameral dexamethasone reduces inflammation on the first postoperative day after cataract surgery in eyes with and without glaucoma. Clinical ophthalmology (Auckland, N.Z.) 20090101
Gemifloxacin use in the treatment of acute bacterial exacerbation of chronic bronchitis. International journal of chronic obstructive pulmonary disease 20090101
Effects of prophylactic administration of bacteriophages to immunosuppressed mice infected with Staphylococcus aureus. BMC microbiology 20090101
Treatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days). BMC infectious diseases 20090101
Comparative analysis of length of stay, total costs, and treatment success between intravenous moxifloxacin 400 mg and levofloxacin 750 mg among hospitalized patients with community-acquired pneumonia. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20090101
Outer membrane porin M35 of Moraxella catarrhalis mediates susceptibility to aminopenicillins. BMC microbiology 20090101
Mycoplasma pneumoniae community-acquired pneumonia (CAP) in the elderly: Diagnostic significance of acute thrombocytosis. Heart & lung : the journal of critical care 20090101
Pharmacokinetics of moxifloxacin in patients undergoing continuous ambulatory peritoneal dialysis. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 20090101
Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome biology 20090101
Anti-inflammatory effects of antibacterials on human Bronchial epithelial cells. Respiratory research 20090101
Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics. Clinical ophthalmology (Auckland, N.Z.) 20090101
Drugs associated with more suicidal ideations are also associated with more suicide attempts. PloS one 20090101
Safety profile of Coartem: the evidence base. Malaria journal 20090101
Ofloxacin induced leucopenia in complicated falciparum malaria: a case report. Cases journal 20090101
Moxifloxacin induced fatal hepatotoxicity in a 72-year-old man: a case report. Cases journal 20090101
Empiric antibiotic therapy in acute uncomplicated urinary tract infections and fluoroquinolone resistance: a prospective observational study. Annals of clinical microbiology and antimicrobials 20090101
Intracameral recombinant tissue plasminogen activator for refractory glaucoma secondary to a fungal corneal abscess. The open ophthalmology journal 20090101
Intraocular penetration of sequentially instilled topical moxifloxacin, gatifloxacin, and levofloxacin. Clinical ophthalmology (Auckland, N.Z.) 20090101
Mycobacterium marinum Hand Infection in a 'Sushi Chef'. Eplasty 20090101
Non-specific interstitial pneumonia as the initial presentation of biphenotypic acute leukemia: a case report. Cases journal 20090101
New antibiotics: optimal use in current clinical practice. International journal of antimicrobial agents 20090101
Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United States. BMC ophthalmology 20090101
C. pneumoniae community-acquired pneumonia (CAP) in mimicking Mycoplasma pneumoniae meningoencephalitis complicated by asthma. Heart & lung : the journal of critical care 20090101
Fesoterodine for the treatment of urinary incontinence and overactive bladder. Therapeutics and clinical risk management 20090101
The treatment of diabetic foot infections: focus on ertapenem. Vascular health and risk management 20090101
Managing human bites. Journal of emergencies, trauma, and shock 20090101
Moxifloxacin-based triple therapy versus clarithromycin-based triple therapy for first-line treatment of Helicobacter pylori infection: a meta-analysis of randomized controlled trials. Internal medicine (Tokyo, Japan) 20090101
The Differential Gene Expression Pattern of Mycobacterium tuberculosis in Response to Capreomycin and PA-824 versus First-Line TB Drugs Reveals Stress- and PE/PPE-Related Drug Targets. International journal of microbiology 20090101
Clonal dissemination of the multi-drug resistant Salmonella enterica serovar Braenderup, but not the serovar Bareilly, of prevalent serogroup C1 Salmonella from Taiwan. BMC microbiology 20090101
Effect of the novel influenza A (H1N1) virus in the human immune system. PloS one 20090101
[Efficacy of levofloxacin, lomefloxacin and moxifloxacin vs. other fluoroquinolones in experimental plague due to FI+ and FI- strains of Yersinia pestis in Albino mice]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20090101
Anaerobic bacteria as a cause of mycotic aneurysm of the aorta: microbiology and antimicrobial therapy. Current cardiology reviews 20090101
Lemierre's syndrome, reemergence of a forgotten disease: a case report. Cases journal 20090101
Increasing resistance to quinolones: A four-year prospective study of urinary tract infection pathogens. International journal of general medicine 20090101
Prevention of acute chemotherapy-induced nausea and vomiting: the role of palonosetron. Cancer management and research 20090101
Palonosetron for the prevention of chemotherapy-induced nausea and vomiting: approval and efficacy. Cancer management and research 20090101
Dosing Recommendations for Continuous Venovenous Hemodiafiltration with AN69 Filter Membranes and Prismaflex Dialyzers. The Canadian journal of hospital pharmacy 20090101
Trace analysis of quinolone and fluoroquinolone antibiotics from wastewaters by liquid chromatography-electrospray tandem mass spectrometry. Journal of chromatography. A 20081219
Increased number of Clostridium difficile infections and prevalence of Clostridium difficile PCR ribotype 001 in southern Germany. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 20081204
Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20081202
Moxifloxacine plus amoxicillin and ranitidine bismuth citrate or esomeprazole triple therapies for Helicobacter pylori infection. Digestive diseases and sciences 20081201
Epidemiology of Clostridium difficile-associated disease at University Hospital Basel including molecular characterisation of the isolates 2006-2007. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20081201
Penicillin compared with other advanced broad spectrum antibiotics regarding antibacterial activity against oral pathogens isolated from odontogenic abscesses. Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 20081201
In vitro elution of moxifloxacin and fusidic acid by a synthetic crystallic semihydrate form of calcium sulphate (Stimulan). International journal of antimicrobial agents 20081201
Interpretive categorical accuracy of fluoroquinolone reference broth microdilution MIC results when testing Streptococcus pneumoniae: selection of a surrogate testing agent. Diagnostic microbiology and infectious disease 20081201
Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 System. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20081201
Comparison of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens- and non-contact lens-related keratitis. Journal of medical microbiology 20081201
Determination of the inhibitory potential of 6 fluoroquinolones on CYP1A2 and CYP2C9 in human liver microsomes. Acta pharmacologica Sinica 20081201
Calculation of AQCmax: comparison of five ophthalmic fluoroquinolone solutions*. Current medical research and opinion 20081201
A comparison of fluoroquinolone penetration into human conjunctival tissue. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20081201
Gas-forming parotid abscess in a diabetic patient: an unusual complication of Salmonella enteritidis bacteremia. The American journal of the medical sciences 20081201
An update on invasive pneumococcal antibiotic resistance in Turkey, 2008. Journal of chemotherapy (Florence, Italy) 20081201
Use of azithromycin in the treatment of acute exacerbations of COPD. International journal of chronic obstructive pulmonary disease 20081201
Effects of treatment with antimicrobial agents on the human colonic microflora. Therapeutics and clinical risk management 20081201
Duloxetine in the treatment of generalized anxiety disorder. Neuropsychiatric disease and treatment 20081201
Extensively drug-resistant tuberculosis. The New England journal of medicine 20081127
Linking bisphosphonates to the free amino groups in fluoroquinolones: preparation of osteotropic prodrugs for the prevention of osteomyelitis. Journal of medicinal chemistry 20081113
Disposition kinetics of moxifloxacin in lactating ewes. Veterinary journal (London, England : 1997) 20081101
Thorough QT/QTc study in patients with advanced Parkinson's disease: cardiac safety of rotigotine. Clinical pharmacology and therapeutics 20081101
Development and validation of a HPLC method for simultaneous quantitation of gatifloxacin, sparfloxacin and moxifloxacin using levofloxacin as internal standard in human plasma: application to a clinical pharmacokinetic study. Biomedical chromatography : BMC 20081101
[Severe febrile illness with renal impairment after travel to Southeast Asia]. Der Internist 20081101
Disseminated salmonellosis in a patient treated with temozolomide. The Journal of infection 20081101
Isoniazid or moxifloxacin in rifapentine-based regimens for experimental tuberculosis? American journal of respiratory and critical care medicine 20081101
Emerging therapies for the treatment of Helicobacter pylori infections. The Annals of pharmacotherapy 20081101
Bacteremia caused by Mycobacterium wolinskyi. Emerging infectious diseases 20081101
[Traumatic Endophthalmitis Prevention Trial (TEPT)]. Klinische Monatsblatter fur Augenheilkunde 20081101
Contamination of chicken meat with Salmonella enterica Serovar Haardt with nalidixic acid resistance and reduced fluoroquinolone susceptibility. Journal of microbiology and biotechnology 20081101
Anti-inflammatory effects of besifloxacin, a novel fluoroquinolone, in primary human corneal epithelial cells. Current eye research 20081101
[A severe side effect of antitubercular therapy: pyrazinamide induced thrombocytopenia]. Revue des maladies respiratoires 20081101
Conjunctival tissue pharmacokinetic properties of topical azithromycin 1% and moxifloxacin 0.5% ophthalmic solutions: a single-dose, randomized, open-label, active-controlled trial in healthy adult volunteers. Clinical therapeutics 20081101
Ethyl 1-cyclo-propyl-6,7-difluoro-8-meth-oxy-4-oxo-1,4-dihydro-quinoline-3-carboxyl-ate. Acta crystallographica. Section E, Structure reports online 20081101
Distribution and antimicrobial susceptibility patterns of Clostridium difficile PCR ribotypes in English hospitals, 2007-08. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 20081009
Facilitated permeation of antibiotics across membrane channels--interaction of the quinolone moxifloxacin with the OmpF channel. Journal of the American Chemical Society 20081008
Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease. Sexually transmitted infections 20081001
An intrinsic pattern of reduced susceptibility to fluoroquinolones in pediatric isolates of Streptococcus pyogenes. Diagnostic microbiology and infectious disease 20081001
Eikenella corrodens as a causative agent for neonatal conjunctivitis. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 20081001
Comparison of the effects of fourth-generation fluoroquinolones on corneal re-epithelialization in rabbit eyes. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20081001
Successful treatment of post-neurosurgical intracranial Mycoplasma hominis infection using gatifloxacin. The Journal of infection 20081001
Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20081001
Surveillance study of the susceptibility of Haemophilus influenzae to various antibacterial agents in Europe and Canada. Current medical research and opinion 20081001
Mycoplasma hominis meningitis in a neonate: case report and review. The Journal of infection 20081001
Antimicrobial activity of acrylic intraocular lenses soaked in fourth generation fluoroquinolones. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20081001
Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study. International journal of STD & AIDS 20081001
Moxifloxacin as an adjunctive antibiotic in the treatment of severe chronic periodontitis. Journal of periodontology 20081001
Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy. Advances in therapy 20081001
Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis. Therapeutics and clinical risk management 20081001
The effect of moxifloxacin on QTc and implications for the design of thorough QT studies. Clinical pharmacology and therapeutics 20081001
Recent Advances in Multi-Drug-Resistant Tuberculosis and RNTCP. Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine 20081001
Pharmacogenomics. Indian journal of pharmacology 20081001
Moxifloxacin monotherapy in severe pneumonia: do we really need it? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080915
Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20080901
Single- and multiple-dose pharmacokinetics of intravenous moxifloxacin in patients with severe hepatic impairment. The Journal of antimicrobial chemotherapy 20080901
Contrasting effects of human THP-1 cell differentiation on levofloxacin and moxifloxacin intracellular accumulation and activity against Staphylococcus aureus and Listeria monocytogenes. The Journal of antimicrobial chemotherapy 20080901
Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects. British journal of clinical pharmacology 20080901
Acute bacterial maxillary sinusitis: time to symptom resolution and return to normal activities with moxifloxacin. International journal of clinical practice 20080901
Mechanism of binding of fluoroquinolones to the quinolone resistance-determining region of DNA gyrase: towards an understanding of the molecular basis of quinolone resistance. Chembiochem : a European journal of chemical biology 20080901
Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery. Journal of cataract and refractive surgery 20080901
Third- and fourth-generation fluoroquinolones: retrospective comparison of endophthalmitis after cataract surgery performed over 10 years. Journal of cataract and refractive surgery 20080901
Effect of nepafenac sodium 0.1% on delayed corneal epithelial healing and haze after photorefractive keratectomy: retrospective comparative study. Journal of cataract and refractive surgery 20080901
Evaluation of toxicity of commercial ophthalmic fluoroquinolone antibiotics as assessed on immortalized corneal and conjunctival epithelial cells. Cornea 20080901
[In vitro generation of mutants of Klebsiella pneumoniae following exposure to fluorquinolones. Relationship with the presence of extended spectrum betalactamases]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20080901
Therapeutic effect of a novel oxazolidinone, DA-7867, in BALB/c mice infected with Nocardia brasiliensis. PLoS neglected tropical diseases 20080901
Biofilm formation is not necessary for development of quinolone-resistant 'persister' cells in an attached Staphylococcus epidermidis population. The International journal of artificial organs 20080901
Antimicrobial activity among multidrug-resistant Streptococcus pneumoniae isolated in the United States, 2001-2005. Postgraduate medicine 20080901
Decline in the prevalence of pandemic clones Spain23F-1 and Spain9V-3 among US fluoroquinolone-resistant Streptococcus pneumoniae TRUST Surveillance isolates since 2001. Postgraduate medicine 20080901
Role of macrolide therapy in chronic obstructive pulmonary disease. International journal of chronic obstructive pulmonary disease 20080901
Delayed epithelial ingrowth caused by viral conjunctivitis after LASIK. Yonsei medical journal 20080830
[Novel side effects of moxifloxacin: making a balanced decision again]. Nederlands tijdschrift voor geneeskunde 20080823
Penetration and accumulation of moxifloxacin in uterine tissue. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20080801
Doxycycline or moxifloxacin for the management of community-acquired pneumonia in the UK? International journal of antimicrobial agents 20080801
A case of fungal keratitis: a clinical and in vivo confocal microscopy assessment. Contact lens & anterior eye : the journal of the British Contact Lens Association 20080801
Effect of brivaracetam on cardiac repolarisation--a thorough QT study. Current medical research and opinion 20080801
Literature-based evaluation of four 'hard endpoint' models for assessing drug-induced torsades de pointes liability. British journal of pharmacology 20080801
Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 1: aqueous concentration of moxifloxacin. Journal of cataract and refractive surgery 20080801
Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 2: residual conjunctival flora. Journal of cataract and refractive surgery 20080801
Prospective comparison of topical moxifloxacin in eliminating conjunctival bacterial flora following a one-day or one-hour application. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20080801
Moxifloxacin as the likely cause of drug-induced linear immunoglobulin A bullous dermatosis. Journal of drugs in dermatology : JDD 20080801
Activity of moxifloxacin against the urogenital mycoplasmas Ureaplasma spp., Mycoplasma hominis and Mycoplasma genitalium and Chlamydia trachomatis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20080801
[Pseudomonas aeruginosa keratitis associated with the use of last generation contact lens made of silicone hydrogel: case report]. Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia 20080801
[Synthesis and antibacterial activity of 7-(3-amino-4-alkoxyimino-1 -piperidyl) -quinolones]. Yao xue xue bao = Acta pharmaceutica Sinica 20080801
New compounds in the management of venous thromboembolism after orthopedic surgery: focus on rivaroxaban. Vascular health and risk management 20080801
Moxifloxacin: update and perspectives after 8 years of usage. Expert review of respiratory medicine 20080801
Intravesical treatments of bladder cancer: review. Pharmaceutical research 20080701
Moxifloxacin resistance is prevalent among Bacteroides and Prevotella species in Greece. The Journal of antimicrobial chemotherapy 20080701
Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae. The Journal of antimicrobial chemotherapy 20080701
Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cells. American journal of physiology. Lung cellular and molecular physiology 20080701
Effects of aliskiren, a direct Renin inhibitor, on cardiac repolarization and conduction in healthy subjects. Journal of clinical pharmacology 20080701
In vitro synergism of beta-lactams with ciprofloxacin and moxifloxacin against genetically distinct multidrug-resistant isolates of Pseudomonas aeruginosa. International journal of antimicrobial agents 20080701
Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins. The Journal of infection 20080701
A pharmacoeconomic review of the management of respiratory tract infections with moxifloxacin. Expert opinion on pharmacotherapy 20080701
Moxifloxacin: a respiratory fluoroquinolone. Expert opinion on pharmacotherapy 20080701
Safety of intracameral moxifloxacin for prophylaxis of endophthalmitis after cataract surgery. Journal of cataract and refractive surgery 20080701
Report of a case of Streptococcus agalactiae mycotic aneurysm and review of the literature. International journal of surgical pathology 20080701
Management of accidental laboratory exposure to Burkholderia pseudomallei and B. mallei. Emerging infectious diseases 20080701
Toxinotype V Clostridium difficile in humans and food animals. Emerging infectious diseases 20080701
A significant interaction between moxifloxacin and warfarin in a patient with a mitral bioprosthetic valve. Heart and vessels 20080701
Antimicrobial susceptibility of Streptococcus pneumoniae in the oropharynx of healthy preschool children and identification of risk factors. Japanese journal of infectious diseases 20080701
Pharmacokinetics of moxifloxacin in non-inflamed cerebrospinal fluid of humans: implication for a bactericidal effect. The Journal of antimicrobial chemotherapy 20080601
Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates. American journal of ophthalmology 20080601
Cellular pharmacokinetics of telavancin, a novel lipoglycopeptide antibiotic, and analysis of lysosomal changes in cultured eukaryotic cells (J774 mouse macrophages and rat embryonic fibroblasts). The Journal of antimicrobial chemotherapy 20080601
Raltegravir thorough QT/QTc study: a single supratherapeutic dose of raltegravir does not prolong the QTcF interval. Journal of clinical pharmacology 20080601
Etravirine has no effect on QT and corrected QT interval in HIV-negative volunteers. The Annals of pharmacotherapy 20080601
Mutations in the quinolone resistance determining region in Staphylococcus epidermidis recovered from conjunctiva and their association with susceptibility to various fluoroquinolones. The British journal of ophthalmology 20080601
Genomes of model organisms: know thy tools. Environmental microbiology 20080601
Characterization of clinical Clostridium difficile isolates by PCR ribotyping and detection of toxin genes in Austria, 2006-2007. Journal of medical microbiology 20080601
Antibiotics involved in Clostridium difficile-associated disease increase colonization factor gene expression. Journal of medical microbiology 20080601
Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe. Journal of medical microbiology 20080601
Moxifloxacin for bacterial keratitis. Ophthalmology 20080601
Acute streptococcal myopericarditis mimicking myocardial infarction. The American journal of emergency medicine 20080601
Extensively drug-resistant tuberculosis, Lesotho. Emerging infectious diseases 20080601
Mycobacterium peregrinum: bactericidal activity of antibiotics alone and in combination. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20080601
[Resistance profiles to fluoroquinolones in clinical isolates of Gram positive cocci]. Biomedica : revista del Instituto Nacional de Salud 20080601
Prevalence of antimicrobial resistances in Streptococcus pneumoniae in Australia, 2005: report from the Australian Group on Antimicrobial Resistance. Communicable diseases intelligence quarterly report 20080601
Efficacy and tolerability of a fixed-dose moxifloxacin - dexamethasone formulation for topical prophylaxis in LASIK: a comparative, double-masked clinical trial. Clinical ophthalmology (Auckland, N.Z.) 20080601
Potential bias in ophthalmic pharmaceutical clinical trials. Clinical ophthalmology (Auckland, N.Z.) 20080601
In vitro activity of moxifloxacin and piperacillin/sulbactam against pathogens of acute cholangitis. World journal of gastroenterology 20080528
Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080515
Low selection of topoisomerase mutants from strains of Escherichia coli harbouring plasmid-borne qnr genes. The Journal of antimicrobial chemotherapy 20080501
Determination of moxifloxacin anaerobic susceptibility breakpoints according to the Clinical and Laboratory Standards Institute guidelines. Diagnostic microbiology and infectious disease 20080501
A cost-minimisation analysis comparing moxifloxacin with levofloxacin plus ceftriaxone for the treatment of patients with community-acquired pneumonia in Germany: results from the MOTIV trial. Current medical research and opinion 20080501
Interactions between warfarin and three commonly prescribed fluoroquinolones. The Annals of pharmacotherapy 20080501
Multidrug-resistant viridans streptococcus (MDRVS) osteomyelitis of the mandible successfully treated with moxifloxacin. Southern medical journal 20080501
Primary Nocardia farcinica brain abscess with secondary meningitis and ventriculitis in an immunocompetent patient, successfully treated with moxifloxacin. Acta neurochirurgica 20080501
Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given in different concentrations in a wick before cataract surgery. Journal of cataract and refractive surgery 20080501
Microbial cultures of the microkeratome blade immediately after flap construction in laser in situ keratomileusis. Journal of cataract and refractive surgery 20080501
Prevention of endophthalmitis by collagen shields presoaked in fourth-generation fluoroquinolones versus by topical prophylaxis. Journal of cataract and refractive surgery 20080501
Minimising moxifloxacin resistance with tuberculosis. The Lancet. Infectious diseases 20080501
Comparison of the effect of intracameral moxifloxacin, levofloxacin and cefazolin on rabbit corneal endothelial cells. Clinical & experimental ophthalmology 20080501
Characterization of the interactions between fluoroquinolone antibiotics and lipids: a multitechnique approach. Biophysical journal 20080415
Atomic absorption spectroscopic, conductometric and colorimetric methods for determination of some fluoroquinolone antibacterials using ammonium reineckate. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20080401
Infectious scleritis after retinal surgery. American journal of ophthalmology 20080401
Effect of single doses of maraviroc on the QT/QTc interval in healthy subjects. British journal of clinical pharmacology 20080401
Moxifloxacin-associated neutropenia in a cirrhotic elderly woman with lower extremity cellulitis. The Annals of pharmacotherapy 20080401
Virulence characteristics of community-associated Staphylococcus aureus and in vitro activities of moxifloxacin alone and in combination against community-associated and healthcare-associated meticillin-resistant and -susceptible S. aureus. Journal of medical microbiology 20080401
Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty. Cornea 20080401
[Fluoroquinolones and Gram-negative bacteria: antimicrobial activity and mechanisms of resistance]. Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20080401
Fluoroquinolones compared with beta-lactam antibiotics for the treatment of acute bacterial sinusitis: a meta-analysis of randomized controlled trials. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20080325
Quinolones as enhancers of camptothecin-induced cytotoxic and anti-topoisomerase I effects. Biochemical pharmacology 20080315
The epidemiology and treatment of infections in cancer patients. International journal of antimicrobial agents 20080301
Frequency of 1st- and 2nd-step topoisomerase mutations in Streptococcus pneumoniae following levofloxacin and moxifloxacin exposure. Diagnostic microbiology and infectious disease 20080301
Deep infection of a total knee implant as a complication of disseminated pneumococcal sepsis. A case report and review of literature. The Knee 20080301
Does in vitro susceptibility predict clinical outcome in bacterial keratitis? American journal of ophthalmology 20080301
Plasma protein binding of fluoroquinolones affects antimicrobial activity. The Journal of antimicrobial chemotherapy 20080301
A cost-effectiveness analysis of antimicrobial treatment of community-acquired pneumonia taking into account resistance in Belgium. Current medical research and opinion 20080301
Moxifloxacin versus ampicillin + gentamicin in the therapy of experimental Listeria monocytogenes meningitis. The Journal of antimicrobial chemotherapy 20080301
Haemophilus influenzae type-b and non-b-type invasive diseases in urban children (<5years) of Bangladesh: implications for therapy and vaccination. The Journal of infection 20080301
In vitro safety of intravitreal moxifloxacin for endophthalmitis treatment. Journal of cataract and refractive surgery 20080301
Phlyctenular keratoconjunctivitis in a patient with Staphylococcal blepharitis and ocular rosacea. Optometry (St. Louis, Mo.) 20080301
Experience of Comamonas acidovorans keratitis with delayed onset and treatment response in immunocompromised cornea. Korean journal of ophthalmology : KJO 20080301
In vitro susceptibilities of bacterial isolates from conjunctival flora to gatifloxacin, levofloxacin, tosufloxacin, and moxifloxacin. Eye & contact lens 20080301
Vitreal penetration of oral moxifloxacin in humans. Retina (Philadelphia, Pa.) 20080301
A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay. Current medical research and opinion 20080301
[Diagnosis and treatment of acute rhinosinusitis: second consensus]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20080301
Moxifloxacin. Tuberculosis (Edinburgh, Scotland) 20080301
Optimizing antibiotic selection in treating COPD exacerbations. International journal of chronic obstructive pulmonary disease 20080301
Review of moxifloxacin hydrochloride ophthalmic solution in the treatment of bacterial eye infections. Clinical ophthalmology (Auckland, N.Z.) 20080301
Fluoroquinolones compared to 1% azithromycin in DuraSite for bacterial conjunctivitis. Clinical ophthalmology (Auckland, N.Z.) 20080301
Response to correspondence from Lichtenstein and Granet Re: Fluoroquinolones compared to 1% azithromycin in DuraSite for bacterial conjunctivitis. Clinical ophthalmology (Auckland, N.Z.) 20080301
Influence of bacterial resistances on the efficiency of antibiotic treatments for community-acquired pneumonia. The European journal of health economics : HEPAC : health economics in prevention and care 20080201
Chitosan microspheres for intrapulmonary administration of moxifloxacin: interaction with biomembrane models and in vitro permeation studies. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20080201
In vitro pharmacodynamics of moxifloxacin versus levofloxacin against 4 strains of Streptococcus pneumoniae: 1 wild type, 2 first-step parC mutants, and 1 pump mutant. Diagnostic microbiology and infectious disease 20080201
Serum bactericidal activities of moxifloxacin and levofloxacin against aerobic and anaerobic intra-abdominal pathogens. Anaerobe 20080201
In vitro activity of fluoroquinolones against clinical isolates of Nocardia identified by partial 16S rRNA sequencing. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20080201
Do fluoroquinolones predispose patients to Clostridium difficile associated disease? A review of the evidence. Current medical research and opinion 20080201
Chronic bacterial prostatitis and relapsing Enterococcus faecalis bacteraemia successfully treated with moxifloxacin. The Journal of infection 20080201
Novel chemotherapy for tuberculosis: chemotherapeutic potential of econazole- and moxifloxacin-loaded PLG nanoparticles. International journal of antimicrobial agents 20080201
Intrinsic cytotoxic effects of fluoroquinolones on human corneal keratocytes and endothelial cells. Current medical research and opinion 20080201
One-week once-daily triple therapy with esomeprazole, moxifloxacin, and rifabutin for eradication of persistent Helicobacter pylori resistant to both metronidazole and clarithromycin. Helicobacter 20080201
Late-onset interface inflammation associated with wearing cosmetic lenses 18 months after laser in situ keratomileusis. Cornea 20080201
A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20080201
Moxifloxacin vs ampicillin/sulbactam in aspiration pneumonia and primary lung abscess. Infection 20080201
Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis. Journal of cataract and refractive surgery 20080201
Endophthalmitis. Ophthalmology 20080201
Early diagnosis of disseminated Mycobacterium genavense infection. Emerging infectious diseases 20080201
Fluoroquinolone-resistant group B streptococci in acute exacerbation of chronic bronchitis. Emerging infectious diseases 20080201
Stenotrophomonas maltophilia endocarditis treated with moxifloxacin-ceftazidime combination and annular wrapping technique. Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 20080201
In vitro antimicrobial susceptibility of Mycobacterium abscessus in Korea. Journal of Korean medical science 20080201
Cigarette smoking-induced acute eosinophilic pneumonia: a case report including a provocation test. Journal of Korean medical science 20080201
Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study. Clinical therapeutics 20080201
Antimicrobial susceptibility profile of contemporary clinical strains of Stenotrophomonas maltophilia isolates: can moxifloxacin activity be predicted by levofloxacin MIC results? Journal of chemotherapy (Florence, Italy) 20080201
In vitro bactericidal activity of antibiotic combinations against clinical isolates of Mycobacterium chelonae. Journal of chemotherapy (Florence, Italy) 20080201
Comparison of rifampicin and moxifloxacin efficacy in an experimental model of animal brucellosis. Journal of chemotherapy (Florence, Italy) 20080201
Topical 0.5% moxifloxacin prevents endophthalmitis in an intravitreal injection rabbit model. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20080201
In vitro activity of tigecycline, tetracycline and fluoroquinolones against Brucella melitensis. Journal of chemotherapy (Florence, Italy) 20080201
Fluoroquinolones for treating tuberculosis. The Cochrane database of systematic reviews 20080123
Ritonavir 100 mg does not cause QTc prolongation in healthy subjects: a possible role as CYP3A inhibitor in thorough QTc studies. Clinical pharmacology and therapeutics 20080101
Mycobacterium fortuitum infection following total knee arthroplasty: a case report and literature review. The Knee 20080101
Antimicrobial susceptibility of invasive group B streptococcal isolates from south-west Sweden 1988-2001. Scandinavian journal of infectious diseases 20080101
Besifloxacin, a novel fluoroquinolone antimicrobial agent, exhibits potent inhibition of pro-inflammatory cytokines in human THP-1 monocytes. The Journal of antimicrobial chemotherapy 20080101
Variation in the mutation frequency determining quinolone resistance in Chlamydia trachomatis serovars L2 and D. The Journal of antimicrobial chemotherapy 20080101
Concentrations of moxifloxacin in plasma and urine, and penetration into prostatic fluid and ejaculate, following single oral administration of 400 mg to healthy volunteers. International journal of antimicrobial agents 20080101
Involvement of Mrp2 (Abcc2) in biliary excretion of moxifloxacin and its metabolites in the isolated perfused rat liver. The Journal of pharmacy and pharmacology 20080101
Randomized, double-blind, crossover study to investigate the effect of rivaroxaban on QT-interval prolongation. Drug safety 20080101
Promising results for new tuberculosis therapy. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20080101
Case-control study of antibiotic use and subsequent Clostridium difficile-associated diarrhea in hospitalized patients. Infection control and hospital epidemiology 20080101
Comparison of the sterilising activities of the nitroimidazopyran PA-824 and moxifloxacin against persisting Mycobacterium tuberculosis. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20080101
Antimicrobial efficacy of prophylactic gatifloxacin 0.3% and moxifloxacin 0.5% in patients undergoing phacoemulsification surgery. Eye & contact lens 20080101
Comparing the protective effects of ciprofloxacin, moxifloxacin and levofloxacin in mice with lipopolysaccharide-induced acute lung injuries. Respirology (Carlton, Vic.) 20080101
Primary photophysical properties of moxifloxacin--a fluoroquinolone antibiotic. Photochemistry and photobiology 20080101
Pharmacokinetics and tissue penetration of moxifloxacin in intervention therapy for intra-abdominal abscess. Clinical drug investigation 20080101
Immunomodulatory effect of gatifloxacin on mouse peritoneal macrophages in vitro and in models of endotoxin-induced rat conjunctivitis and rabbit bacterial keratitis. Ophthalmic research 20080101
In vitro activity of telithromycin against Haemophilus influenzae at epithelial lining fluid concentrations. BMC microbiology 20080101
Early bacterial keratitis after presbyopic LASIK. Cornea 20080101
Evaluation of clinical, laboratory, and therapeutic features of 145 tularemia cases: the role of quinolones in oropharyngeal tularemia. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 20080101
Peripheral blood B lymphocytes derived from patients with idiopathic pulmonary arterial hypertension express a different RNA pattern compared with healthy controls: a cross sectional study. Respiratory research 20080101
Bench-to-bedside review: Clostridium difficile colitis. Critical care (London, England) 20080101
Fatal necrotizing pneumonia due to a Panton-Valentine leukocidin positive community-associated methicillin-sensitive Staphylococcus aureus and Influenza co-infection: a case report. Annals of clinical microbiology and antimicrobials 20080101
Direct aspiration of capsular bag material in a case of sequestered endophthalmitis. Indian journal of ophthalmology 20080101
Improving the detection of subtle I(Kr)-inhibition: assessing electrocardiographic abnormalities of repolarization induced by moxifloxacin. Drug safety 20080101
Moxifloxacin-associated drug hypersensitivity syndrome with drug-induced hypersensitivity pneumonitis. Journal of investigational allergology & clinical immunology 20080101
Pulmonary tuberculosis in a young pregnant female: challenges in diagnosis and management. Infectious diseases in obstetrics and gynecology 20080101
Dental general anaesthetic receipt among Australians aged 15+ years, 1998-1999 to 2004-2005. BMC oral health 20080101
Medical management approach to infectious keratitis. Indian journal of ophthalmology 20080101
Acute orbital abscess complicating deep posterior subtenon triamcinolone injection. Indian journal of ophthalmology 20080101
[Use of molecular-biological microchip TB-BIOCHIP-2 for detecting of Mycobacterium tuberculosis with multidrug resistance to fluoroquinolones in patients with new detected and chronic tuberculosis]. Vestnik Rossiiskoi akademii meditsinskikh nauk 20080101
Extensively drug resistant tuberculosis in a high income country: a report of four unrelated cases. BMC infectious diseases 20080101
A statistical assessment of QT data following placebo and moxifloxacin dosing in thorough QT studies. Journal of biopharmaceutical statistics 20080101
Validation testing in thorough QT/QTc clinical trials. Journal of biopharmaceutical statistics 20080101
Statistical issues of QT prolongation assessment based on linear concentration modeling. Journal of biopharmaceutical statistics 20080101
Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial. PloS one 20080101
A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam. PloS one 20080101
An overview of harms associated with beta-lactam antimicrobials: where do the carbapenems fit in? Critical care (London, England) 20080101
Fluoroquinolone resistance during 2000-2005: an observational study. BMC infectious diseases 20080101
Prevalence of putative virulence factors and antimicrobial susceptibility of Enterococcus faecalis isolates from patients with dental Diseases. BMC oral health 20080101
Severe acute polyarthritis in a child after high doses of moxifloxacin. Scandinavian journal of infectious diseases 20080101
Levofloxacin-induced delirium with psychotic features. General hospital psychiatry 20080101
Novel gyrase mutations and characterization of ciprofloxacin-resistant clinical strains of Enterococcus faecalis isolated in Poland. Polish journal of microbiology 20080101
Moxifloxacin-induced torsades de pointes. Cardiology journal 20080101
A comparison of moxifloxacin and levofloxacin topical prophylaxis in a fluoroquinolone-resistant Staphylococcus aureus rabbit model. Japanese journal of ophthalmology 20080101
Circulating angiopoietin-1 and angiopoietin-2 in critically ill patients: development and clinical application of two new immunoassays. Critical care (London, England) 20080101
Improving antibiotic prescribing for adults with community acquired pneumonia: Does a computerised decision support system achieve more than academic detailing alone?--A time series analysis. BMC medical informatics and decision making 20080101
Allergic reactions to oral drugs: A case/non-case study from an Italian spontaneous reporting database (GIF). Pharmacological research 20080101
Pegaptanib combined with intravitreal injection of moxifloxacin as treatment of wet macular degeneration. Retina (Philadelphia, Pa.) 20080101
Management of extensively drug-resistant tuberculosis in Peru: cure is possible. PloS one 20080101
Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China. PloS one 20080101
Evaluation of killing kinetics of anti-tuberculosis drugs on Mycobacterium tuberculosis using a bacteriophage-based assay. Chemotherapy 20080101
[Treatment of cutaneous infections due to Mycobacterium fortuitum: two cases]. Annales de dermatologie et de venereologie 20080101
Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants. BMC microbiology 20080101
Late development of esophageal stricture following radiation and chemotherapy for small cell carcinoma of the lung: A case report. Cases journal 20080101
Diagnostic difficulties of Lactobacillus casei bacteraemia in immunocompetent patients: a case report. Journal of medical case reports 20080101
[Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007]. Pathologie-biologie 20080101
The problems of meta-analysis for antibiotic treatment of chronic obstructive pulmonary disease, a heterogeneous disease: a commentary on Puhan et al. BMC medicine 20080101
Persistence of Mycoplasma genitalium following azithromycin therapy. PloS one 20080101
Spontaneous pneumomediastinum: diagnostic and therapeutic interventions. Journal of cardiothoracic surgery 20080101
First isolation of Clostridium difficile PCR-ribotype 027/toxinotype III in Poland. Polish journal of microbiology 20080101
[Culture proven bacterial endophthalmitis: a 6-year review]. Arquivos brasileiros de oftalmologia 20080101
Moxifloxacin versus polymyxin B/trimethoprim sulfate in pediatric bacterial conjunctivitis. Journal of pediatric ophthalmology and strabismus 20080101
A multicenter comparison of polymyxin B sulfate/trimethoprim ophthalmic solution and moxifloxacin in the speed of clinical efficacy for the treatment of bacterial conjunctivitis. Journal of pediatric ophthalmology and strabismus 20080101
The effects of moxifloxacin ophthalmic solution 0.5% or gatifloxacin ophthalmic solution 0.3% treatment on corneal wound healing in pigmented rabbits following anterior keratectomy. Veterinary ophthalmology 20080101
[Unwanted side effects of antibacterials--a diagnostic challenge]. Deutsche medizinische Wochenschrift (1946) 20080101
Severe QT interval prolongation associated with moxifloxacin: a case report. Cases journal 20080101
Medical management of genitourinary tuberculosis. Indian journal of urology : IJU : journal of the Urological Society of India 20080101
Change in astigmatism after temporal clear corneal cataract extraction in the pediatric population. The open ophthalmology journal 20080101
Mycobacterium fortuitum abdominal wall abscesses following liposuction. Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India 20080101
Patch testing in non-immediate drug eruptions. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 20080101
Transconjunctival Sutureless 23-gauge Vitrectomy for Vitreoretinal Diseases: Outcome of 30 Consecutive Cases. Middle East African journal of ophthalmology 20080101
Mastoiditis secondary to mycobacterium abscessus imaged with gallium-67 scintigraphy. Biomedical imaging and intervention journal 20080101
Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis. International journal of pharmaceutics 20071210
Acute endophthalmitis after 25-gauge sutureless vitrectomy. International ophthalmology 20071201
The influence of continuous venovenous haemodialysis on the pharmacokinetics of multiple oral moxifloxacin administration to patients with severe renal dysfunction. British journal of clinical pharmacology 20071201
Ocular cysticercosis of the anterior segment. Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 20071201
Comment on: Failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS). Rheumatology (Oxford, England) 20071201
Efficacy and tolerability of a combined moxifloxacin/dexamethasone formulation for topical prophylaxis and reduction of inflammation in phacoemulsification: a comparative, double masked clinical trial. Current medical research and opinion 20071201
Pharmacokinetic variables of moxifloxacin in healthy male camels following intravenous and intramuscular administration. Journal of veterinary pharmacology and therapeutics 20071201
Anti-inflammatory effects of moxifloxacin and human beta-defensin 2 association in human lung epithelial cell line (A549) stimulated with lipopolysaccharide. Peptides 20071201
Corneal wound healing in New Zealand White Rabbits following anterior keratectomy and treatment with moxifloxacin ophthalmic solution 0.5% or gatifloxacin ophthalmic solution 0.3%. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20071201
Second-line treatment for Helicobacter pylori infection: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapy. Helicobacter 20071201
A randomized study of sequential intravenous/oral moxifloxacin in comparison to sequential intravenous ceftriaxone/oral cefuroxime axetil in patients with hospital-acquired pneumonia. Infection 20071201
Nosocomial pneumonia - are economical considerations important? Infection 20071201
Late bacterial keratitis after intracorneal ring segments (Ferrara ring) insertion for keratoconus. Cornea 20071201
Electroconvulsive therapy and antibiotics: a case report. The journal of ECT 20071201
Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model. PLoS medicine 20071201
[Antibacterial activity and pharmacological features of fluoroquinolones and considerations on their use in a nosocomial setting]. Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20071201
Comparative pharmacodynamics of garenoxacin, gemifloxacin, and moxifloxacin in community-acquired pneumonia caused by Streptococcus pneumoniae: a Monte Carlo simulation analysis. Clinical therapeutics 20071201
Clinical applications of azithromycin microspheres in respiratory tract infections. International journal of nanomedicine 20071201
Penetration of moxifloxacin and levofloxacin into cancellous and cortical bone in patients undergoing total hip arthroplasty. Journal of chemotherapy (Florence, Italy) 20071201
Tissue concentrations of vancomycin and Moxifloxacin in periprosthetic infection in rats. Acta orthopaedica 20071201
Rhodococcus equi infection after alemtuzumab therapy for T-cell prolymphocytic leukemia. Emerging infectious diseases 20071201
Ototoxicity of topical moxifloxacin in a chinchilla animal model. The Laryngoscope 20071201
Infectious keratitis secondary to Histoplasma capsulatum: the first case reports in humans. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 20071201
[Prediction on the efficacy of fluoroquinolones for anaerobic infections using Monte Carlo simulation]. The Japanese journal of antibiotics 20071201
History and evolution of antibiotic resistance in coagulase-negative staphylococci: Susceptibility profiles of new anti-staphylococcal agents. Therapeutics and clinical risk management 20071201
Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infections. Therapeutics and clinical risk management 20071201
Paliperidone ER: a review of the clinical trial data. Neuropsychiatric disease and treatment 20071201
In the aftermath of the Fusarium keratitis outbreak: What have we learned? Clinical ophthalmology (Auckland, N.Z.) 20071201
An assessment of the tolerability of moxifloxacin 0.5% compared to azithromycin 1.0% in DuraSite. Clinical ophthalmology (Auckland, N.Z.) 20071201
Selection of quinolone resistance in Streptococcus pneumoniae exposed in vitro to subinhibitory drug concentrations. The Journal of antimicrobial chemotherapy 20071101
Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis. International journal of antimicrobial agents 20071101
In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains. The Journal of antimicrobial chemotherapy 20071101
Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro. The Journal of antimicrobial chemotherapy 20071101
Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20071101
Levocetirizine does not prolong the QT/QTc interval in healthy subjects: results from a thorough QT study. European journal of clinical pharmacology 20071101
[Interest of the disk diffusion method for screening Clostridium difficile isolates with decreased susceptibility to antibiotics]. Pathologie-biologie 20071101
[In vitro activity of moxifloxacin (8-methoxyquinolone) alone or in combination with cefotaxime against group B streptococci]. Pathologie-biologie 20071101
Population genetics and antibiotic susceptibility of invasive Haemophilus influenzae in Manitoba, Canada, from 2000 to 2006. FEMS immunology and medical microbiology 20071101
The increasing problem of antibiotic resistance. Journal of cataract and refractive surgery 20071101
Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial. Journal of cataract and refractive surgery 20071101
Fourth-generation fluoroquinolone-resistant mycobacterial keratitis after laser in situ keratomileusis. Journal of cataract and refractive surgery 20071101
Building clinical trials capacity for tuberculosis drugs in high-burden countries. PLoS medicine 20071101
Overview of anti-tuberculosis (TB) drugs and their resistance mechanisms. Mini reviews in medicinal chemistry 20071101
In vitro permeation characteristics of moxifloxacin from oil drops through excised goat, sheep, buffalo and rabbit corneas. Die Pharmazie 20071101
Doctors report breakthrough antibiotic treatment for TB. The AIDS reader 20071101
Pulmonary disease caused by Mycobacterium xenopi: the first case in Korea. Yonsei medical journal 20071031
Synthesis and antitubercular activity of lipophilic moxifloxacin and gatifloxacin derivatives. Bioorganic & medicinal chemistry letters 20071015
Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20071015
Validated spectrophotometric methods for the estimation of moxifloxacin in bulk and pharmaceutical formulations. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20071001
[Tuberculosis treatment in 2007]. Medecine et maladies infectieuses 20071001
Emergency department drug orders: does drug storage location make a difference? Annals of emergency medicine 20071001
Dose-related selection of fluoroquinolone-resistant Escherichia coli. The Journal of antimicrobial chemotherapy 20071001
TARGETed surveillance: susceptibility of Streptococcus pneumoniae isolated from community-acquired respiratory tract infections in 2003 to fluoroquinolones and other agents. International journal of antimicrobial agents 20071001
Low efficacy rate of moxifloxacin-containing Helicobacter pylori eradication treatment: in an observational study in a Turkish population. Helicobacter 20071001
Susceptibility of oral obligate anaerobes to telithromycin, moxifloxacin and a number of commonly used antibacterials. Oral microbiology and immunology 20071001
Allometric scaling of marbofloxacin, moxifloxacin, danofloxacin and difloxacin pharmacokinetics: a retrospective analysis. Journal of veterinary pharmacology and therapeutics 20071001
Antimicrobial susceptibility and mechanism of resistance to fluoroquinolones in Staphylococcus intermedius and Staphylococcus schleiferi. Journal of veterinary pharmacology and therapeutics 20071001
Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin. Journal of cataract and refractive surgery 20071001
Patterns of perioperative prophylaxis for cataract surgery in Canada. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20071001
Topical ophthalmic fourth-generation fluoroquinolones: Appropriate use and cost considerations. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20071001
Drug combo speeds up TB treatment. AIDS patient care and STDs 20071001
Generation of resistant mutants of Mycobacterium chelonae and Mycobacterium fortuitum after exposure to subinhibitory concentrations of clarithromycin and moxifloxacin. Journal of chemotherapy (Florence, Italy) 20071001
Rapid increase of genetically diverse methicillin-resistant Staphylococcus aureus, Copenhagen, Denmark. Emerging infectious diseases 20071001
Ciprofloxacin-resistant Neisseria meningitidis, Delhi, India. Emerging infectious diseases 20071001
[Mycoplasma genitalium--aetiological agent of sexually transmitted infection]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20070906
Antimicrobial phenotypes and molecular basis in clinical strains of Clostridium difficile. Diagnostic microbiology and infectious disease 20070901
Antimicrobial resistance among invasive isolates of Streptococcus pneumoniae collected across Canada. Diagnostic microbiology and infectious disease 20070901
Susceptibility of Bacillus anthracis, Bacillus cereus, Bacillus mycoides, Bacillus pseudomycoides and Bacillus thuringiensis to 24 antimicrobials using Sensititre automated microbroth dilution and Etest agar gradient diffusion methods. The Journal of antimicrobial chemotherapy 20070901
[Modification of the histopathologic degree of inflammation in asymptomatic prostatitis (NIH IV) by moxifloxacin]. Der Urologe. Ausg. A 20070901
What are the most appropriate antibiotics for the treatment of acute exacerbation of chronic obstructive pulmonary disease? A therapeutic outcomes model. The Journal of antimicrobial chemotherapy 20070901
Antistaphylococcal activities of CG400549, a new bacterial enoyl-acyl carrier protein reductase (FabI) inhibitor. The Journal of antimicrobial chemotherapy 20070901
In vitro efficacy of imipenem in combination with six antimicrobial agents against Mycobacterium abscessus. International journal of antimicrobial agents 20070901
Vitreous and aqueous penetration of orally administered moxifloxacin in humans. Eye (London, England) 20070901
Treatment of respiratory tract infections with moxifloxacin: results of postmarketing surveillance in China. International journal of clinical practice 20070901
Comparison of azithromycin and moxifloxacin against bacterial isolates causing conjunctivitis. Current medical research and opinion 20070901
Bilateral peripheral infiltrative keratitis after LASIK. Korean journal of ophthalmology : KJO 20070901
Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial. Ophthalmology 20070901
Torsade de pointes associated with moxifloxacin: a rare but potentially fatal adverse event. The Canadian journal of cardiology 20070901
Validated polarographic methods for the determination of certain antibacterial drugs. Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20070901
Activity of ulifloxacin against clinical hospital isolates. Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20070901
Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD. International journal of chronic obstructive pulmonary disease 20070901
Failure of isoniazid chemoprophylaxis during infliximab therapy. Emerging infectious diseases 20070901
Delayed intraocular foreign body removal without endophthalmitis during Operations Iraqi Freedom and Enduring Freedom. Ophthalmology 20070801
Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate. The Journal of antimicrobial chemotherapy 20070801
Dexamethasone as adjuvant therapy to moxifloxacin attenuates valve destruction in experimental aortic valve endocarditis due to Staphylococcus aureus. Antimicrobial agents and chemotherapy 20070801
Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile. Infection control and hospital epidemiology 20070801
Acute appendicitis in the setting of Clostridium difficile colitis: case report and review of the literature. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20070801
Differential aqueous and vitreous concentrations of moxifloxacin and ofloxacin after topical administration one hour before vitrectomy. American journal of ophthalmology 20070801
Fourth-generation fluoroquinolone-resistant bacterial keratitis. Journal of cataract and refractive surgery 20070801
Antimicrobial resistance and the management of anaerobic infections. Expert review of anti-infective therapy 20070801
Ocular toxicity of fluoroquinolones. Clinical & experimental ophthalmology 20070801
A novel in vivo rabbit model that mimics human dosing to determine the distribution of antibiotics in ocular tissues. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20070801
[Abstracts of the 6th Moxifloxacin Research Workshop, March 1-2, 2007, Leverkusen, Germany]. Infection 20070801
Drug forecast - the peptide deformylase inhibitors as antibacterial agents. Therapeutics and clinical risk management 20070801
Aspiration pneumonia and primary lung abscess: diagnosis and therapy of an aerobic or an anaerobic infection? Expert review of respiratory medicine 20070801
Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model. Eye (London, England) 20070701
Cross-over assessment of serum bactericidal activity of moxifloxacin and levofloxacin versus penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae in healthy volunteers. Diagnostic microbiology and infectious disease 20070701
Occurrence of enterotoxigenic and nonenterotoxigenic Bacteroides fragilis in calves and evaluation of their antimicrobial susceptibility. FEMS microbiology letters 20070701
Nationwide surveillance of Streptococcus pneumoniae in Greece: patterns of resistance and serotype epidemiology. International journal of antimicrobial agents 20070701
Molecular characterization and antimicrobial susceptibility patterns of Clostridium difficile strains isolated from hospitals in south-east Scotland. Journal of medical microbiology 20070701
Comparison of antibiotic effect and corneal epithelial toxicity of levofloxacin and moxifloxacin in vitro. Cornea 20070701
Update on the treatment of diabetic foot infections. Clinics in podiatric medicine and surgery 20070701
[Brochiectasis (in the adult)]. Praxis 20070613
Proarrhythmia as a class effect of quinolones: increased dispersion of repolarization and triangulation of action potential predict torsades de pointes. Journal of cardiovascular electrophysiology 20070601
Effect of fourth-generation fluoroquinolones on the healing rate of corneal erosions in an animal model. Cornea 20070601
Clinical response of contact lens-associated fungal keratitis to topical fluoroquinolone therapy. Cornea 20070601
The safety profile of moxifloxacin and other fluoroquinolones in special patient populations. Current medical research and opinion 20070601
Nocardia farcinica brain abscess in a patient without immunocompromise. British journal of neurosurgery 20070601
Mycobacterium tuberculosis DNA gyrase as a target for drug discovery. Infectious disorders drug targets 20070601
Increasing spectrum in antimicrobial resistance of Shigella isolates in Bangladesh: resistance to azithromycin and ceftriaxone and decreased susceptibility to ciprofloxacin. Journal of health, population, and nutrition 20070601
A brief review of moxifloxacin in the treatment of elderly patients with community-acquired pneumonia (CAP). Clinical interventions in aging 20070601
Skin and skin structure infections: treatment with newer generation fluoroquinolones. Therapeutics and clinical risk management 20070601
Treatment of community-acquired pneumonia, with special emphasis on gemifloxacin. Therapeutics and clinical risk management 20070601
A randomized trial assessing the clinical efficacy and microbial eradication of 1% azithromycin ophthalmic solution vs tobramycin in adult and pediatric subjects with bacterial conjunctivitis. Clinical ophthalmology (Auckland, N.Z.) 20070601
Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004). Diagnostic microbiology and infectious disease 20070501
In vitro activity of garenoxacin tested against a worldwide collection of ciprofloxacin-susceptible and ciprofloxacin-resistant Enterobacteriaceae strains (1999-2004). Diagnostic microbiology and infectious disease 20070501
In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative staphylococcus endophthalmitis isolates. Ophthalmology 20070501
Cost-effectiveness of empirical prescribing of antimicrobials in community-acquired pneumonia in three countries in the presence of resistance. The Journal of antimicrobial chemotherapy 20070501
Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC values. Diagnostic microbiology and infectious disease 20070501
Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure. The Journal of antimicrobial chemotherapy 20070501
In vitro activity of amoxicillin, clindamycin, doxycycline, metronidazole, and moxifloxacin against oral Actinomyces. Journal of endodontics 20070501
Central venous catheter-related Streptomyces septic thrombosis. Infection control and hospital epidemiology 20070501
Comparative minimal inhibitory and mutant prevention drug concentrations of four fluoroquinolones against ocular isolates of Haemophilus influenzae. Eye & contact lens 20070501
[Pharmacodynamic profile and clinical efficacy of moxifloxacin ophthalmic solution (Vegamox 0.5% ophthalmic solution]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20070501
The influence of fluoroquinolone drugs on the bacterial growth of S. epidermidis utilizing the unique potential of vibrational spectroscopy. The journal of physical chemistry. A 20070419
Increased polymorphonuclear leukocyte respiratory burst function in type 2 diabetes. Diabetes research and clinical practice 20070401
Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones: a retrospective observational case series. Ophthalmology 20070401
Arrhythmias associated with fluoroquinolone therapy. International journal of antimicrobial agents 20070401
Type II topoisomerase mutations in clinical isolates of Enterobacter cloacae and other enterobacterial species harbouring the qnrA gene. International journal of antimicrobial agents 20070401
Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility. International journal of antimicrobial agents 20070401
Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070401
Factors compromising the activity of moxifloxacin against intracellular Staphylococcus aureus. The Journal of antimicrobial chemotherapy 20070401
Antimicrobial efficacy of gatifloxacin and moxifloxacin with and without benzalkonium chloride compared with ciprofloxacin and levofloxacin against methicillin-resistant Staphylococcus aureus. Journal of chemotherapy (Florence, Italy) 20070401
Effects of intravitreal moxifloxacin and dexamethasone in experimental Staphylococcus aureus endophthalmitis. Current eye research 20070401
The effect of moxifloxacin and gatifloxacin on long-term visual outcomes following photorefractive keratectomy. Journal of refractive surgery (Thorofare, N.J. : 1995) 20070401
XDR-TB in South Africa: theory and practice. PLoS medicine 20070401
Treatment of ankylosing spondylitis with moxifloxacin. Southern medical journal 20070401
[Antibacterial activity of tosufloxacin against major organisms detected from patients with respiratory infections]. The Japanese journal of antibiotics 20070401
Antibiotic resistance testing of the total implant-associated micro-flora and its pure isolates. European journal of medical research 20070326
Pharmacokinetics and milk penetration of moxifloxacin after intramuscular administration to lactating goats. Veterinary journal (London, England : 1997) 20070301
Comparative in vitro and bactericidal activities of telithromycin against penicillin-nonsusceptible, levofloxacin-resistant, and macrolide-resistant Streptococcus pneumoniae by time-kill methodology. International journal of antimicrobial agents 20070301
Concentration of moxifloxacin in serum and human aqueous humor following a single 400 mg oral dose. Journal of cataract and refractive surgery 20070301
Validation of the agar proportion and 2 liquid systems for testing the susceptibility of Mycobacterium tuberculosis to moxifloxacin. Diagnostic microbiology and infectious disease 20070301
Thorough QT study with recommended and supratherapeutic doses of tolterodine. Clinical pharmacology and therapeutics 20070301
QT effects of duloxetine at supratherapeutic doses: a placebo and positive controlled study. Journal of cardiovascular pharmacology 20070301
Worldwide emergence of extensively drug-resistant tuberculosis. Emerging infectious diseases 20070301
gyrA mutations in fluoroquinolone-resistant Clostridium difficile PCR-027. Emerging infectious diseases 20070301
Drug management in chronic rhinosinusitis: identification of the needs. Therapeutics and clinical risk management 20070301
Clinical development of 1% azithromycin in DuraSite, a topical azalide anti-infective for ocular surface therapy. Clinical ophthalmology (Auckland, N.Z.) 20070301
Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy. Antimicrobial agents and chemotherapy 20070201
Influence of structural factors on the enhanced activity of moxifloxacin: a fluorescence and EPR spectroscopic study. Analytical and bioanalytical chemistry 20070201
parE mutations in Streptococcus pneumoniae may reduce bactericidal activity of respiratory fluoroquinolones. International journal of antimicrobial agents 20070201
In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil. Cornea 20070201
A case of vancomycin-resistant enterococcus conjunctivitis and its clinically successful topical treatment. Cornea 20070201
Vitreal penetration of oral and topical moxifloxacin in humans. American journal of ophthalmology 20070201
Moxifloxacin therapy as a risk factor for Clostridium difficile-associated disease during an outbreak: attempts to control a new epidemic strain. Infection control and hospital epidemiology 20070201
Dysglycemia and fluoroquinolones: are you putting patients at risk? The Journal of family practice 20070201
Moxifloxacin and torsade de pointes. The Annals of pharmacotherapy 20070201
Moxifloxacin in the treatment of hospitalised community acquired pneumonia in HIV-infected subjects. Journal of chemotherapy (Florence, Italy) 20070201
[In-vitro and in-vivo activities of moxifloxacin and garenoxacin against Mycobacterium leprae]. Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association 20070201
[Susceptibility of clinical isolates from primary care clinics to oral antibacterial agents]. The Japanese journal of antibiotics 20070201
Successful treatment of pulmonary hemorrhage associated with leptospirosis and scrub typhus coinfection by early plasma exchange. Journal of the Formosan Medical Association = Taiwan yi zhi 20070201
Isothiazoloquinolones with enhanced antistaphylococcal activities against multidrug-resistant strains: effects of structural modifications at the 6-, 7-, and 8-positions. Journal of medicinal chemistry 20070125
Pneumopericardium masquerading as an acute myocardial infarction. International journal of cardiology 20070118
Application of a validated stability-indicating densitometric thin-layer chromatographic method to stress degradation studies on moxifloxacin. Analytica chimica acta 20070116
High-performance liquid chromatography assay for moxifloxacin: pharmacokinetics in human plasma. Journal of pharmaceutical and biomedical analysis 20070104
Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK1/2, JNK, and NF-kappaB activation in a cystic fibrosis epithelial cell line. American journal of physiology. Lung cellular and molecular physiology 20070101
Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria. The Journal of antimicrobial chemotherapy 20070101
Application of a probabilistic method for the determination of drug-induced QT prolongation in telemetered cynomolgus monkeys: effects of moxifloxacin. Journal of pharmacological and toxicological methods 20070101
[The effectiveness of the new fluoroquinolones against the normal bacterial flora of the conjunctiva]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 20070101
Collagen shields as a drug delivery system for the fourth-generation fluoroquinolones. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 20070101
Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis. International journal of antimicrobial agents 20070101
Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given by different methods before cataract surgery. Journal of cataract and refractive surgery 20070101
Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients. Journal of cataract and refractive surgery 20070101
Activity of newer fluoroquinolones against gram-positive and gram-negative bacteria isolated from ocular infections: an in vitro comparison. Indian journal of ophthalmology 20070101
Moxifloxacin-induced arthropathy. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20070101
Determining factors in the prescription of moxifloxacin in exacerbations of chronic bronchitis in the primary-care setting. Clinical drug investigation 20070101
[Clinical efficacy of moxifloxacin in the treatment of exacerbations of chronic bronchitis: a systematic review and meta-analysis]. Archivos de bronconeumologia 20070101
Antibacterial effects of moxifloxacin and levofloxacin simulating epithelial lining fluid concentrations against community-acquired methicillin-resistant Staphylococcus aureus. Drugs in R&D 20070101
ISA 247: trans-ISA 247, trans-R 1524, ISA(TX)247, ISAtx 247, ISATx247, LX 211, LX211, R 1524, R-1524. Drugs in R&D 20070101
Mycobacterium avium-intracellulare cellulitis occurring with septic arthritis after joint injection: a case report. BMC infectious diseases 20070101
An unusual cause of granulomatous disease. BMC clinical pathology 20070101
Moxifloxacin vs amoxicillin/clavulanate in the treatment of acute sinusitis. American journal of otolaryngology 20070101
Antimicrobial susceptibility of invasive pneumococcal isolates from a region in south-west Sweden 1998-2001. Scandinavian journal of infectious diseases 20070101
Methicillin-resistant Staphylococcus aureus caruncle abscess. Ophthalmic plastic and reconstructive surgery 20070101
Effectiveness of topical antibiotics on Staphylococcus aureus biofilm in vitro. American journal of rhinology 20070101
[Nongonococcal urethritis treatment in men with avelox (moxifloxacin)]. Urologiia (Moscow, Russia : 1999) 20070101
Molecular characterization and antimicrobial susceptibilities of extra-intestinal Clostridium difficile isolates. Anaerobe 20070101
Intravenous conivaptan: effects on the QTc interval and other electrocardiographic parameters in healthy volunteers. Advances in therapy 20070101
Comparative activities of antibiotics against intracellular non-typeable Haemophilus influenzae. Wiener klinische Wochenschrift 20070101
Fluoroquinolone susceptibilities to methicillin-resistant and susceptible coagulase-negative Staphylococcus isolated from eye infection. Arquivos brasileiros de oftalmologia 20070101
High eradication rate of H. pylori with moxifloxacin-based treatment: a randomized controlled trial. Wiener klinische Wochenschrift 20070101
A highly sensitive canine telemetry model for detection of QT interval prolongation: studies with moxifloxacin, haloperidol and MK-499. Journal of pharmacological and toxicological methods 20070101
Bilateral hilar lymphadenopathy in a young female: a case report. Journal of medical case reports 20070101
Comparison of the QT interval response during sinus and paced rhythm in conscious and anesthetized beagle dogs. Journal of pharmacological and toxicological methods 20070101
Novel agents in the management of Mycobacterium tuberculosis disease. Current medicinal chemistry 20070101
Incidence of allergic reactions associated with antibacterial use in a large, managed care organisation. Drug safety 20070101
A cluster of Candida krusei infections in a haematological unit. BMC infectious diseases 20070101
Burkholderia pseudomallei: in vitro susceptibility to some new and old antimicrobials. Scandinavian journal of infectious diseases 20070101
Fluoroquinolones for the treatment of pulmonary tuberculosis. Drugs 20070101
Laboratory detection methods for methicillin resistance in coagulase negative Staphylococcus isolated from ophthalmic infections. Arquivos brasileiros de oftalmologia 20070101
Acute cholecystitis - early laparoskopic surgery versus antibiotic therapy and delayed elective cholecystectomy: ACDC-study. Trials 20070101
[Avelox efficacy in the treatment of acute purulent rhinosinusitis]. Terapevticheskii arkhiv 20070101
[Survey of susceptibility of clinical Clostridium diffiicile strains isolated from patients hospitalised in different departments of paediatric hospital to antimicrobial agents]. Medycyna doswiadczalna i mikrobiologia 20070101
Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroquinolones and linezolid. Chemotherapy 20070101
Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up. BMC ear, nose, and throat disorders 20070101
[Pulmonary fibrosis induced by amiodarone--a pitfall of antiarrhytmic treatment]. Pneumologia (Bucharest, Romania) 20070101
Infections caused by mycobacterium tuberculosis in patients with hematological disorders and in recipients of hematopoietic stem cell transplant, a twelve year retrospective study. Annals of clinical microbiology and antimicrobials 20070101
Speed of bacterial kill with a fluoroquinolone compared with nonfluoroquinolones: clinical implications and a review of kinetics of kill studies. Advances in therapy 20070101
The cardiovascular safety profile of renzapride, a novel treatment for irritable bowel syndrome. The Journal of international medical research 20070101
Acute hepatitis associated with Q fever in a man in Greece: a case report. Journal of medical case reports 20070101
Endophthalmitis caused by staphylococcus epidermidis: in vitro antibiotic susceptibilities and clinical outcomes. Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 20070101
Therapy-refractory Panton Valentine Leukocidin-positive community-acquired methicillin-sensitive Staphylococcus aureus sepsis with progressive metastatic soft tissue infection: a case report. Journal of medical case reports 20070101
Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria. PloS one 20070101
Analysis of an SIR epidemic model with pulse vaccination and distributed time delay. Journal of biomedicine & biotechnology 20070101
[Genetical conditioning of fluoroquinolone resistance mechanisms of clinical enterococcus faecalis strains. II. The mutations present in the qrdrs of gyrA, gyrB, parC and parE genes]. Medycyna doswiadczalna i mikrobiologia 20070101
[MALDI-ToF mass-spectrometry in analysis of genetically determined resistance of Streptococcus pneumoniae to fluoroquinolones]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20070101
[Investigation of moxifloxacin, a new antimicrobial of the fluoroquinolone group in Russia]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20070101
Extensively drug-resistant tuberculosis (XDR-TB) - a potential threat in Ireland. The open respiratory medicine journal 20070101
Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial. Sexually transmitted infections 20061201
Design, synthesis and activity against Toxoplasma gondii, Plasmodium spp., and Mycobacterium tuberculosis of new 6-fluoroquinolones. European journal of medicinal chemistry 20061201
High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile. The Journal of antimicrobial chemotherapy 20061201
In vitro development of resistance to DX-619 and other quinolones in enterococci. The Journal of antimicrobial chemotherapy 20061201
No proarrhythmic properties of the antibiotics Moxifloxacin or Azithromycin in anaesthetized dogs with chronic-AV block. British journal of pharmacology 20061201
Bilateral simultaneous Achromobacter xylosoxidans keratitis following penetrating keratoplasty. Journal of cataract and refractive surgery 20061201
Stability indicating methods for the determination of some fluoroquinolones in the presence of their decarboxylated degrades. Chemical & pharmaceutical bulletin 20061201
Evaluation of the penetration of fluoroquinolones in human conjunctival tissue. Archives of ophthalmology (Chicago, Ill. : 1960) 20061201
In vitro antifungal activity of the fourth generation fluoroquinolones against Candida isolates from human ocular infections. Ocular immunology and inflammation 20061201
Stability of moxifloxacin injection in peritoneal dialysis solution bags (Dianeal PD1 1.36% and Dianeal PD1 3.86%). Journal of clinical pharmacy and therapeutics 20061201
Control of rapid heart rate changes for electrocardiographic analysis: implications for thorough QT studies. Clinical cardiology 20061201
[Study investigating the activity of several fluoroquinolones against Pseudomonas aeruginosa using the mutant prevention concentration]. Enfermedades infecciosas y microbiologia clinica 20061201
[Development of antituberculous drugs: current status and future prospects]. Kekkaku : [Tuberculosis] 20061201
Moxifloxacin and gatifloxacin in an acid model of persistent Mycobacterium tuberculosis. Journal of chemotherapy (Florence, Italy) 20061201
The first steps towards fluoroquinolone resistance in Hungarian pneumococci. Journal of chemotherapy (Florence, Italy) 20061201
Editorial foreword. Therapeutics and clinical risk management 20061201
Moxifloxacin in the treatment of skin and skin structure infections. Therapeutics and clinical risk management 20061201
Optimization and validation of the direct HPLC method for the determination of moxifloxacin in plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20061121
Vitreous and aqueous penetration of orally administered moxifloxacin in humans. Eye (London, England) 20061101
Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study. The European respiratory journal 20061101
Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model. The Journal of antimicrobial chemotherapy 20061101
Penetration of moxifloxacin into the human pancreas following a single intravenous or oral dose. The Journal of antimicrobial chemotherapy 20061101
The in vitro impact of moxifloxacin and gatifloxacin concentration (0.5% vs 0.3%) and the addition of benzalkonium chloride on antibacterial efficacy. American journal of ophthalmology 20061101
Acute endophthalmitis in eyes treated prophylactically with gatifloxacin and moxifloxacin. American journal of ophthalmology 20061101
Penetration of moxifloxacin into sternal bone of patients undergoing routine cardiopulmonary bypass surgery. International journal of antimicrobial agents 20061101
In vitro activity of fluoroquinolones, vancomycin, and gentamicin against methicillin-resistant Staphylococcus aureus ocular isolates. American journal of ophthalmology 20061101
Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis. Clinical journal of the American Society of Nephrology : CJASN 20061101
Moxifloxacin enhances antiproliferative and apoptotic effects of etoposide but inhibits its proinflammatory effects in THP-1 and Jurkat cells. British journal of cancer 20061023
Simultaneous separation of five fluoroquinolone antibiotics by capillary zone electrophoresis. Analytica chimica acta 20061010
Eradication of H. influenzae in AECB: A pooled analysis of moxifloxacin phase III trials compared with macrolide agents. Respiratory medicine 20061001
Moxifloxacin prophylaxis in neutropenic patients. The Journal of antimicrobial chemotherapy 20061001
In vitro susceptibility of Bartonella species to 17 antimicrobial compounds: comparison of Etest and agar dilution. The Journal of antimicrobial chemotherapy 20061001
Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia. Stroke 20061001
Evolution of resistance patterns and identification of risk factors for Streptococcus pneumoniae colonisation in daycare centre attendees in Athens, Greece. International journal of antimicrobial agents 20061001
Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium. Helicobacter 20061001
Hydrophilic acrylic intraocular lens as a drug-delivery system for fourth-generation fluoroquinolones. Journal of cataract and refractive surgery 20061001
The effect of moxifloxacin on the normal human cornea. Current medical research and opinion 20061001
[Cardiac tolerance of moxifloxacin: Clinical experience from a large observational French study in usual medical practice (IMMEDIAT study)]. Medecine et maladies infectieuses 20061001
Serum and prostatic tissue concentrations of moxifloxacin in patients undergoing transurethral resection of the prostate. Journal of chemotherapy (Florence, Italy) 20061001
Efficacy and safety of moxifloxacin as an additive in Optisol-GS a preservation medium for corneal donor tissue. Cornea 20061001
Effect of the fourth-generation fluoroquinolones on corneal reepithelialization after penetrating keratoplasty. Cornea 20061001
Pharmacokinetics and milk penetration of moxifloxacin after intravenous and subcutaneous administration to lactating goats. Veterinary journal (London, England : 1997) 20060901
Long-term moxifloxacin in complicated tuberculosis patients with adverse reactions or resistance to first line drugs. Respiratory medicine 20060901
Moxifloxacin versus levofloxacin against acute exacerbations of chronic bronchitis: the Latin American Cohort. Respiratory medicine 20060901
The effect of treatment with moxifloxacin or azithromycin on acute bacterial rhinosinusitis in mice. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20060901
Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus. The Journal of antimicrobial chemotherapy 20060901
Clinical significance of overexpression of multiple RND-family efflux pumps in Bacteroides fragilis isolates. The Journal of antimicrobial chemotherapy 20060901
Evaluation of bacterial kill when modelling the bronchopulmonary pharmacokinetic profile of moxifloxacin and levofloxacin against parC-containing isolates of Streptococcus pneumoniae. The Journal of antimicrobial chemotherapy 20060901
Pharmacokinetics and peritoneal penetration of moxifloxacin in peritonitis. The Journal of antimicrobial chemotherapy 20060901
Comparative elution of moxifloxacin from Norian skeletal repair system and acrylic bone cement: an in vitro study. International journal of antimicrobial agents 20060901
Intracranial Nocardia recurrence during fluorinated quinolones therapy. Transplant infectious disease : an official journal of the Transplantation Society 20060901
Selecting between gatifloxacin and moxifloxacin drops in ambulatory ophthalmic surgery. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20060901
Institutional difference of antibiotic resistance of Helicobacter pylori strains in Korea. Journal of clinical gastroenterology 20060901
Susceptibility testing of clinical isolates of pseudomonas aeruginosa to levofloxacin, moxifloxacin, and gatifloxacin as a guide to treating pseudomonas ocular infections. Eye & contact lens 20060901
Patterns of Helicobacter pylori isolate resistance to fluoroquinolones, amoxicillin, clarithromycin and metronidazoles. The Southeast Asian journal of tropical medicine and public health 20060901
Newer fluoroquinolones in the treatment of acute exacerbations of COPD. International journal of chronic obstructive pulmonary disease 20060901
Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis. American journal of respiratory and critical care medicine 20060801
European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe. The Journal of antimicrobial chemotherapy 20060801
A pharmacodynamic approach to antimicrobial activity in serum and epithelial lining fluid against in vivo-selected Streptococcus pneumoniae mutants and association with clinical failure in pneumonia. The Journal of antimicrobial chemotherapy 20060801
Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections. Annals of surgery 20060801
Prospects for advancing tuberculosis control efforts through novel therapies. PLoS medicine 20060801
Permeability of pig urinary bladder wall: time and concentration dependent effect of chitosan. Biological & pharmaceutical bulletin 20060801
Moxifloxacinium chloride-water-methanol (2/1/1), a novel antibacterial agent. Acta crystallographica. Section C, Crystal structure communications 20060801
Moxifloxacin versus standard therapy in patients with pneumonia hospitalized after failure of preclinical anti-infective treatment. Infection 20060801
In vitro antimicrobial activity of moxifloxacin against bacterial strains isolated from blood of neutropenic cancer patients. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20060801
Pharmacokinetics of moxifloxacin in rabbits after intravenous, subcutaneous and a long-acting poloxamer 407 gel formulation administration. Journal of veterinary medicine. A, Physiology, pathology, clinical medicine 20060801
In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia. Pathology 20060801
Relation between induction of the mar operon and cyclohexane tolerance and reduction in fluoroquinolone susceptibility in Salmonella spp. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20060801
Application of two methods to determine killing of Streptococcus pneumoniae by various fluoroquinolones. Journal of chemotherapy (Florence, Italy) 20060801
Relative potential for selection of quinolone-resistance-determining-region mutations in Streptococcus pneumoniae by gemifloxacin, gatifloxacin and moxifloxacin. Journal of chemotherapy (Florence, Italy) 20060801
Severe corneal toxicity after topical fluoroquinolone therapy: report of two cases. Cornea 20060801
Potent twice-weekly rifapentine-containing regimens in murine tuberculosis. American journal of respiratory and critical care medicine 20060701
Differentiation of arrhythmia risk of the antibacterials moxifloxacin, erythromycin, and telithromycin based on analysis of monophasic action potential duration alternans and cardiac instability. The Journal of pharmacology and experimental therapeutics 20060701
Comparative in vitro activity of PGE 9262932 and fluoroquinolones against Canadian clinical Streptococcus pneumoniae isolates, including molecularly characterized ciprofloxacin-resistant isolates. The Journal of antimicrobial chemotherapy 20060701
Comparison of primary and secondary antimicrobial minimum inhibitory concentrations for Helicobacter pylori isolated from Korean patients. International journal of antimicrobial agents 20060701
Treatment of hospitalized patients with community-acquired pneumonia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060701
Treatment with moxifloxacin versus standard therapy for community-acquired pneumonia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060701
[New antibiotics for the therapy of respiratory tract infections]. Pneumologie (Stuttgart, Germany) 20060701
Azithromycin failure in Mycoplasma genitalium urethritis. Emerging infectious diseases 20060701
Confocal assessment of the effects of fourth-generation fluoroquinolones on the cornea. Eye & contact lens 20060701
Validation of a levofloxacin HPLC assay in plasma and dialysate for pharmacokinetic studies. Journal of pharmaceutical and biomedical analysis 20060616
Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004). Diagnostic microbiology and infectious disease 20060601
Fourth-generation fluoroquinolone penetration into the aqueous humor in humans. Ophthalmology 20060601
Determination of ofloxacin and moxifloxacin and their penetration in human aqueous and vitreous humor by using high-performance liquid chromatography fluorescence detection. Analytical biochemistry 20060601
Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerging infectious diseases 20060601
Man versus machine: is there an optimal method for QT measurements in thorough QT studies? Journal of clinical pharmacology 20060601
Controversies in antibiotic choices for odontogenic infections. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20060601
Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20060601
New trends in development of antimycobacterial compounds. Infectious disorders drug targets 20060601
Penetration of moxifloxacin into bone in patients undergoing total knee arthroplasty. The Journal of antimicrobial chemotherapy 20060501
Screening for drug-induced spoliation of the hydrogel optic of the AlphaCor artificial cornea. Contact lens & anterior eye : the journal of the British Contact Lens Association 20060501
Recent advances in the medical and surgical treatment of multi-drug resistant tuberculosis. Current opinion in pulmonary medicine 20060501
[Pathogenesis, diagnosis and therapy of Legionella infections]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 20060501
Treatment of murine pneumonic Francisella tularensis infection with gatifloxacin, moxifloxacin or ciprofloxacin. International journal of antimicrobial agents 20060501
Treatment of implant-associated infections with moxifloxacin: an animal study. International journal of antimicrobial agents 20060501
Correlation of quinolone resistance levels and differences in basal and quinolone-induced expression from three qnrA-containing plasmids. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20060501
Antibiotic consumption and generation of resistance in Streptococcus pneumoniae: the paradoxical impact of quinolones in a complex selective landscape. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20060501
Phakic status affects vitreous penetration of topical moxifloxacin. Archives of ophthalmology (Chicago, Ill. : 1960) 20060501
[Antibiotic resistance of Helicobacter pylori isolated from Korean patients]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20060501
Vigamox: how good is its self-preservation? Journal of cataract and refractive surgery 20060501
Mutagenesis induced by 12 quinolone antibacterial agents in Escherichia coli WP2uvrA/pKM101. Toxicology in vitro : an international journal published in association with BIBRA 20060401
First successful treatment of Nocardia farcinica brain abscess with moxifloxacin. The Journal of infection 20060401
Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis. Thorax 20060401
Mechanism of hERG K+ channel blockade by the fluoroquinolone antibiotic moxifloxacin. British journal of pharmacology 20060401
Concentration of moxifloxacin in plasma and tonsillar tissue after multiple administration in adult patients. The Journal of antimicrobial chemotherapy 20060401
Correlation between in vitro and in vivo activity of levofloxacin and moxifloxacin against pneumococcal strains with different susceptibilities to fluoroquinolones. International journal of antimicrobial agents 20060401
Drug interactions during therapy with three major groups of antimicrobial agents. Expert opinion on pharmacotherapy 20060401
Antimicrobial susceptibilities of Pasteurella strains isolated from humans. International journal of antimicrobial agents 20060401
Intracameral Vigamox (moxifloxacin 0.5%) is not effective in preventing endophthalmitis in a rabbit model. American journal of ophthalmology 20060401
Intravitreal moxifloxacin: retinal safety study with electroretinography and histopathology in animal models. Investigative ophthalmology & visual science 20060401
Rapid microbiologic and pharmacologic evaluation of experimental compounds against Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy 20060401
In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates. Archives of ophthalmology (Chicago, Ill. : 1960) 20060401
A novel bacterium associated with lymphadenitis in a patient with chronic granulomatous disease. PLoS pathogens 20060401
Determination of the newer quinolones levofloxacin and moxifloxacin in plasma by high-performance liquid chromatography with fluorescence detection. Journal of chromatographic science 20060401
Hydrophilic acrylic intraocular lens as a drug-delivery system: Pilot study. Journal of cataract and refractive surgery 20060401
[Risk factors for increased cost of exacerbations of chronic bronchitis and chronic obstructive pulmonary disease]. Archivos de bronconeumologia 20060401
Moxifloxacin superior to vancomycin for treatment of bone infections--a study in rats. Acta orthopaedica 20060401
Outpatient gatifloxacin therapy and dysglycemia in older adults. The New England journal of medicine 20060330
Determination of the extent of protein binding of antibiotics by means of an automated continuous ultrafiltration method. International journal of pharmaceutics 20060327
Glucose homeostasis abnormalities and gatifloxacin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060315
Biological evaluation of isothiazoloquinolones containing aromatic heterocycles at the 7-position: In vitro activity of a series of potent antibacterial agents that are effective against methicillin-resistant Staphylococcus aureus. Bioorganic & medicinal chemistry letters 20060301
Analysis of genetic variability, antimicrobial susceptibility and virulence markers in Helicobacter pylori identified in Central Italy. Scandinavian journal of gastroenterology 20060301
Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas. AAPS PharmSciTech 20060301
Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery. Journal of cataract and refractive surgery 20060301
Urinary tract infections in patients with chronic renal insufficiency. Clinical journal of the American Society of Nephrology : CJASN 20060301
Telithromycin in the treatment of acute bacterial sinusitis, acute exacerbations of chronic bronchitis, and community-acquired pneumonia. Therapeutics and clinical risk management 20060301
An increase in late sodium current potentiates the proarrhythmic activities of low-risk QT-prolonging drugs in female rabbit hearts. The Journal of pharmacology and experimental therapeutics 20060201
Anti-inflammatory effects of moxifloxacin on IL-8, IL-1beta and TNF-alpha secretion and NFkappaB and MAP-kinase activation in human monocytes stimulated with Aspergillus fumigatus. The Journal of antimicrobial chemotherapy 20060201
Intraocular concentrations of gatifloxacin and moxifloxacin in the anterior chamber via diffusion through the cornea using collagen shields. Cornea 20060201
In vitro activity of sitafloxacin compared with several fluoroquinolones against Streptococcus anginosus and Streptococcus constellatus. International journal of antimicrobial agents 20060201
Efficacy of moxifloxacin-based triple therapy as second-line treatment for Helicobacter pylori infection. Helicobacter 20060201
Moxifloxacin versus levofloxacin for treatment of acute rhinosinusitis: a retrospective database analysis of treatment duration, outcomes, and charges. Current medical research and opinion 20060201
Intravitreal toxicity of moxifloxacin. Retina (Philadelphia, Pa.) 20060201
Vitreous penetration of topical moxifloxacin and gatifloxacin in humans. Retina (Philadelphia, Pa.) 20060201
Vitreous and aqueous penetration of orally administered moxifloxacin in humans. Archives of ophthalmology (Chicago, Ill. : 1960) 20060201
Antimicrobial drug resistance, regulation, and research. Emerging infectious diseases 20060201
[Rhinosinusitis: etiopathogenesis and antimicrobial therapy, an update]. Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale 20060201
[Cervical spondylodiscitis: one pathogen may hide another]. Medecine et maladies infectieuses 20060101
Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060101
[Antimicrobial resistance of Streptococcus pneumoniae strains isolated in the Reunion Island during 2004]. Medecine et maladies infectieuses 20060101
Clearance of intravitreal moxifloxacin. Investigative ophthalmology & visual science 20060101
T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 20060101
Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo. Current eye research 20060101
Do fluoroquinolones actually increase mortality in community-acquired pneumonia? Critical care (London, England) 20060101
Effects of three fluoroquinolones on QT analysis after standard treatment courses. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20060101
Fluoroquinolones: an important class of antibiotics against tuberculosis. Current medicinal chemistry 20060101
The pediatrician's dilemma. Journal of pediatric ophthalmology and strabismus 20060101
Controlling contagious bacterial conjunctivitis. Journal of pediatric ophthalmology and strabismus 20060101
Pharmacokinetic and pharmacodynamic aspects of oral moxifloxacin 400 mg/day in elderly patients with acute exacerbation of chronic bronchitis. Clinical pharmacokinetics 20060101
Use of arterially perfused rabbit ventricular wedge in predicting arrhythmogenic potentials of drugs. Journal of pharmacological and toxicological methods 20060101
Stepwise decrease in moxifloxacin susceptibility amongst clinical isolates of multidrug-resistant Mycobacterium tuberculosis: correlation with ofloxacin susceptibility. Microbial drug resistance (Larchmont, N.Y.) 20060101
Doxycycline plus streptomycin versus ciprofloxacin plus rifampicin in spinal brucellosis [ISRCTN31053647]. BMC infectious diseases 20060101
Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation. BMC health services research 20060101
[A multicentre study on the pathogenic agents in 665 adult patients with community-acquired pneumonia in cities of China]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 20060101
Eradication of common pathogens at days 2, 3 and 4 of moxifloxacin therapy in patients with acute bacterial sinusitis. BMC ear, nose, and throat disorders 20060101
Cardiovascular monkey telemetry: sensitivity to detect QT interval prolongation. Journal of pharmacological and toxicological methods 20060101
Susceptibility of Mycobacterium tuberculosis strains to gatifloxacin and moxifloxacin by different methods. Chemotherapy 20060101
A preoperative mixture of anesthetic jelly, dilating drops, antibiotics, and anti-inflammatories for cataract surgery. Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 20060101
In vitro activity of fluoroquinolones against common respiratory pathogens. The West Indian medical journal 20060101
Surveillance of antibiotic resistance in non invasive clinical isolates of Streptococcus pneumoniae collected in Belgium during winters 2003 and 2004. Acta clinica Belgica 20060101
Nursing home-acquired pneumonia: update on treatment options. Drugs & aging 20060101
[Blood and respiratory diffusion of antibiotics. A critical analysis of predictive parameters for clinical effectiveness]. Medecine et maladies infectieuses 20060101
[Acute community-acquired pneumonia. A review of clinical trials]. Medecine et maladies infectieuses 20060101
Comparison of in vitro activities of tigecycline with other antimicrobial agents against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in Taiwan. Microbial drug resistance (Larchmont, N.Y.) 20060101
Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans. Survey of ophthalmology 20060101
Peritonitis - the Western experience. World journal of emergency surgery : WJES 20060101
Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: an increasing problem. Annals of clinical microbiology and antimicrobials 20060101
Tuberculosis chemotherapy: current drug delivery approaches. Respiratory research 20060101
Moxifloxacin distribution in the interstitial space of infected decubitus ulcer tissue of patients with spinal cord injury measured by in vivo microdialysis. Scandinavian journal of infectious diseases 20060101
In vitro susceptibilities of Brucella melitensis isolates to eleven antibiotics. Annals of clinical microbiology and antimicrobials 20060101
Integrating iquix, vigamox, and zymar in the management of ocular infectious disease. International ophthalmology clinics 20060101
Evidence-based review of moxifloxacin. International ophthalmology clinics 20060101
Fluoroquinolone-associated anaphylaxis in spontaneous adverse drug reaction reports in Germany: differences in reporting rates between individual fluoroquinolones and occurrence after first-ever use. Drug safety 20060101
[Antibiotherapy for acute CAP in adults]. Medecine et maladies infectieuses 20060101
[Mutation window for the 'pneumococcus-fluoroquinolone' couple. Contribution of experimental models]. Medecine et maladies infectieuses 20060101
13--Antibiotic therapy of community-acquired pneumonia (CAP) caused by atypical agents. Medecine et maladies infectieuses 20060101
Efficacy and safety of intravenous moxifloxacin versus cefoperazone with azithromycin in the treatment of community acquired pneumonia. Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20060101
Large B-cell lymphoma presenting as acute abdominal pain and spontaneous splenic rupture; a case report and review of relevant literature. World journal of emergency surgery : WJES 20060101
Efficacy and tolerability of moxifloxacin in patients with respiratory tract infections treated in general practice: Results of a post-marketing surveillance study. Clinical drug investigation 20060101
A comparative study on the cost of new antibiotics and drugs of other therapeutic categories. PloS one 20060101
Real-life treatment of acute exacerbations of chronic bronchitis with moxifloxacin or macrolides: a comparative post-marketing surveillance study in general practice. Clinical drug investigation 20060101
[Efficacy of moxifloxacin in the treatment of secondary peritonitis]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20060101
Electrocardiographic method for identifying drug-induced repolarization abnormalities associated with a reduction of the rapidly activating delayed rectifier potassium current. Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 20060101
[Moxifloxacin clinical and microbiological efficacy in therapy of infectious endocarditis]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20060101
[Study of antituberculous activity of moxifloxacin conjugate with macrophage scavenger-receptor ligand]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20060101
Tigecycline: an evidence-based review of its antibacterial activity and effectiveness in complicated skin and soft tissue and intraabdominal infections. Core evidence 20060101
Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20051215
An epidemic, toxin gene-variant strain of Clostridium difficile. The New England journal of medicine 20051208
Weekly moxifloxacin and rifapentine is more active than the denver regimen in murine tuberculosis. American journal of respiratory and critical care medicine 20051201
Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model. American journal of respiratory and critical care medicine 20051201
Successful moxifloxacin prophylaxis against experimental streptococcal aortic valve endocarditis. The Journal of antimicrobial chemotherapy 20051201
In vitro activities of 11 fluoroquinolones against 226 Campylobacter jejuni strains isolated from Finnish patients, with special reference to ciprofloxacin resistance. The Journal of antimicrobial chemotherapy 20051201
Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis. The Journal of antimicrobial chemotherapy 20051201
In vivo efficacy of fluoroquinolones against systemic tularaemia infection in mice. The Journal of antimicrobial chemotherapy 20051201
Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in 60Co-gamma-photon-irradiated and sham-irradiated mice. The Journal of antimicrobial chemotherapy 20051201
Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan. International journal of antimicrobial agents 20051201
Activity of five quinolones, three macrolides and telithromycin against 12 Haemophilus influenzae strains with different resistance phenotypes. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20051201
Hopkins scientist tunes in to treat tuberculosis. The Journal of clinical investigation 20051201
Emergence of quinolone resistance among viridans group streptococci isolated from the oropharynx of neutropenic peripheral blood stem cell transplant patients receiving quinolone antimicrobial prophylaxis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20051201
In vitro antimicrobial effect of cefazolin and cefotaxime combined with minocycline against Vibrio cholerae non-O1 non-O139. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 20051201
Fourth-generation fluoroquinolones in the treatment of mycobacterial infectious keratitis after laser-assisted in situ keratomileusis surgery. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20051201
Pharmacodynamics of moxifloxacin and levofloxacin simulating human serum and lung concentrations. Infection 20051201
The integrated use of pharmacokinetic and pharmacodynamic models for the definition of breakpoints. Infection 20051201
Effect of pH on the in vitro activity of and propensity for emergence of resistance to fluoroquinolones, macrolides, and a ketolide. Infection 20051201
Contribution of immunocompetence to the antibacterial activities of ciprofloxacin and moxifloxacin in an in vitro pharmacodynamic model. Infection 20051201
Moxifloxacin and ciprofloxacin protect human respiratory epithelial cells against Streptococcus pneumoniae, Staphylococcus aureus, Pseudomonas aeruginosa, and Haemophilus influenzae in vitro. Infection 20051201
Immunomodulatory activities of fluoroquinolones. Infection 20051201
Intravitreal clearance of moxifloxacin. Transactions of the American Ophthalmological Society 20051201
QT prolongation and proarrhythmia by moxifloxacin: concordance of preclinical models in relation to clinical outcome. British journal of pharmacology 20051101
Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients. The Journal of antimicrobial chemotherapy 20051101
Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients. Ophthalmology 20051101
An ophthalmologist's guide to understanding antibiotic susceptibility and minimum inhibitory concentration data. Ophthalmology 20051101
Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients. The Journal of antimicrobial chemotherapy 20051101
Glucose homeostasis abnormalities associated with use of gatifloxacin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20051101
Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa. International journal of antimicrobial agents 20051101
Absorption of topical moxifloxacin ophthalmic solution into human aqueous humor. Cornea 20051101
Sequential intravenous/oral moxifloxacin versus intravenous piperacillin-tazobactam followed by oral amoxicillin-clavulanate for the treatment of complicated skin and skin structure infection. International journal of antimicrobial agents 20051101
Efficacy of moxifloxacin for treatment of penicillin-, macrolide- and multidrug-resistant Streptococcus pneumoniae in community-acquired pneumonia. International journal of clinical practice 20051101
Changing patterns of fluoroquinolone resistance among Bacteroides fragilis group organisms over a 6-year period (1997-2002). Diagnostic microbiology and infectious disease 20051101
Ophthalmic infections and their anti-infective challenges. Survey of ophthalmology 20051101
In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone. Survey of ophthalmology 20051101
Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans. Survey of ophthalmology 20051101
Safety of moxifloxacin as shown in animal and in vitro studies. Survey of ophthalmology 20051101
Clinical safety of moxifloxacin ophthalmic solution 0.5% (VIGAMOX) in pediatric and nonpediatric patients with bacterial conjunctivitis. Survey of ophthalmology 20051101
Future of ophthalmic anti-infective therapy and the role of moxifloxacin ophthalmic solution 0.5% (VIGAMOX). Survey of ophthalmology 20051101
Overview of the potency of moxifloxacin ophthalmic solution 0.5% (VIGAMOX). Survey of ophthalmology 20051101
Q Fever pneumonia: are clarithromycin and moxifloxacin alternative treatments only? The American journal of tropical medicine and hygiene 20051101
A randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community-acquired pneumonia. Chest 20051101
Effect of gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions on human corneal epithelium following 2 dosing regimens. Journal of cataract and refractive surgery 20051101
Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device. Journal of cataract and refractive surgery 20051101
Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20051015
The effect of the fourth-generation fluoroquinolones on corneal reepithelialization after penetrating keratoplasty. Cornea 20051001
How effective is moxifloxacin for the first-line treatment of patients with Helicobacter pylori infection? Nature clinical practice. Gastroenterology & hepatology 20051001
Cost analyses of community-acquired pneumonia from the hospital perspective. Chest 20051001
Nocardia keratitis after laser in situ keratomileusis: clinicopathologic correlation. Journal of cataract and refractive surgery 20051001
[The basic and clinical studies of moxifloxacin: the profile as respiratory quinolones]. The Japanese journal of antibiotics 20051001
In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals. The Medical journal of Malaysia 20051001
Differential effects of three antibiotics on T helper cell cytokine expression. The Journal of antimicrobial chemotherapy 20050901
Moxifloxacin is efficacious for treatment of community-acquired lung abscesses in adults. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050901
Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model. American journal of ophthalmology 20050901
QT and QTc interval with standard and supratherapeutic doses of darifenacin, a muscarinic M3 selective receptor antagonist for the treatment of overactive bladder. Journal of clinical pharmacology 20050901
The selection of resistance to and the mutagenicity of different fluoroquinolones in Staphylococcus aureus and Streptococcus pneumoniae. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20050901
Nasopharyngeal carriage, antimicrobial susceptibility, serotype distribution and clonal relatedness of Streptococcus pneumoniae isolates in healthy children in Malatya, Turkey. International journal of antimicrobial agents 20050901
Empirical antimicrobial therapy for odontogenic infections. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20050901
Biliary secretion of moxifloxacin in obstructive cholangitis and the non-obstructed biliary tract. Alimentary pharmacology & therapeutics 20050901
Evaluation of moxifloxacin, ciprofloxacin, gatifloxacin, ofloxacin, and levofloxacin concentrations in human conjunctival tissue. Archives of ophthalmology (Chicago, Ill. : 1960) 20050901
[Treatment of Helicobacter pylori infection]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20050901
In-use study of potential bacterial contamination of ophthalmic moxifloxacin. Journal of cataract and refractive surgery 20050901
Hospital-level rates of fluoroquinolone use and the risk of hospital-acquired infection with ciprofloxacin-nonsusceptible Pseudomonas aeruginosa. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050815
A chiral benzoquinolizine-2-carboxylic acid arginine salt active against vancomycin-resistant Staphylococcus aureus. Journal of medicinal chemistry 20050811
Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. Respiratory medicine 20050801
Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates. The Journal of antimicrobial chemotherapy 20050801
Telavancin: in vitro activity against staphylococci in a biofilm model. The Journal of antimicrobial chemotherapy 20050801
Clearance of moxifloxacin during continuous haemofiltration (CVVHF) in vitro. The Journal of antimicrobial chemotherapy 20050801
Activity of moxifloxacin against Bacteroides fragilis and Escherichia coli in an in vitro pharmacokinetic/pharmacodynamic model employing pure and mixed cultures. Journal of medical microbiology 20050801
In vitro activity of fluoroquinolones against Mycobacterium abscessus and Mycobacterium chelonae causing infectious keratitis after LASIK in Brazil. Cornea 20050801
Pharmacokinetic-pharmacodynamic integration of moxifloxacin in rabbits after intravenous, intramuscular and oral administration. Journal of veterinary pharmacology and therapeutics 20050801
Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use. Emerging infectious diseases 20050801
Vancomycin-tolerance among clinical isolates of Streptococcus pneumoniae in Mississippi during 1999-2001. The American journal of the medical sciences 20050801
Influence of human ascitic fluid on the in vitro antibacterial activity of moxifloxacin. Journal of chemotherapy (Florence, Italy) 20050801
Telithromycin: the first ketolide antimicrobial. Clinical therapeutics 20050801
Acute interstitial nephritis associated with moxifloxacin use. Clinical therapeutics 20050801
Pharmacoeconomic considerations associated with the use of intravenous-to-oral moxifloxacin for community-acquired pneumonia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050715
Challenges in the management of community-acquired pneumonia: the role of quinolones and moxifloxacin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050715
Current management of acute bacterial rhinosinusitis and the role of moxifloxacin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050715
Moxifloxacin for the treatment of acute exacerbations of chronic obstructive pulmonary disease. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050715
Susceptibility of European beta-lactamase-positive and -negative Haemophilus influenzae isolates from the periods 1997/1998 and 2002/2003. The Journal of antimicrobial chemotherapy 20050701
Pharmacodynamic studies of moxifloxacin and erythromycin against intracellular Legionella pneumophila in an in vitro kinetic model. The Journal of antimicrobial chemotherapy 20050701
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure. Journal of pharmaceutical sciences 20050701
Antibacterial activities of gemifloxacin, levofloxacin, gatifloxacin, moxifloxacin and erythromycin against intracellular Legionella pneumophila and Legionella micdadei in human monocytes. The Journal of antimicrobial chemotherapy 20050701
The effect of fourth-generation fluoroquinolones gatifloxacin and moxifloxacin on epithelial healing following photorefractive keratectomy. American journal of ophthalmology 20050701
Treating respiratory tract infections in ambulatory care in Belgium: fluoroquinolone consumption and resistance development. International journal of antimicrobial agents 20050701
In vitro activity of telithromycin against respiratory tract pathogens in comparison with other antimicrobial agents. Chemotherapy 20050701
Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting. The American journal of medicine 20050701
Antimicrobial treatment of lower respiratory tract infections in the hospital setting. The American journal of medicine 20050701
Treatment of rhinosinusitis in the outpatient setting. The American journal of medicine 20050701
Facial bite wounds: management update. International journal of oral and maxillofacial surgery 20050701
Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin. Cancer 20050615
Prophylactic use of moxifloxacin in patients receiving bone marrow transplants was not associated with increased ciprofloxacin resistance in Escherichia coli and enterococci. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050615
Acyl glucuronidation of fluoroquinolone antibiotics by the UDP-glucuronosyltransferase 1A subfamily in human liver microsomes. Drug metabolism and disposition: the biological fate of chemicals 20050601
In vitro activity of linezolid, clarithromycin and moxifloxacin against clinical isolates of Mycobacterium kansasii. The Journal of antimicrobial chemotherapy 20050601
Evaluation of the in vitro activity of NVP-LMB415 against clinical anaerobic isolates with emphasis on the Bacteroides fragilis group. The Journal of antimicrobial chemotherapy 20050601
A double mutation in the gyrA gene is necessary to produce high levels of resistance to moxifloxacin in Campylobacter spp. clinical isolates. International journal of antimicrobial agents 20050601
Effects of fluoroquinolones on the migration of human phagocytes through Chlamydia pneumoniae-infected and tumor necrosis factor alpha-stimulated endothelial cells. The Journal of urology 20050601
Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003. International journal of antimicrobial agents 20050601
Enantiomeric purity assay of moxifloxacin hydrochloride by capillary electrophoresis. Journal of pharmaceutical and biomedical analysis 20050601
Antimycobacterial agents differ with respect to their bacteriostatic versus bactericidal activities in relation to time of exposure, mycobacterial growth phase, and their use in combination. Antimicrobial agents and chemotherapy 20050601
Moxifloxacin and warfarin: additional evidence for a clinically relevant interaction. Pharmacotherapy 20050601
New fluoroquinolones in lower respiratory tract infections and emerging patterns of pneumococcal resistance. Infection 20050601
Moxifloxacin monotherapy compared to amoxicillin-clavulanate plus roxithromycin for nonsevere community-acquired pneumonia in adults with risk factors. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20050601
Effects of moxifloxacin on QT interval in conscious dogs. Journal of veterinary pharmacology and therapeutics 20050601
Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae. Diagnostic microbiology and infectious disease 20050601
A comparison of therapeutic regimens containing moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% ophthalmic solution for surgical prophylaxis in patients undergoing LASIK or LASEK. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20050601
Therapeutic options for pneumococcal pneumonia in Turkey. Clinical therapeutics 20050601
[In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20050601
Trospium chloride: an update on a quaternary anticholinergic for treatment of urge urinary incontinence. Therapeutics and clinical risk management 20050601
Expert Canadian consensus suggestions on the rational, clinical use of ziprasidone in the treatment of schizophrenia and related psychotic disorders. Neuropsychiatric disease and treatment 20050601
Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection. Alimentary pharmacology & therapeutics 20050515
Vibrational spectroscopic characterization of fluoroquinolones. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20050501
Penetration of moxifloxacin into the human aqueous humour after oral administration. The British journal of ophthalmology 20050501
Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males. British journal of clinical pharmacology 20050501
Susceptibility and resistance genes to fluoroquinolones in methicillin-resistant Staphylococcus aureus isolated in 2002. International journal of antimicrobial agents 20050501
Permeability of pig urinary bladder wall: the effect of chitosan and the role of calcium. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20050501
Susceptibilities of Neisseria gonorrhoeae and Ureaplasma urealyticum isolates from male patients with urethritis to several antibiotics including telithromycin. Chemotherapy 20050501
The impact of mechanical ventilation on the moxifloxacin treatment of experimental pneumonia caused by Streptococcus pneumoniae. Critical care medicine 20050501
Clostridium clostridioforme: a mixture of three clinically important species. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20050501
Antimicrosporidial activity of (fluoro)quinolones in vitro and in vivo. Folia parasitologica 20050501
Evaluation of phototoxic and photoallergic potentials of 13 compounds by different in vitro and in vivo methods. Journal of photochemistry and photobiology. B, Biology 20050404
Bacteriostatic and bactericidal activities of eight fluoroquinolones against MexAB-OprM-overproducing clinical strains of Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy 20050401
Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages. The Journal of antimicrobial chemotherapy 20050401
Comparison of gatifloxacin, moxifloxacin and ciprofloxacin for treatment of experimental Burkholderia pseudomallei infection. The Journal of antimicrobial chemotherapy 20050401
Quinolones in 2005: an update. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20050401
Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing. International journal of antimicrobial agents 20050401
Antibiotic susceptibility of preoperative normal conjunctival bacteria. American journal of ophthalmology 20050401
Antimicrobial-resistant invasive Escherichia coli, Spain. Emerging infectious diseases 20050401
What's new in antibiotics? Dermatologic clinics 20050401
Individual QT-R-R relationship: average stability over time does not rule out an individual residual variability: implication for the assessment of drug effect on the QT interval. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20050401
Infected cat-bite wound treated successfully with moxifloxacin after failure of parenteral cefuroxime and ciprofloxacin. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20050401
Clinical assessment of drug-induced QT prolongation in association with heart rate changes. Clinical pharmacology and therapeutics 20050401
In vitro selection of resistance to clarithromycin in Streptococcus pneumoniae clinical isolates. Journal of chemotherapy (Florence, Italy) 20050401
In vitro activity of fluoroquinolones against Mycobacterium tuberculosis. Journal of chemotherapy (Florence, Italy) 20050401
Microbiology and antimicrobial management of sinusitis. The Journal of laryngology and otology 20050401
[Sensitivity of clinical strains of Neisseria gonorrhoeae circulating in Yekaterinburg and the Sverdlovsk region]. Klinicheskaia laboratornaia diagnostika 20050401
Moxifloxacin inhibits cytokine-induced MAP kinase and NF-kappaB activation as well as nitric oxide synthesis in a human respiratory epithelial cell line. The Journal of antimicrobial chemotherapy 20050301
Treatment of Staphylococcus epidermidis endophthalmitis with intravitreal moxifloxacin in a rabbit model. The Tohoku journal of experimental medicine 20050301
Comparative efficacy of topical moxifloxacin versus ciprofloxacin and vancomycin in the treatment of P. aeruginosa and ciprofloxacin-resistant MRSA keratitis in rabbits. Cornea 20050301
Usefulness of various antibiotics against Mycobacterium avium-intracellulare, measured by their mutant prevention concentration. International journal of antimicrobial agents 20050301
Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor. Ophthalmology 20050301
Antimicrobial drug prescribing for pneumonia in ambulatory care. Emerging infectious diseases 20050301
[Pharmacokinetic/pharmacodynamic analysis of antibiotic therapy in dentistry and stomatology]. Enfermedades infecciosas y microbiologia clinica 20050301
Nonfermentative gram-negative bacilli in cancer patients: increasing frequency of infection and antimicrobial susceptibility of clinical isolates to fluoroquinolones. Diagnostic microbiology and infectious disease 20050301
Reproducibility of gemifloxacin and comparison fluoroquinolone MIC results using Sensititre commercial dry-form panels. Diagnostic microbiology and infectious disease 20050301
[In vitro susceptibility to antibiotics and the most common Streptococcus pneumoniae serotypes: a multicenter study]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20050301
Protonation equilibrium and lipophilicity of moxifloxacin. Journal of pharmaceutical and biomedical analysis 20050223
Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001-2003 tracking resistance in the United States today surveillance studies. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050215
In vitro comparison of agar and microbroth dilution methods for determination of MICs for Mycoplasma hominis. Journal of microbiological methods 20050201
Moxifloxacin-warfarin interaction: a series of five case reports. The Annals of pharmacotherapy 20050201
Antimicrobial susceptibility of community-acquired respiratory tract pathogens in the UK during 2002/3 determined locally and centrally by BSAC methods. The Journal of antimicrobial chemotherapy 20050201
In vivo activity of gemifloxacin, moxifloxacin and levofloxacin against pneumococci with gyrA and parC point mutations in a sepsis mouse model measured with the all or nothing mortality end-point. International journal of antimicrobial agents 20050201
A case of melioidosis presenting as migrating pulmonary infiltration: the first case in Korea. Journal of Korean medical science 20050201
[Trial of moxifloxacin-containing triple therapy after initial and second-line treatment failures for Helicobacter pylori infection]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20050201
Moxifloxacin in respiratory tract infections. Expert opinion on pharmacotherapy 20050201
Antimicrobial resistance of nosocomial strains of Staphylococcus aureus in Russia: results of a prospective study. Journal of chemotherapy (Florence, Italy) 20050201
[New fluoroquinolones: levofloxacin, moxifloxacin and gatifloxacin]. Nederlands tijdschrift voor geneeskunde 20050108
Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics. The Journal of antimicrobial chemotherapy 20050101
Comparison of corneal surface effects of gatifloxacin and moxifloxacin using intensive and prolonged dosing protocols. Cornea 20050101
Enterococci spp. isolated from Cuba: species frequency of occurrence and antimicrobial susceptibility profile. Diagnostic microbiology and infectious disease 20050101
Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous. Archives of ophthalmology (Chicago, Ill. : 1960) 20050101
Activity of the new quinolone WCK 771 against pneumococci. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20050101
Steroid-refractory ulcerative colitis treated with corticosteroids, metronidazole and vancomycin: a case report. BMC gastroenterology 20050101
[Tendinitis in the Achilles in the elderly]. Atencion primaria 20050101
Demand for prophylaxis after bioterrorism-related anthrax cases, 2001. Emerging infectious diseases 20050101
Kytococcus schroeteri endocarditis. Emerging infectious diseases 20050101
Tolerability of moxifloxacin in patients with antibiotic hypersensitivity. Allergologia et immunopathologia 20050101
Retrospective analysis of the safety profile of oral moxifloxacin in elderly patients enrolled in clinical trials. Drug safety 20050101
Ocular penetration of moxifloxacin 0.5% and gatifloxacin 0.3% ophthalmic solutions into the aqueous humor following topical administration prior to routine cataract surgery. Current medical research and opinion 20050101
[Comparative efficiency of treatment with moxyfloxacin and lomefloxacin for generalized murine tuberculosis caused by drug-resistant Mycobacterium strains]. Problemy tuberkuleza i boleznei legkikh 20050101
Guide to selection of fluoroquinolones in patients with lower respiratory tract infections. Drugs 20050101
Acquisition of rifabutin resistance by a rifampicin resistant mutant of Mycobacterium tuberculosis involves an unusual spectrum of mutations and elevated frequency. Annals of clinical microbiology and antimicrobials 20050101
Campylobacter jejuni pancolitis mimicking idiopathic ulcerative colitis. Heart & lung : the journal of critical care 20050101
Immediate hypersensitivity to quinolones: moxifloxacin cross-reactivity. Journal of investigational allergology & clinical immunology 20050101
Effects of enteral feeding on the oral bioavailability of moxifloxacin in healthy volunteers. Clinical pharmacokinetics 20050101
In vitro activities of 11 fluoroquinolones against 816 non-typhoidal strains of Salmonella enterica isolated from Finnish patients with special reference to reduced ciprofloxacin susceptibility. Annals of clinical microbiology and antimicrobials 20050101
Evaluation of antibacterial in vitro activity of moxifloxacin and its effects on pulmonary clearance of Klebsiella pneumoniae in an animal experimental model. Arzneimittel-Forschung 20050101
Biological assay and liquid chromatographic method for analysis of moxifloxacin in tablets. Journal of AOAC International 20050101
Moxifloxacin in experimental Streptococcus pneumoniae cerebritis and meningitis. Neurocritical care 20050101
[Treatment of community-acquired pneumonia in adults]. Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia 20050101
[Flouroquinolone activity in clinical isolates of Streptococcus pneumoniae with different susceptibility to penicilline: an epidemiological study in five cities of Mexico]. Gaceta medica de Mexico 20050101
Cure of Q fever pneumonia with moxifloxacin: case report. Scandinavian journal of infectious diseases 20050101
[Efficacy of moxifloxacin in the treatment of respiratory tract infections: the Croatian post-marketing study]. Lijecnicki vjesnik 20050101
In vitro activities of various antimicrobials against Brucella melitensis strains in the Aegean region in Turkey. Medical principles and practice : international journal of the Kuwait University, Health Science Centre 20050101
[A comparative analysis of antibiotics efficacy in acute ENT infections]. Vestnik otorinolaringologii 20050101
High carriage rate of high-level penicillin-resistant Streptococcus pneumoniae in a Taiwan kindergarten associated with a case of pneumococcal meningitis. BMC infectious diseases 20050101
Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia. BMC infectious diseases 20050101
Catheter-associated bacteremia by Mycobacterium senegalense in Korea. BMC infectious diseases 20050101
[Moxifloxacin, a novel extended spectrum fluoroquinolone in the treatment of severe infectious inflammatory diseases]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20050101
High prevalence of penicillin resistance and comparative in vitro activity of various antibiotics in clinical isolates of streptococcus pneumoniae isolated in the Province of Hainaut during winter 2004. Acta clinica Belgica 20050101
[Characteristic of clinical fluoroquinolone resistant isolates E. faecalis]. Medycyna doswiadczalna i mikrobiologia 20050101
Fluoroquinolone therapy for uncomplicated skin and skin structure infections : a retrospective database comparison of treatment duration, failures and charges. Clinical drug investigation 20050101
In vivo comparative pharmacokinetics and pharmacodynamics of moxifloxacin and levofloxacin in human neutrophils. Clinical drug investigation 20050101
Efficacy and tolerability of sequential intravenous/oral moxifloxacin therapy in pneumonia: results of the first post-marketing surveillance study with intravenous moxifloxacin in hospital practice. Clinical drug investigation 20050101
Place of newer quinolones and rifampicin in the treatment of Gram-positive bone and joint infections. The Journal of antimicrobial chemotherapy 20041201
Efficacy of the latest fluoroquinolones against experimental Yersinia pestis. International journal of antimicrobial agents 20041201
Moxifloxacin-associated drug hypersensitivity syndrome with toxic epidermal necrolysis and fulminant hepatic failure. Archives of dermatology 20041201
Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration. Transactions of the American Ophthalmological Society 20041201
[Mutant prevention concentrations of fluoroquinolones for Staphylococcus aureus]. Zhonghua yi xue za zhi 20041117
Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis. American journal of respiratory and critical care medicine 20041115
[Antibiotic therapy of respiratory tract infections. Rapid and good effectiveness]. MMW Fortschritte der Medizin 20041111
[Moxifloxacin in general practice. Economical concept]. MMW Fortschritte der Medizin 20041111
Impact of plasma protein binding on antimicrobial activity using time-killing curves. The Journal of antimicrobial chemotherapy 20041101
Resolution of symptoms in patients with community-acquired pneumonia treated on an ambulatory basis. The Journal of infection 20041101
Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling. The Journal of infectious diseases 20041101
Antimicrobial susceptibility of Enterococcus faecalis isolated from canals of root filled teeth with periapical lesions. International endodontic journal 20041101
Safety and efficacy of sequential i.v. to p.o. moxifloxacin versus conventional combination therapies for the treatment of community-acquired pneumonia in patients requiring initial i.v. therapy. The Journal of emergency medicine 20041101
Action of fluoroquinolones and Linezolid on logarithmic- and stationary-phase culture of Mycobacterium tuberculosis. Chemotherapy 20041101
A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability. Current medical research and opinion 20041101
MOSAIC acronym. Chest 20041101
[Role of moxifloxacin in the treatment of community-acquired pneumonia]. Orvosi hetilap 20041031
[After stroke threatens pneumonia. Antibiotics to be given prophylactically?]. MMW Fortschritte der Medizin 20041028
[New fluoroquinolones: levofloxacin, moxifloxacin and gatifloxacin]. Nederlands tijdschrift voor geneeskunde 20041023
Synthesis and antibacterial activity of novel 6-fluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-4-oxoquinoline-3-carboxylic acids bearing cyclopropane-fused 2-amino-8-azabicyclo[4.3.0]nonan-8-yl substituents at the C-7 position. Bioorganic & medicinal chemistry letters 20041018
Simultaneous determination of levofloxacin, gatifloxacin and moxifloxacin in serum by liquid chromatography with column switching. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20041015
Effect of low-level resistance on subsequent enrichment of fluoroquinolone-resistant Streptococcus pneumoniae in rabbits. The Journal of infectious diseases 20041015
In vitro activity of moxifloxacin compared to other antimicrobials against streptococci isolated from iatrogenic oral bacteremia in Spain. Oral microbiology and immunology 20041001
Pharmacokinetics of moxifloxacin in patients undergoing continuous venovenous haemodiafiltration. The Journal of antimicrobial chemotherapy 20041001
Bactericidal activity of moxifloxacin against multidrug-resistant Streptoccocus pneumoniae at clinically achievable serum and epithelial lining fluid concentrations compared with three other antimicrobials. International journal of antimicrobial agents 20041001
Comparative penetration of moxifloxacin and gatifloxacin in rabbit aqueous humor after topical dosing. Journal of cataract and refractive surgery 20041001
The effect of cataract surgery on ocular levels of topical moxifloxacin. American journal of ophthalmology 20041001
Fluoroquinolone resistance in penicillin-resistant Streptococcus pneumoniae clones, Spain. Emerging infectious diseases 20041001
Efficacy of antibiotics against periodontopathogenic bacteria within epithelial cells: an in vitro study. Journal of periodontology 20041001
Economic evaluation of the antibiotic treatment of exacerbations of chronic bronchitis and COPD in primary care. International journal of clinical practice 20041001
Efficacy and safety of sequential moxifloxacin for treatment of community-acquired pneumonia associated with atypical pathogens. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20041001
In vitro activity of moxifloxacin against community respiratory pathogens in Qatar. International journal of antimicrobial agents 20040901
SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease. Antimicrobial agents and chemotherapy 20040901
Penetration of newer quinolones in the empyema fluid. The European respiratory journal 20040901
What is a MOSAIC study? Chest 20040901
Efficacy and safety of oral telithromycin once daily for 5 days versus moxifloxacin once daily for 10 days in the treatment of acute bacterial rhinosinusitis. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20040901
Selection of Bacillus anthracis isolates resistant to antibiotics. The Journal of antimicrobial chemotherapy 20040801
In vitro antibacterial activity of fluoroquinolones against Porphyromonas gingivalis strains. The Journal of antimicrobial chemotherapy 20040801
Fourth-generation fluoroquinolones: new topical agents in the war on ocular bacterial infections. Current opinion in ophthalmology 20040801
In vitro activities of mutant prevention concentration-targeted concentrations of fluoroquinolones against Staphylococcus aureus in a pharmacodynamic model. International journal of antimicrobial agents 20040801
Comparison of minimal inhibitory and mutant prevention drug concentrations of 4 fluoroquinolones against clinical isolates of methicillin-susceptible and -resistant Staphylococcus aureus. International journal of antimicrobial agents 20040801
Urinary concentrations and bactericidal activities of newer fluoroquinolones in healthy volunteers. International journal of antimicrobial agents 20040801
In vitro activity of older and newer fluoroquinolones against efflux-mediated high-level ciprofloxacin-resistant Streptococcus pneumoniae. International journal of antimicrobial agents 20040801
A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa. American journal of ophthalmology 20040801
Moxifloxacin--a new fluoroquinolone antibacterial. Drug and therapeutics bulletin 20040801
Evaluation of moxifloxacin activity in vitro against Mycobacterium tuberculosis, including resistant and multidrug-resistant strains. Journal of chemotherapy (Florence, Italy) 20040801
Melioidosis in a traveller from Thailand: case report. Journal of chemotherapy (Florence, Italy) 20040801
Vibrio vulnificus in Taiwan. Emerging infectious diseases 20040801
Severe Chlamydia pneumoniae infection in a patient with mild neutropenia during treatment of Hodgkin's disease. Annals of hematology 20040701
Post-exposure prophylaxis of systemic anthrax in mice and treatment with fluoroquinolones. The Journal of antimicrobial chemotherapy 20040701
Inhibition of TNF-alpha production in THP-1 macrophages by glatiramer acetate does not alter their susceptibility to infection by Listeria monocytogenes and does not impair the efficacy of ampicillin or moxifloxacin against intracellular bacteria. The Journal of antimicrobial chemotherapy 20040701
Effects of a new antibacterial, telavancin, on cardiac repolarization (QTc interval duration) in healthy subjects. Journal of clinical pharmacology 20040701
Antibiotic prescribing policy and Clostridium difficile diarrhoea. QJM : monthly journal of the Association of Physicians 20040701
Invasive Streptococcus pneumoniae from Portugal: implications for vaccination and antimicrobial therapy. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20040701
Antimicrobial susceptibility of invasive isolates of Streptococcus pneumoniae in Ireland. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20040701
Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model. American journal of ophthalmology 20040701
[Acute and bilateral uveitis secondary to moxifloxacin]. Archivos de la Sociedad Espanola de Oftalmologia 20040701
Fluoroquinolone and other antimicrobial resistance in invasive pneumococci, Hong Kong, 1995-2001. Emerging infectious diseases 20040701
Safety profile of oral and intravenous moxifloxacin: cumulative data from clinical trials and postmarketing studies. Clinical therapeutics 20040701
Synthesis of new fluoroquinolones and evaluation of their in vitro activity on Toxoplasma gondii and Plasmodium spp. Bioorganic & medicinal chemistry letters 20040607
Quinolone-resistant Haemophilus influenzae in a long-term care facility: clinical and molecular epidemiology. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040601
Evaluation of vardenafil and sildenafil on cardiac repolarization. The American journal of cardiology 20040601
New real-time PCR-based method for in vitro susceptibility testing of Anaplasma phagocytophilum against antimicrobial agents. International journal of antimicrobial agents 20040601
Therapeutic efficacy of moxifloxacin, a new quinolone, in the treatment of experimental intra-abdominal abscesses induced by Bacteroides fragilis in mice. Chemotherapy 20040601
Moxifloxacin and biofilm production by coagulase-negative staphylococci. Chemotherapy 20040601
In vitro activity of ABT-492 against anaerobic bacteria. Journal of chemotherapy (Florence, Italy) 20040601
The role of PK/PD parameters to avoid selection and increase of resistance: mutant prevention concentration. Journal of chemotherapy (Florence, Italy) 20040601
Monotherapy versus dual therapy for community-acquired pneumonia in hospitalized patients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040515
Clinical experience with moxifloxacin in patients with respiratory tract infections. The Annals of pharmacotherapy 20040501
Comparative in vitro activity of telavancin (TD-6424), a rapidly bactericidal, concentration-dependent anti-infective with multiple mechanisms of action against Gram-positive bacteria. The Journal of antimicrobial chemotherapy 20040501
Moxifloxacin penetration into human gastrointestinal tissues. The Journal of antimicrobial chemotherapy 20040501
Efficacy of antibiotics to strains of periodontopathogenic bacteria within a single species biofilm - an in vitro study. Journal of clinical periodontology 20040501
Evaluation of the OSIRIS video reader as an automated measurement system for the agar disk diffusion technique. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20040501
Prevention of the selection of resistant Staphylococcus aureus by moxifloxacin plus doxycycline in an in vitro dynamic model: an additive effect of the combination. International journal of antimicrobial agents 20040501
In vitro selection of resistance in haemophilus influenzae by 4 quinolones and 5 beta-lactams. Diagnostic microbiology and infectious disease 20040501
Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients. Emerging infectious diseases 20040501
Quantitative comparison of fluoroquinolone therapies of experimental gram-negative bacterial keratitis. Current eye research 20040501
Photophysical and phototoxic properties of the antibacterial fluoroquinolones levofloxacin and moxifloxacin. Chemistry & biodiversity 20040501
In vitro post-antibiotic effect of fluoroquinolones, macrolides, beta-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis. The Journal of antimicrobial chemotherapy 20040401
Apparent failure of moxifloxacin to prevent ciprofloxacin- and levofloxacin-susceptible Pseudomonas aeruginosa bacteremia in neutropenic patients undergoing peripheral blood stem cell transplantation. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20040401
Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity. Antimicrobial agents and chemotherapy 20040401
Susceptibilities of Neisseria gonorrhoeae to fluoroquinolones and other antimicrobial agents in Hyogo and Osaka, Japan. Sexually transmitted infections 20040401
Concentrations of moxifloxacin in serum and synovial fluid, and ex vivo bactericidal activity against arthritis-causing pathogens. Diagnostic microbiology and infectious disease 20040401
Comparative in vitro activities of three new quinolones and azithromycin against aerobic pathogens causing respiratory tract and abdominal wound infections. Chemotherapy 20040401
New therapies for pneumococcal meningitis. Expert opinion on investigational drugs 20040401
Evaluation of the corneal effects of topical ophthalmic fluoroquinolones using in vivo confocal microscopy. Eye & contact lens 20040401
Ophthalmic moxifloxacin (Vigamox) and gatifloxacin (Zymar). The Medical letter on drugs and therapeutics 20040329
Structural identification and characterization of impurities in moxifloxacin. Journal of pharmaceutical and biomedical analysis 20040310
[Gigantic study planned. 100,000 patients with COPD test general practice antibiotic]. MMW Fortschritte der Medizin 20040304
Voltammetric behaviour and determination of moxifloxacin in pharmaceutical products and human plasma. Analytical and bioanalytical chemistry 20040301
Mutant prevention concentration: comparison of fluoroquinolones and linezolid with Mycobacterium tuberculosis. The Journal of antimicrobial chemotherapy 20040301
Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study. Antimicrobial agents and chemotherapy 20040301
No more equivalence trials for antibiotics in exacerbations of COPD, please. Chest 20040301
Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis. Chest 20040301
Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults. Chest 20040301
Susceptibility testing of Singapore strains of Mycoplasma hominis to tetracycline, gatifloxacin, moxifloxacin, ciprofloxacin, clindamycin, and azithromycin by the Etest method. Diagnostic microbiology and infectious disease 20040301
Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones. Survey of ophthalmology 20040301
In vivo experimental approach for the risk assessment of fluoroquinolone antibacterial agents-induced long QT syndrome. European journal of pharmacology 20040220
Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis. American journal of respiratory and critical care medicine 20040201
In vitro susceptibility of Bacillus anthracis to various antibacterial agents and their time-kill activity. The Journal of antimicrobial chemotherapy 20040201
Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coli. The Journal of antimicrobial chemotherapy 20040201
Pharmacologic considerations for cataract surgery. Current opinion in ophthalmology 20040201
Sinus tissue concentration of moxifloxacin after a single oral dose. The Annals of otology, rhinology, and laryngology 20040201
Moxifloxacin pharmacokinetics in horses and disposition into phagocytes after oral dosing. Journal of veterinary pharmacology and therapeutics 20040201
Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis. International journal of antimicrobial agents 20040201
Effect of prophylactic antibiotics on antimicrobial resistance of viridans streptococci in the normal flora of cataract surgery patients. Journal of cataract and refractive surgery 20040201
Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis and treatment. Clinical therapeutics 20040201
Efficacy and tolerability of moxifloxacin in the treatment of acute bacterial sinusitis caused by penicillin-resistant Streptococcus pneumoniae: a pooled analysis. Clinical therapeutics 20040201
Effect of moxifloxacin on bacterial pathogenicity factors in comparison with amoxicillin, clarithromycin and ceftriaxone. Journal of chemotherapy (Florence, Italy) 20040201
New agents active against Mycobacterium avium complex selected by molecular topology: a virtual screening method. The Journal of antimicrobial chemotherapy 20040101
Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke. Stroke 20040101
Pharmacokinetics of moxifloxacin are not influenced by a 7-day pretreatment with 200 mg oral itraconazole given once a day in healthy subjects. International journal of clinical pharmacology and therapeutics 20040101
New developments in antibacterial choice for lower respiratory tract infections in elderly patients. Drugs & aging 20040101
Potential role of moxifloxacin in methicillin-resistant Staphylococcus aureus (MRSA) infections. JPMA. The Journal of the Pakistan Medical Association 20040101
Ciprofloxacin-resistant Salmonella enterica Typhimurium and Choleraesuis from pigs to humans, Taiwan. Emerging infectious diseases 20040101
Quinolone safety and efficacy more important than potency. Emerging infectious diseases 20040101
Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae from Asian countries: ANSORP study. Microbial drug resistance (Larchmont, N.Y.) 20040101
Recurrent tendinitis after treatment with two different fluoroquinolones. Scandinavian journal of infectious diseases 20040101
Moxifloxacin and glucose homeostasis: a pooled-analysis of the evidence from clinical and postmarketing studies. Drug safety 20040101
Newer treatment options for skin and soft tissue infections. Drugs 20040101
Activity of telithromycin and comparators against bacterial pathogens isolated from 1,336 patients with clinically diagnosed acute sinusitis. Annals of clinical microbiology and antimicrobials 20040101
[Efficacy of moxifloxacin (Avelox) in prophylaxis of infection in patients with profound neutropenia]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20040101
Susceptibility of Mexican brucella isolates to moxifloxacin, ciprofloxacin and other antimicrobials used in the treatment of human brucellosis. Scandinavian journal of infectious diseases 20040101
Moxifloxacin: a review of its use in the management of bacterial infections. Drugs 20040101
[Dynamics of Streptococcos pneumoniae antibiotic resistance extension in Moscow in 1998-2003]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20040101
Fluoroquinolones as chemotherapeutics against mycobacterial infections. Current pharmaceutical design 20040101
Effects of macrolides and ketolides on mycobacterial infections. Current pharmaceutical design 20040101
Symptom resolution in patients with Mycoplasma pneumoniae pneumonia. Canadian respiratory journal 20040101
[Optimization of tuberculosis complex chemotherapy with the use of moxifloxacin]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20040101
Recently introduced antibiotics: a guide for the general physician. Clinical medicine (London, England) 20040101
[Comparative assessment of fluoroquinolones efficacy in the treatment of patients with infectious exacerbation of chronic obstructive bronchitis]. Likars'ka sprava 20040101
Efficacy and tolerability of moxifloxacin in patients with sinusitis treated in general practice : results of a post-marketing surveillance study. Clinical drug investigation 20040101
Once-daily moxifloxacin therapy for community-acquired pneumonia in general practice : evidence from a post-marketing surveillance study of 1467 patients. Clinical drug investigation 20040101
Daily-practice treatment of acute exacerbations of chronic bronchitis with moxifloxacin in a large cohort in Germany. Clinical drug investigation 20040101
The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis. American journal of respiratory and critical care medicine 20031201
Emergence of a fluoroquinolone-resistant strain of Streptococcus pneumoniae in England. The Journal of antimicrobial chemotherapy 20031201
Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae: data from the global PROTEKT surveillance programme. The Journal of antimicrobial chemotherapy 20031201
In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents. The Journal of antimicrobial chemotherapy 20031201
Fluoroquinolone resistance in patients with newly diagnosed tuberculosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20031201
Clinical presentation and bacteriologic analysis of infected human bites in patients presenting to emergency departments. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20031201
In vitro activities of nine peptide deformylase inhibitors and five comparator agents against respiratory and skin pathogens. International journal of antimicrobial agents 20031201
Disposition and intracellular levels of moxifloxacin in human THP-1 monocytes in unstimulated and stimulated conditions. International journal of antimicrobial agents 20031201
In vitro pharmacodynamic activity of gatifloxacin, gemifloxacin, moxifloxacin and levofloxacin against Streptococcus pneumoniae containing specific mutations in DNA gyrase and topoisomerase IV. Diagnostic microbiology and infectious disease 20031201
Factors influencing fluoroquinolone resistance. Emerging infectious diseases 20031201
Drawbacks of antibiotic susceptibility of Streptococcus pneumoniae. Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 20031201
Morphostructural damage and the inhibition of bacterial adhesiveness of Staphylococcus aureus and Moraxella catarrhalis induced by moxifloxacin. Journal of chemotherapy (Florence, Italy) 20031201
Diffusion of oral and intravenous 400 mg once-daily moxifloxacin into lung tissue at pharmacokinetic steady-state. Journal of chemotherapy (Florence, Italy) 20031201
Serum bactericidal activity of the methoxyfluoroquinolones gatifloxacin and moxifloxacin against clinical isolates of Staphylococcus species: are the susceptibility breakpoints too high? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20031115
Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens. The Journal of antimicrobial chemotherapy 20031101
Gatifloxacin, gemifloxacin, and moxifloxacin: the role of 3 newer fluoroquinolones. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20031101
In vitro activity of telithromycin compared with macrolides and fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. International journal of antimicrobial agents 20031101
Moxifloxacin-induced Clostridium difficile-associated diarrhea. Pharmacotherapy 20031101
Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerging infectious diseases 20031101
Invasive Mycobacterium marinum infections. Emerging infectious diseases 20031101
Effects of moxifloxacin in zymogen A or S. aureus stimulated human THP-1 monocytes on the inflammatory process and the spread of infection. Life sciences 20031010
[Acute exacerbated chronic bronchitis. Antibiotics in comparison]. MMW Fortschritte der Medizin 20031002
Frequencies and mechanisms of resistance to moxifloxacin in nosocomial isolates of Acinetobacter baumannii. The Journal of antimicrobial chemotherapy 20031001
Accumulation of garenoxacin by Bacteroides fragilis compared with that of five fluoroquinolones. The Journal of antimicrobial chemotherapy 20031001
Emergence of resistant Streptococcus pneumoniae in an in vitro dynamic model that simulates moxifloxacin concentrations inside and outside the mutant selection window: related changes in susceptibility, resistance frequency and bacterial killing. The Journal of antimicrobial chemotherapy 20031001
Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from normal flora. The Journal of antimicrobial chemotherapy 20031001
Fluoroquinolone-containing third-line regimen against Mycobacterium tuberculosis in vivo. Antimicrobial agents and chemotherapy 20031001
Penicillin enhances the toll-like receptor 2-mediated proinflammatory activity of Streptococcus pneumoniae. The Journal of infectious diseases 20031001
In vitro antimicrobial activity of moxifloxacin compared to other quinolones against recent clinical bacterial isolates from hospitalized and community-based cancer patients. Diagnostic microbiology and infectious disease 20031001
Population pharmacokinetics of moxifloxacin in plasma and bronchial secretions in patients with severe bronchopneumonia. Clinical pharmacology and therapeutics 20031001
Sequential IV/PO moxifloxacin treatment of patients with severe community-acquired pneumonia. Respiratory medicine 20031001
In vitro activity of ertapenem against anaerobes isolated from the respiratory tract. Pathologie-biologie 20031001
In vitro antibacterial activity of moxifloxacin against hospital isolates: a multicentre study. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20031001
Moxifloxacin (Avelox): a novel fluoroquinolone with a broad spectrum of activity. Expert review of anti-infective therapy 20031001
Advances in the management of Chlamydia pneumoniae infections. Expert review of anti-infective therapy 20031001
Prulifloxacin: in vitro (HERG current) and in vivo (conscious dog) assessment of cardiac risk. European journal of pharmacology 20030905
Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 250 invasive Streptococcus pneumoniae isolates from France. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20030901
Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates. American journal of ophthalmology 20030901
[A comparison of moxifloxacin and amoxicillin in the treatment of community-acquired pneumonia in Latin America: results of a multicenter clinical trial]. Archivos de bronconeumologia 20030901
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods. Bioorganic & medicinal chemistry letters 20030818
Cross-resistance, relatedness and allele analysis of fluoroquinolone-resistant US clinical isolates of Streptococcus pneumoniae (1998-2000). The Journal of antimicrobial chemotherapy 20030801
Emergence of fluoroquinolone resistance among Bacteroides species. The Journal of antimicrobial chemotherapy 20030801
Treatment of bacterial skin and skin structure infections. Expert opinion on pharmacotherapy 20030801
Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in mice. Antimicrobial agents and chemotherapy 20030801
An economic evaluation of sequential i.v./po moxifloxacin therapy compared to i.v./po co-amoxiclav with or without clarithromycin in the treatment of community-acquired pneumonia. Chest 20030801
In vitro susceptibility of 4903 bacterial isolates to gemifloxacin--an advanced fluoroquinolone. International journal of antimicrobial agents 20030801
Therapeutic efficacy of moxifloxacin in a murine model of severe systemic mixed infection with Escherichia coli and Bacteroides fragilis. Anaerobe 20030801
Intra-hospital dissemination of quinupristin/dalfopristin- and vancomycin-resistant Enterococcus faecium in a paediatric ward of a German hospital. The Journal of antimicrobial chemotherapy 20030701
Effect of chloramphenicol, erythromycin, moxifloxacin, penicillin and tetracycline concentration on the recovery of resistant mutants of Mycobacterium smegmatis and Staphylococcus aureus. The Journal of antimicrobial chemotherapy 20030701
In vitro activity of gemifloxacin against clinical isolates of Neisseria gonorrhoeae with and without mutations in the gyrA gene. International journal of antimicrobial agents 20030701
A novel method of estimating cost of therapy by using patient population characteristics: analysis of fluoroquinolones in various populations with different distributions of renal function. Pharmacotherapy 20030701
The penetration of moxifloxacin into the pancreas of male rats in experimental acute necrotizing pancreatitis. Chemotherapy 20030701
Comparative in vitro activity of three fluoroquinolones against clinical isolates by E test. Chemotherapy 20030701
Antimicrobial susceptibility breakpoints and first-step parC mutations in Streptococcus pneumoniae: redefining fluoroquinolone resistance. Emerging infectious diseases 20030701
In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000-2001. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20030701
Proceedings of the 99th meeting of the Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee. May 29th and 30th, 2003. Circulation 20030617
Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease. The Journal of infectious diseases 20030615
Selection of moxifloxacin-resistant Staphylococcus aureus compared with five other fluoroquinolones. The Journal of antimicrobial chemotherapy 20030601
Immunomodulatory effects of quinolones. The Lancet. Infectious diseases 20030601
Inhibitory and bactericidal activities of gemifloxacin and other antimicrobials against Mycoplasma pneumoniae. International journal of antimicrobial agents 20030601
In vitro activity of garenoxacin against recent clinical isolates of Chlamydia pneumoniae. International journal of antimicrobial agents 20030601
In vitro activity of new fluoroquinolones and linezolid against non-tuberculous mycobacteria. International journal of antimicrobial agents 20030601
Re-evaluation of quality control guidelines for gatifloxacin and garenoxacin (BMS284756) when susceptibility testing Haemophilus influenzae and Streptococcus pneumoniae. Diagnostic microbiology and infectious disease 20030601
New drugs and dosage forms. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20030601
Costs of broad-spectrum antibiotic use for acute sinusitis, chronic bronchitis, and pneumonia in a managed care population. Managed care interface 20030601
Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20030601
Antecedent use of fluoroquinolones is associated with resistance to moxifloxacin in Clostridium difficile. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20030601
Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy. Journal of chemotherapy (Florence, Italy) 20030601
[Susceptibility of Campylobacter jejuni clinical isolates from children to eight antibiotics]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20030601
Development of the quinolones. The Journal of antimicrobial chemotherapy 20030501
Maximizing efficacy and reducing the emergence of resistance. The Journal of antimicrobial chemotherapy 20030501
Comparison of the bactericidal activity of moxifloxacin and levofloxacin against Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli and Klebsiella pneumoniae. Chemotherapy 20030501
In vitro synergy studies using aztreonam and fluoroquinolone combinations against six species of Gram-negative bacilli. Chemotherapy 20030501
National surveillance programme on susceptibility patterns of respiratory pathogens in South Africa: moxifloxacin compared with eight other antimicrobial agents. Journal of clinical pathology 20030501
Five-year analysis of Haemophilus influenzae isolates with reduced susceptibility to fluoroquinolones: prevalence results from the SENTRY antimicrobial surveillance program. Diagnostic microbiology and infectious disease 20030501
Influence of patient age on the susceptibility patterns of Streptococcus pneumoniae isolates in North America (2000-2001): report from the SENTRY Antimicrobial Surveillance Program. Diagnostic microbiology and infectious disease 20030501
[Unusual gram positive rods, causing pneumonia]. Pneumologie (Stuttgart, Germany) 20030501
[Playing it safe in bronchopulmonary infections]. MMW Fortschritte der Medizin 20030501
Development of resistance in Pseudomonas aeruginosa obtained from patients with cystic fibrosis at different times. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20030501
Antibiotic susceptibility and serotypes of Streptococcus pneumoniae isolates from Hungary. The Journal of antimicrobial chemotherapy 20030401
Activity of beta-lactams (ampicillin, meropenem), gentamicin, azithromycin and moxifloxacin against intracellular Listeria monocytogenes in a 24 h THP-1 human macrophage model. The Journal of antimicrobial chemotherapy 20030401
AUC(0-t)/MIC is a continuous index of fluoroquinolone exposure and predictive of antibacterial response for Streptococcus pneumoniae in an in vitro infection model. The Journal of antimicrobial chemotherapy 20030401
Synergic activity of fluoroquinolones and linezolid against Mycobacterium tuberculosis. International journal of antimicrobial agents 20030401
In vitro antibacterial activity and pharmacodynamics of new quinolones. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20030401
Effects of three fluoroquinolones on QT interval in healthy adults after single doses. Clinical pharmacology and therapeutics 20030401
Antimicrobial susceptibility of community-acquired respiratory tract pathogens in North America in 1999-2000: findings of the PROTEKT surveillance study. Diagnostic microbiology and infectious disease 20030401
Comparative activity of garenoxacin (BMS 284756), a novel desfluoroquinolone, tested against 8,331 isolates from community-acquired respiratory tract infections: North American results from the SENTRY Antimicrobial Surveillance Program (1999-2001). Diagnostic microbiology and infectious disease 20030401
Comparative bactericidal activity of fluoroquinolones against clinical isolates resistant to fluoroquinolones. Journal of chemotherapy (Florence, Italy) 20030401
Synthesis and structure-activity relationships of 5-amino-6-fluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-8-methylquinolonecarboxylic acid antibacterials having fluorinated 7-[(3R)-3-(1-aminocyclopropan-1-yl)pyrrolidin-1-yl] substituents. Journal of medicinal chemistry 20030313
Prevalence and association of macrolide-lincosamide-streptogramin B (MLS(B)) resistance with resistance to moxifloxacin in Clostridium difficile. The Journal of antimicrobial chemotherapy 20030301
Experimental pneumococcal pleural empyema model: the effect of moxifloxacin. The Journal of antimicrobial chemotherapy 20030301
[Pneumococcus and quinolone resistance]. Archivos de bronconeumologia 20030301
[Infection due to Mycobacterium kansasii in Elche, Spain]. Medicina clinica 20030301
Multidrug-resistant tuberculosis in pregnancy: case report and review of the literature. Chest 20030301
Moxifloxacin-induced Clostridium difficile diarrhea. The Annals of pharmacotherapy 20030301
New antibiotics for bacterial infections. Ophthalmology clinics of North America 20030301
[New antibiotics in primary care]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20030301
Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates. Pediatric pulmonology 20030201
Sterilizing activities of fluoroquinolones against rifampin-tolerant populations of Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy 20030201
Rapid in vivo screening of experimental drugs for tuberculosis using gamma interferon gene-disrupted mice. Antimicrobial agents and chemotherapy 20030201
Development and mechanism of fluoroquinolone resistance in Legionella pneumophila. The Journal of antimicrobial chemotherapy 20030201
Long-term tolerance and effectiveness of moxifloxacin therapy for tuberculosis: preliminary results. Journal of chemotherapy (Florence, Italy) 20030201
A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus. The Journal of antimicrobial chemotherapy 20030101
Activities of 13 quinolones by three susceptibility testing methods against a collection of Haemophilus influenzae isolates with different levels of susceptibility to ciprofloxacin: evidence for cross-resistance. The Journal of antimicrobial chemotherapy 20030101
Garenoxacin (BMS-284756) and moxifloxacin in experimental meningitis caused by vancomycin-tolerant pneumococci. Antimicrobial agents and chemotherapy 20030101
Activities of moxifloxacin alone and in combination with other antimicrobial agents against multidrug-resistant Mycobacterium tuberculosis infection in BALB/c mice. Antimicrobial agents and chemotherapy 20030101
Maintaining fluoroquinolone class efficacy: review of influencing factors. Emerging infectious diseases 20030101
Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three italian regions. Drug safety 20030101
Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia. The European respiratory journal 20030101
Molecular characterization of fluoroquinolone resistant Streptococcus pneumoniae clinical isolates obtained from across Canada. Diagnostic microbiology and infectious disease 20030101
Comparison of the efficacy and safety of moxifloxacin and trovafloxacin for the treatment of acute, bacterial maxillary sinusitis in adults. The Journal of laryngology and otology 20030101
Fluoroquinolones in the elderly: safety considerations. Drugs & aging 20030101
Antimicrobial resistance in recent fecal enterococci from healthy volunteers and food handlers in Spain: genes and phenotypes. Microbial drug resistance (Larchmont, N.Y.) 20030101
Antibiotic susceptibility and serotype distribution of 240 Streptococcus pneumoniae causing meningitis in Belgium 1997-2000. Acta clinica Belgica 20030101
In vitro susceptibility of six fluoroquinolones against invasive Streptococcus pneumoniae isolated from 1996 to 2001 in Taiwan. Microbial drug resistance (Larchmont, N.Y.) 20030101
Anaphylactoid reaction to ciprofloxacin. The Annals of pharmacotherapy 20030101
[Experience in using the new drug moxifloxacin (Avelox, 'Bayer', Germaniia) in urologic practice]. Urologiia (Moscow, Russia : 1999) 20030101
[New approaches to antibacterial therapy of infections in the surgical practice]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20030101
Beau's lines in a patient treated with moxifloxacin for anaerobic pulmonary infection. Scandinavian journal of infectious diseases 20030101
Effect of topical fluoroquinolones on the expression of matrix metalloproteinases in the cornea. BMC ophthalmology 20030101
Moxifloxacin in the treatment of acute maxillary sinusitis after first-line treatment failure and acute sinusitis with high risk of complications. The Journal of international medical research 20030101
Pseudomonal infections in patients with COPD: epidemiology and management. American journal of respiratory medicine : drugs, devices, and other interventions 20030101
Antibacterial activity of the fourth-generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens. Advances in therapy 20030101
Speed of recovery from acute exacerbations of chronic obstructive pulmonary disease after treatment with antimicrobials : results of a two-year study. Clinical drug investigation 20030101
Antibacterial activity of moxifloxacin against periodontal anaerobic pathogens involved in systemic infections. International journal of antimicrobial agents 20021201
In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis. International journal of antimicrobial agents 20021201
Identification and characterization of a novel efflux-related multidrug resistance phenotype in Staphylococcus aureus. The Journal of antimicrobial chemotherapy 20021201
Synergic activity of cephalosporins plus fluoroquinolones against Pseudomonas aeruginosa with resistance to one or both drugs. The Journal of antimicrobial chemotherapy 20021201
Moxifloxacin: new preparation. A me-too with more cardiac risks. Prescrire international 20021201
In vitro activity of gemifloxacin against recent clinical isolates of bacteria in Korea. Journal of Korean medical science 20021201
Efficacy and safety of short course (5-day) moxifloxacin vs 7-day ceftriaxone in the treatment of acute exacerbations of chronic bronchitis (AECB). Journal of chemotherapy (Florence, Italy) 20021201
[In vitro activity of moxifloxacin against respiratory pathogens in Latin America]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20021201
Determination of moxifloxacin in human plasma by liquid chromatography electrospray ionization tandem mass spectrometry. Journal of pharmaceutical and biomedical analysis 20021107
Examination of single and multiple mutations involved in resistance to quinolones in Staphylococcus aureus by a combination of PCR and denaturing high-performance liquid chromatography (DHPLC). The Journal of antimicrobial chemotherapy 20021101
Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and beta-lactams. International journal of antimicrobial agents 20021101
[Diagnosis and treatment of legionella pneumonia]. Pneumologie (Stuttgart, Germany) 20021101
[Respiratory tract infections. Increasingly more established antibiotics fail]. MMW Fortschritte der Medizin 20021017
Simultaneous drug allergies. Allergy 20021001
Comparison of the in vitro activities of several new fluoroquinolones against respiratory pathogens and their abilities to select fluoroquinolone resistance. The Journal of antimicrobial chemotherapy 20021001
AUC/MIC relationships to different endpoints of the antimicrobial effect: multiple-dose in vitro simulations with moxifloxacin and levofloxacin. The Journal of antimicrobial chemotherapy 20021001
Comparative in vitro activity of penicillin G, levofloxacin, moxifloxacin, telithromycin, pristinamycin, quinupristin-dalfopristin and linezolid against ofloxacin-intermediate and -resistant Streptococcus pneumoniae. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20021001
Concurrent use of selected agents with moxifloxacin: an examination of labeling compliance within 1 year of marketing. Archives of internal medicine 20020923
Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20020901
Alternative and rescue treatment regimens for Helicobacter pylori eradication. Expert opinion on pharmacotherapy 20020901
The community-acquired pneumonia symptom questionnaire: a new, patient-based outcome measure to evaluate symptoms in patients with community-acquired pneumonia. Chest 20020901
Clinical relevance of penicillin-resistant Streptococcus pneumoniae. Seminars in respiratory infections 20020901
Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin. The Journal of antimicrobial chemotherapy 20020901
In vitro activity of moxifloxacin against recent community-acquired respiratory tract pathogens isolated in France: a national survey. International journal of antimicrobial agents 20020901
Moxifloxacin activity against clinical isolates compared with the activity of ciprofloxacin. International journal of antimicrobial agents 20020901
Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan. Emerging infectious diseases 20020801
In vitro activity of linezolid, quinupristin-dalfopristin, vancomycin, teicoplanin, moxifloxacin and mupirocin against methicillin-resistant Staphylococcus aureus: comparative evaluation by the E test and a broth microdilution method. Diagnostic microbiology and infectious disease 20020801
Pharmacodynamic characterization of efflux and topoisomerase IV-mediated fluoroquinolone resistance in Streptococcus pneumoniae. The Journal of antimicrobial chemotherapy 20020801
Calculation of composite recovery time: a new pharmacodynamic parameter. The Journal of antimicrobial chemotherapy 20020801
[Prospects for development of new antituberculous drugs]. Kekkaku : [Tuberculosis] 20020801
Influence of moxifloxacin, comparator drugs and some fractions of pulmonary surfactant on adherence of some respiratory pathogens. Infection 20020801
Single and multi-step resistance selection study in Streptococcus pneumoniae comparing ceftriaxone with levofloxacin, gatifloxacin and moxifloxacin. International journal of antimicrobial agents 20020801
In vitro antimicrobial susceptibility of oral strains of Actinobacillus actinomycetemcomitans to seven antibiotics. Journal of clinical periodontology 20020801
In vitro activity of linezolid, synercid and telithromycin against genetically defined high level fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus. International journal of antimicrobial agents 20020701
Moxifloxacin-induced acute liver injury. The American journal of gastroenterology 20020701
Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval. Expert opinion on drug safety 20020701
Resistance among Streptococcus pneumoniae: Implications for drug selection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20020615
Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20020601
Bactericidal activity of increasing daily and weekly doses of moxifloxacin in murine tuberculosis. Antimicrobial agents and chemotherapy 20020601
Streptococcus pneumoniae, Brooklyn, New York: fluoroquinolone resistance at our doorstep. Emerging infectious diseases 20020601
Single- and multistep selection study of the antipneumococcal activity of BMS-284756 compared to ciprofloxacin, levofloxacin, trovafloxacin and moxifloxacin. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20020601
'There's no such thing as a free meal'. Connecticut medicine 20020601
In vitro photochemical clastogenicity of quinolone antibacterial agents studied by a chromosomal aberration test with light irradiation. Mutation research 20020527
Separation of levofloxacin, ciprofloxacin, gatifloxacin, moxifloxacin, trovafloxacin and cinoxacin by high-performance liquid chromatography: application to levofloxacin determination in human plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20020525
Effect of antipyretic agents on uptake, transport, and release of antimicrobial agents by human polymorphonuclear leukocytes. The Journal of infectious diseases 20020501
Serial passage of Chlamydia spp. in sub-inhibitory fluoroquinolone concentrations. The Journal of antimicrobial chemotherapy 20020501
Pharmacodynamic activity of fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae. The Journal of antimicrobial chemotherapy 20020501
A prospective, multicentre study of moxifloxacin concentrations in the sinus mucosa tissue of patients undergoing elective surgery of the sinus. The Journal of antimicrobial chemotherapy 20020501
Torsades de pointes associated with fluoroquinolones. Pharmacotherapy 20020501
In vitro and in vivo activities of gatifloxacin against Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy 20020401
Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. American journal of ophthalmology 20020401
Evaluation of survival and pharmacodynamic relationships for five fluoroquinolones in a neutropenic murine model of pneumococcal lung infection. Pharmacotherapy 20020401
Successful treatment of refractory disseminated Mycobacterium avium complex infection with the addition of linezolid and mefloquine. The Journal of infection 20020401
In vitro antibacterial activities of DQ-113, a potent quinolone, against clinical isolates. Antimicrobial agents and chemotherapy 20020301
Activity of clinafloxacin, compared with six other quinolones, against Acinetobacter baumannii clinical isolates. The Journal of antimicrobial chemotherapy 20020301
Pharmacokinetics of moxifloxacin, a novel 8-methoxy-quinolone, in patients with renal dysfunction. British journal of clinical pharmacology 20020301
Mono, dual and triple moxifloxacin-based therapies for Helicobacter pylori eradication. Alimentary pharmacology & therapeutics 20020301
Broth microdilution and E-test for determining fluoroquinolone activity against Streptococcus pneumoniae. The Annals of pharmacotherapy 20020301
Levofloxacin treatment failure in a patient with fluoroquinolone-resistant Streptococcus pneumoniae pneumonia. Pharmacotherapy 20020301
Avelox. Respiratory antibiotic now in i.v. form. Nursing 20020301
In-vitro activity of moxifloxacin and other fluoroquinolones against Chlamydia species. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20020301
Increased in vitro activity of the novel des-fluoro(6) quinolone BMS-284756 against genetically defined clinical isolates of Staphylococcus aureus. The Journal of antimicrobial chemotherapy 20020201
Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates. International journal of antimicrobial agents 20020201
Apparent plateau in beta-lactamase production among clinical isolates of Haemophilus influenzae and Moraxella catarrhalis in the United States: results from the LIBRA Surveillance initiative. International journal of antimicrobial agents 20020201
Quinolones: a comprehensive review. American family physician 20020201
In vitro activity of clinafloxacin in comparison with other quinolones against Stenotrophomonas maltophilia clinical isolates in the presence and absence of reserpine. Diagnostic microbiology and infectious disease 20020201
Moxifloxacin sensitivity of respiratory pathogens in the United Kingdom. Journal of chemotherapy (Florence, Italy) 20020201
Pharmacokinetic and pharmacodynamic predictors of antimicrobial efficacy: moxifloxacin and Streptococcus pneumoniae. Journal of chemotherapy (Florence, Italy) 20020201
Improving care for patients with respiratory tract infections. Journal of chemotherapy (Florence, Italy) 20020201
An updated safety profile of moxifloxacin. Journal of chemotherapy (Florence, Italy) 20020201
A critical review of the fluoroquinolones: focus on respiratory infections. Drugs 20020101
Comparative in vitro activity of gemifloxacin to other fluoroquinolones and non-quinolone agents against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in the United States in 1999-2000. International journal of antimicrobial agents 20020101
Susceptibility to moxifloxacin and other antimicrobial agents of major pathogens responsible for community acquired respiratory tract infection in Poland. International journal of antimicrobial agents 20020101
The role of fluoroquinolones in skin and skin structure infections. American journal of clinical dermatology 20020101
Influence of CO(2) incubation on quinolone activity against Streptococcus pneumoniae and Haemophilus influenzae. Diagnostic microbiology and infectious disease 20020101
Effect of moxifloxacin on secretion of cytokines by human monocytes stimulated with lipopolysaccharide. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20020101
E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20020101
Moxifloxacin in uncomplicated skin and skin structure infections. Drugs 20020101
[Perspectives of use of moxifloxacin for treatment of urogenital infections]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20020101
Anaphylactoid reaction caused by moxifloxacin. Journal of investigational allergology & clinical immunology 20020101
Clinical role of protein binding of quinolones. Clinical pharmacokinetics 20020101
Levofloxacin: an updated review of its use in the treatment of bacterial infections. Drugs 20020101
[Moxifloxacin--antimicrobial activity and pharmacokinetic properties]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20020101
[Use of avelox in treating urogenital infections in men]. Urologiia (Moscow, Russia : 1999) 20020101
Demonstration of in vitro antagonism between fusidic acid and quinolones. The Journal of international medical research 20020101
[Effectiveness of a new fluoroquinolone antibiotic avelox in the treatment of suppurative sinusitis]. Vestnik otorinolaringologii 20020101
Single- and multiple-dose pharmacokinetics of oral moxifloxacin and clarithromycin, and concentrations in serum, saliva and faeces. Scandinavian journal of infectious diseases 20020101
Simulated in vitro quinolone pharmacodynamics at clinically achievable AUC/MIC ratios: advantage of I E over other integral parameters. Chemotherapy 20020101
[Moxifloxacin: results of clinical use]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20020101
Safety of fluoroquinolones: An update. The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses 20020101
Oral fluoroquinolones in the treatment of pneumonia, bronchitis and sinusitis. The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses 20020101
Quinolones and false-positive urine screening for opiates by immunoassay technology. JAMA 20011226
Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice. Antimicrobial agents and chemotherapy 20011201
Accumulation of five fluoroquinolones by Mycobacterium tuberculosis H37Rv. The Journal of antimicrobial chemotherapy 20011201
Influence of the decrease in ciprofloxacin susceptibility and the presence of human serum on the in vitro susceptibility of Streptococcus pneumoniae to five new quinolones. The Journal of antimicrobial chemotherapy 20011201
Comparative activity of linezolid and other new agents against methicillin-resistant Staphylococcus aureus and teicoplanin-intermediate coagulase-negative staphylococci. The Journal of antimicrobial chemotherapy 20011201
Human aqueous humor levels of oral ciprofloxacin, levofloxacin, and moxifloxacin. Journal of cataract and refractive surgery 20011201
Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin. Pharmacotherapy 20011201
Activity of telithromycin against 26 quinolone-resistant pneumococci with known quinolone-resistance mechanisms. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20011201
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20011201
[In vitro activity of six fluoroquinolones and penicillin against 101 viridans group streptococci characterized by their susceptibility to erythromycin]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20011201
Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance. Antimicrobial agents and chemotherapy 20011101
Comparison of antimicrobial in vitro activities against Streptococcus pneumoniae independent of MIC susceptibility breakpoints using MIC frequency distribution curves, scattergrams and linear regression analyses. The Journal of antimicrobial chemotherapy 20011101
Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000. The Journal of antimicrobial chemotherapy 20011101
[The safety of new quinolone treatment--levoflaxacin (tavanic) and moxiflocacin (megaxin)-- in the community]. Harefuah 20011101
In vitro activity of moxifloxacin against local bacterial isolates. Annals of the Academy of Medicine, Singapore 20011101
A comparative study of the fluoroquinolone antibacterial agents on the action potential duration in guinea pig ventricular myocardia. Japanese journal of pharmacology 20011101
Moxifloxacin does increase the corrected QT interval. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20011015
Fluoroquinolone susceptibilities of efflux-mediated multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia. The Journal of antimicrobial chemotherapy 20011001
Pharmacokinetics and pharmacodynamics of fluoroquinolones. Pharmacotherapy 20011001
Clinical isolates of Streptococcus pneumoniae resistant to levofloxacin contain mutations in both gyrA and parC genes. International journal of antimicrobial agents 20011001
Multicentre study of the in vitro evaluation of moxifloxacin and other quinolones against community acquired respiratory pathogens. International journal of antimicrobial agents 20011001
[Diagnosis and therapy of abscess forming pneumonia]. Therapeutische Umschau. Revue therapeutique 20011001
Moxifloxacin (Avelox) for the treatment of bacterial skin infections. Skin therapy letter 20011001
[Third and fourth generation fluoroquinolones]. Revue medicale de Bruxelles 20011001
Pharmacokinetics and pharmacodynamics of the new fluoroquinolones: focus on respiratory infections. Current opinion in pharmacology 20011001
Assessment of chronic toxicity and carcinogenicity in an accelerated cancer bioassay in rats of moxifloxacin, a quinolone antibiotic. Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20011001
Resistance of Streptococcus pneumoniae to fluoroquinolones--United States, 1995-1999. MMWR. Morbidity and mortality weekly report 20010921
Fluoroquinolone-resistant Streptococcus pneumoniae associated with levofloxacin therapy. The Journal of infectious diseases 20010915
Single- and multi-step resistance selection study of gemifloxacin compared with trovafloxacin, ciprofloxacin, gatifloxacin and moxifloxacin in Streptococcus pneumoniae. The Journal of antimicrobial chemotherapy 20010901
Selection of high-level oxacillin resistance in heteroresistant Staphylococcus aureus by fluoroquinolone exposure. The Journal of antimicrobial chemotherapy 20010901
Comparison of the in vitro activities of BMS-284756 and four fluoroquinolones against Streptococcus pneumoniae. The Journal of antimicrobial chemotherapy 20010901
Future of the quinolones. Seminars in respiratory infections 20010901
Is more than one quinolone needed in clinical practice? The Annals of pharmacotherapy 20010901
The efficacy of moxifloxacin in acute exacerbations of chronic bronchitis: a Spanish physician and patient experience. International journal of clinical practice 20010901
In vitro activity of moxifloxacin against common clinical bacterial isolates in Taiwan. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 20010901
A nosocomial outbreak of fluoroquinolone-resistant Streptococcus pneumoniae. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010815
The inhibition and selectivity of bacterial topoisomerases by BMS-284756 and its analogues. The Journal of antimicrobial chemotherapy 20010801
In vitro activity of fosfomycin in combination with various antistaphylococcal substances. The Journal of antimicrobial chemotherapy 20010801
Treatment of Staphylococcus aureus endocarditis using moxifloxacin. International journal of medical microbiology : IJMM 20010801
Fluoroquinolone susceptibility, resistance, and pharmacodynamics versus clinical isolates of Streptococcus pneumoniae from Indiana. Diagnostic microbiology and infectious disease 20010801
[Hypertensive crisis and transitory left brunch block with QT interval prolongation associated to moxifloxacin]. Medicina clinica 20010707
Comparative in vitro study of the activity of moxifloxacin and other antibiotics against 150 strains of penicillin non-susceptible Streptococcus pneumoniae and against 110 strains of ampicillin-resistant Haemophilus influenzae isolated in 1999-2000 in Spain. The Journal of antimicrobial chemotherapy 20010701
The use of fluoroquinolones as antiinfective transition-therapy agents in community-acquired pneumonia. Pharmacotherapy 20010701
The efficacy and safety of two oral moxifloxacin regimens compared to oral clarithromycin in the treatment of community-acquired pneumonia. Respiratory medicine 20010701
Comparative in vitro bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of Legionella spp. International journal of antimicrobial agents 20010701
Ciprofloxacin- and methicillin-resistant staphylococcus aureus susceptible to moxifloxacin, levofloxacin, teicoplanin, vancomycin and linezolid. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20010701
Clinical microbiology and infectious diseases - 11th European Congress. 1-4 April 2001, Istanbul, Turkey. IDrugs : the investigational drugs journal 20010701
Pharmacodynamics of moxifloxacin, levofloxacin and sparfloxacin against Streptococcus pneumoniae. The Journal of antimicrobial chemotherapy 20010601
Antimicrobial activity of moxifloxacin, gatifloxacin and six fluoroquinolones against Streptococcus pneumoniae. The Journal of antimicrobial chemotherapy 20010601
Conventional dogma applied to quinolones? Time for a change. The Journal of antimicrobial chemotherapy 20010601
A comparison of the bactericidal activity of quinolone antibiotics in a Mycobacterium fortuitum model. Journal of medical microbiology 20010601
Microbial drug resistance and the roles of the new antibiotics. Cleveland Clinic journal of medicine 20010601
Moxifloxacin versus amoxicillin clavulanate in the treatment of acute maxillary sinusitis: a primary care experience. International journal of clinical practice 20010601
Newer drugs in leprosy. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association 20010601
The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis. Journal of cardiovascular pharmacology 20010501
Activity of moxifloxacin and other quinolones against pneumococci resistant to first-line agents, or with high-level ciprofloxacin resistance. International journal of antimicrobial agents 20010501
Immunomodulatory effects of moxifloxacin in comparison to ciprofloxacin and G-CSF in a murine model of cyclophosphamide-induced leukopenia. European journal of haematology 20010501
A whole blood bactericidal assay for tuberculosis. The Journal of infectious diseases 20010415
Determination of moxifloxacin in growth media by high-performance liquid chromatography. Journal of chromatography. B, Biomedical sciences and applications 20010415
Reassuring safety profile of moxifloxacin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010401
Activity of moxifloxacin against clinical isolates of Streptococcus pneumoniae from England and Wales. The Journal of antimicrobial chemotherapy 20010401
Activity of BMS284756 against 2,681 recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis: Report from The SENTRY Antimicrobial Surveillance Program (2000) in Europe, Canada and the United States. Diagnostic microbiology and infectious disease 20010401
Comparative in vitro and in vivo activity of the C-8 methoxy quinolone moxifloxacin and the C-8 chlorine quinolone BAY y 3118. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010315
Penicillin-resistant streptococcus pneumoniae: review of moxifloxacin activity. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010315
Comparative in vitro activity of moxifloxacin by E-test against Streptococcus pyogenes. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010315
Pharmacodynamics of moxifloxacin and levofloxacin against Staphylococcus aureus and Staphylococcus epidermidis in an in vitro pharmacodynamic model. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010315
Profile of moxifloxacin drug interactions. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010315
Evaluation of the clinical microbiology profile of moxifloxacin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010315
Clinical perspectives on new antimicrobials: focus on fluoroquinolones. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010315
Adverse reactions to fluoroquinolones. an overview on mechanistic aspects. Current medicinal chemistry 20010301
Potassium current antagonist properties and proarrhythmic consequences of quinolone antibiotics. The Journal of pharmacology and experimental therapeutics 20010301
Antimicrobial activity of fluoroquinolone photodegradation products determined by parallel-line bioassay and high performance liquid chromatography. The Journal of antimicrobial chemotherapy 20010301
Moxifloxacin: clinical efficacy and safety. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20010301
What do the new antimicrobials offer? Weighing the advantages and disadvantages compared with traditional agents. Postgraduate medicine 20010301
In vitro activity of four fluoroquinolones against Mycobacterium tuberculosis. International journal of antimicrobial agents 20010301
Bactericidal activity of moxifloxacin against Staphylococcus aureus. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20010301
Activity of oral agents against pediatric isolates of Streptococcus pneumoniae. Diagnostic microbiology and infectious disease 20010301
[One year moxifloxacin. Still effective in the respiratory tract]. MMW Fortschritte der Medizin 20010215
Efficacy of moxifloxacin, trovafloxacin, clinafloxacin and levofloxacin against intracellular Legionella pneumophila. The Journal of antimicrobial chemotherapy 20010201
Advances in DNA gyrase inhibitors. Expert opinion on investigational drugs 20010201
Workplace costs associated with acute exacerbation of chronic bronchitis: a comparison of moxifloxacin and levofloxacin. Managed care interface 20010201
Moxifloxacin: a review of the microbiological, pharmacological, clinical and safety features. Expert opinion on pharmacotherapy 20010201
Drug Points: tachycardia associated with moxifloxacin. BMJ (Clinical research ed.) 20010106
Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium. Antimicrobial agents and chemotherapy 20010101
Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG. Molecular pharmacology 20010101
In vitro development of resistance to three quinolones in Streptococcus pneumoniae. Chemotherapy 20010101
Measurement of the bactericidal activity of fluoroquinolones against Streptococcus pneumoniae using the bactericidal index method. International journal of antimicrobial agents 20010101
Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults. Chest 20010101
Activity of moxifloxacin and twelve other antimicrobial agents against 216 clinical isolates of Streptococcus pneumoniae. Chemotherapy 20010101
In vitro activity of gemifloxacin against Streptococcus pneumoniae isolates in Germany. Chemotherapy 20010101
Acute community-acquired pneumonia: current diagnosis and treatment. Journal of the South Carolina Medical Association (1975) 20010101
In vitro activity of moxifloxacin against Stenotrophomonas maltophilia blood isolates from patients with hematologic malignancies. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20010101
Bactericidal activity of moxifloxacin against pneumococci. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20010101
Pharmacokinetics, safety and tolerability of moxifloxacin, a novel 8-methoxyfluoroquinolone, after repeated oral administration. Clinical pharmacokinetics 20010101
The influence of age and gender on the pharmacokinetics of moxifloxacin. Clinical pharmacokinetics 20010101
Effect of food on the pharmacokinetics of a single oral dose of moxifloxacin 400mg in healthy male volunteers. Clinical pharmacokinetics 20010101
Effect of calcium supplements on the oral bioavailability of moxifloxacin in healthy male volunteers. Clinical pharmacokinetics 20010101
Effects of dairy products on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in healthy volunteers. Clinical pharmacokinetics 20010101
Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers. Clinical pharmacokinetics 20010101
Effects of sucralfate on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in healthy volunteers. Clinical pharmacokinetics 20010101
Effects of iron supplements on the oral bioavailability of moxifloxacin, a novel 8-methoxyfluoroquinolone, in humans. Clinical pharmacokinetics 20010101
Lack of pharmacokinetic interaction between moxifloxacin, a novel 8-methoxyfluoroquinolone, and theophylline. Clinical pharmacokinetics 20010101
Effect of probenecid on the kinetics of a single oral 400mg dose of moxifloxacin in healthy male volunteers. Clinical pharmacokinetics 20010101
Chronic obstructive pulmonary disease. The Journal of international medical research 20010101
Clinical experience in Germany of treating community-acquired respiratory infections with the new 8-methoxyfluoroquinolone, moxifloxacin. The Journal of international medical research 20010101
Moxifloxacin in acute exacerbations of chronic bronchitis: clinical evaluation and assessment by patients. The Journal of international medical research 20010101
Treatment outcomes in acute exacerbations of chronic bronchitis: comparison of macrolides and moxifloxacin from the patient perspective. The Journal of international medical research 20010101
In vitro activity of ABT-773 versus macrolides and quinolones against resistant respiratory tract pathogens. Diagnostic microbiology and infectious disease 20010101
Comparison of side effects of levofloxacin versus other fluoroquinolones. Chemotherapy 20010101
Evidence of different profiles of side effects and drug-drug interactions among the quinolones--the pharmacokinetic standpoint. Chemotherapy 20010101
In vitro activity of novel fluoroquinolones against Streptococcus pneumoniae isolated from children with acute otitis media. Chemotherapy 20010101
A multinational, multicentre, non-blinded, randomized study of moxifloxacin oral tablets compared with co-amoxiclav oral tablets in the treatment of acute exacerbation of chronic bronchitis. The Journal of international medical research 20010101
In vitro susceptibility study of BMS-284756 against Legionella species. Diagnostic microbiology and infectious disease 20010101
Streptococcus pneumoniae as an agent of nosocomial infection: treatment in the era of penicillin-resistant strains. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20010101
In vitro susceptibility and eradication of Chlamydia pneumoniae cardiovascular strains from coronary artery endothelium and smooth muscle cells. Cardiovascular drugs and therapy 20010101
Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli. Microbial drug resistance (Larchmont, N.Y.) 20010101
[Moxifloxacin--a novel antimicrobial preparation for treatment of respiratory infections]. Terapevticheskii arkhiv 20010101
[Flouroquinolones of the third and fourth generations]. Journal de pharmacie de Belgique 20010101
Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756. Antimicrobial agents and chemotherapy 20001201
Prediction of quinolone activity against Mycobacterium avium by molecular topology and virtual computational screening. Antimicrobial agents and chemotherapy 20001001
Anti-toxoplasma activities of 24 quinolones and fluoroquinolones in vitro: prediction of activity by molecular topology and virtual computational techniques. Antimicrobial agents and chemotherapy 20001001
Mutant prevention concentration as a measure of antibiotic potency: studies with clinical isolates of Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy 20000901
Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones. The Journal of antimicrobial chemotherapy 20000501
Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections. Drugs 20000101
Activity of moxifloxacin against mycobacteria. The Journal of antimicrobial chemotherapy 19990901
Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis. Antimicrobial agents and chemotherapy 19990101
In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy 19980801
In vitro activity of BAY 12-8039, a new fluoroquinolone. Antimicrobial agents and chemotherapy 19970101
Properties